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Executive summary 
 
General background 
At the end of 2006 an estimated 39.5 million people were living with HIV and high numbers of 
new HIV infections continue to occur throughout the world. Sub-Saharan Africa remains the 
hardest-hit region with 24.7 million people living with HIV. Epidemics in Eastern Europe and 
Asia continue to grow. 
 
In recent years, global action to combat the HIV pandemic has increased markedly. The world 
made an unprecedented commitment in the United Nations Millenium Declaration and during the 
UN General Assembly Special Session on HIV/AIDS in 2001 to halting and reversing the 
epidemic by 2015. At the 2005 UN World Summit and at the 2006 UN High Level Meeting on 
AIDS, world leaders committed “to pursuing all necessary efforts … towards the goal of 
universal access to comprehensive prevention programmes, treatment, care and support by 
2010.” At the same time, increased resources have been committed to fighting the epidemic. 
 
By the end of 2006, more than 2 million people living with HIV in low- and middle-income 
countries were receiving life-prolonging antiretroviral treatment (ART), compared to 1.3 million 
people at the end of 2005 and less than 500,000 people in 2003. 
 
One of the conditions to achieving the aim of universal access to treatment by 2010 for all who 
need it is an expansion of HIV testing and counseling. The World Health Organization (WHO) 
estimates that only about 10 percent of persons living with HIV/AIDS in low- and middle-
income countries know their HIV status. In many of these countries, access to HIV testing 
remains limited. Many high-income countries also estimate that a significant number of people 
living with HIV are not aware of their HIV status.  
 
The debate about HIV testing (and counseling) 
In recent years, an international consensus has emerged that access to HIV testing must be scaled 
up urgently, and that in addition to the traditional model of client-initiated voluntary counseling 
and testing (VCT), new approaches to HIV testing and counseling must be implemented in more 
settings, and on a much larger scale than has so far been the case. 
 
In 2006, WHO and UNAIDS developed draft guidance on provider-initiated HIV testing and 
counseling (PITC) in health facilities and solicited feedback from experts in the fields of HIV 
testing and counseling, prevention, treatment, and care, as well as human rights experts and HIV 
activists. On 30 May 2007, the final version of the guidance was launched. Of all the documents 
on HIV testing and counseling released over the last years, the WHO/UNAIDS guidance will 
likely have the biggest impact in shaping HIV testing policy and practice in low- and middle-
income countries.  
 
The debate about how to increase access to HIV testing is not occurring in a vacuum. Rather, it 
takes place in an environment in which evidence-based and human rights-based policies and 
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programs are being widely undermined. At the same time, even as vastly increased funding for 
the fight against HIV has become available, those most vulnerable to HIV and its impact 
continue to receive the least access to HIV prevention, care and treatment services. 
 
Methodology and scope of the paper 
This paper was commissioned by the Public Health Program of Open Society Institute (OSI) to 
inform discussions about an OSI position on HIV testing. Both were presented for discussion at a 
meeting of OSI’s Global Health Advisory Committee in October 2006. It was first revised in 
December 2006 following the release of the draft WHO/UNAIDS guidance. At the time, the 
paper was widely disseminated and served as the basis for extensive comments provided by OSI 
and others to WHO and UNAIDS on the draft guidance. The paper was revised again after the 
release of the final version of the WHO/UNAIDS guidance. 
 
The paper is based on a review of the literature and extensive consultations with people 
providing services to, and/or shaping policy for, populations vulnerable to HIV in Sub-Saharan 
Africa, Asia, Eastern Europe, Latin America, and North America.  It focuses on the issues raised 
by proposals to “routinize” HIV testing in low- and middle-income countries. As they are neither 
central to the current debate about routinizing HIV testing nor the motivation for OSI’s decision 
to develop a position on routinizing HIV testing, the paper does not deal in detail with some 
other important and controversial issues, such as pre-marital testing or testing of minors. 
 
Importantly, while most of the literature and policy-making around HIV testing has concerned 
itself primarily with Sub-Saharan Africa or the “hidden epidemic” in high-income countries, the 
paper also seeks to address how this debate affects vulnerable populations in other parts of the 
world where the epidemic is often very different. 
 
Main conclusions 
 
No controversy: The need to scale up access to HIV testing and counseling 
Today, it is undisputed that access to quality HIV testing is essential for an effective global 
response to HIV/AIDS, and there is complete consensus among AIDS and human rights 
activists, public health officials and policy makers in favour of vastly scaled up access to 
affordable and high-quality HIV testing. Greater access to HIV testing and counseling is both a 
public health and a human rights imperative. 
 
It will be important to continue – and scale up – efforts to improve and better resource VCT, but 
there is agreement that this alone will not be sufficient to achieve vastly scaled-up access to HIV 
testing and counseling. The experience of ART roll-out has shown that when VCT and treatment 
are available and the community is mobilized around HIV testing, people do come forward 
voluntarily in larger numbers for testing. Nevertheless, for countries with a generalized HIV 
epidemic, there is consensus about the need to make testing more routinely available, and to 
combine scaled-up VCT with some form of PITC. There is also consensus that efforts to increase 
access to HIV testing should not be limited only to countries with a generalized epidemic, but 
that certain forms of PITC should also be introduced in countries with low-level or concentrated 
HIV epidemics. 
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While there is consensus that HIV testing should be more routinely available, there is lack of 
agreement about a number of other issues concerning PITC and more generally, routinization of 
testing. This paper focuses on these issues. 
 
The need to step up the fight against compulsory and mandatory testing 
However, many of those consulted in the course of drafting the paper and the position for OSI 
strongly recommended that compulsory and mandatory HIV testing be addressed as well. 
Mandatory and compulsory HIV testing occurs in many countries and contexts, in violation of 
ethical principles and basic rights of consent, privacy, and bodily integrity. With the exception of 
HIV screening for blood, blood products, and before all procedures involving transfer of bodily 
fluids or body parts, compulsory or mandatory testing is also ineffective for public health 
purposes. There is concern that making testing more routine – particularly by adopting 
approaches under which people are tested unless they specifically decline the test – may in 
practice result in even more instances of HIV testing without consent. In particular, official 
endorsement of such approaches by WHO and UNAIDS could be understood by some as an 
endorsement of a generally more coercive approach to HIV testing. 
 
In the final version of their guidance, WHO and UNAIDS stress that they “do not support 
mandatory or compulsory testing of individuals on public health grounds”. In addition, they 
should undertake concrete activities to fight policy and practice requiring or permitting 
mandatory or testing. 
 
Human rights and the three Cs: counseling, informed consent, and 
confidentiality 
In the early years of the HIV/AIDS epidemic, aggressive calls for punitive, forcible testing 
sparked widespread concern about the effects of such strategies on individual rights and the 
spread of the epidemic. Eventually, members of affected communities and public health 
professionals recognized that HIV testing must be voluntary and that informed choice was 
central to creating a climate of confidence and trust between the person being tested and service 
providers. Three underpinning principles of HIV testing (the “three Cs”) were established as 
norms: counseling and information about HIV/AIDS before and after the test; consent to be 
tested given in an informed, specific and voluntary way by the person to be tested; and 
confidentiality of test results and of the fact of seeking a test. 
 
Central to the debate about scaling up access to HIV testing is whether and, if so, to what extent, 
these conditions should be relaxed. At their crudest, proponents of more routine forms of testing 
have gone so far as to dismiss the ethical and human rights requirement that testing be voluntary. 
Some have argued that the protections afforded by the three Cs treated HIV/AIDS as 
exceptional, because it was exceptional in the early years of the epidemic, but that “the world has 
changed”, stigma has decreased, and treatment is now “widely available”. 
 
However, arguments in favour of models of HIV testing that eliminate or minimize specific, 
informed consent and counseling often do not adequately take into account the link between 
these elements and human rights. : 
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• Informed consent protects the human right to security of the person as well as the right to 
receive information. 
• Pre-test counseling contributes to the protection of these same human rights. 
• Post-test counseling also imparts information to which people have a right. 
• Confidentiality of test results and of the fact of seeking an HIV test is part of protecting and 
respecting the right to privacy. 
• Beyond the components of the testing process itself, governments have a responsibility to 
ensure that HIV testing is not offered or provided in a way that discriminates against any 
person or group of people. 
• Finally, the right to be free of discrimination and the right to security of the person also 
require that in setting HIV testing policy and overseeing its practice, governments take into 
account the outcomes of HIV testing for people and do all they can to prevent human rights 
violations associated with HIV testing. 
  
Under international law, any public health action by the state that limits human rights must be 
justified by demonstrating that it is rationally connected to achieving a pressing objective, 
infringes human rights as little as possible, and the benefits achieved are proportional to the harm 
done to individuals’ human rights. 
 
The question therefore is whether the conditions exist, particularly in countries with generalized 
HIV epidemics, to justify limiting or infringing upon human rights by relaxing the informed 
consent and counseling requirements of testing. Different conditions and populations may yield a 
different analysis. 
 
Can relaxation or elimination of counseling and informed consent 
requirements ever be justified? 
In the context of the current debate, the main questions are: whether it is justified to replace pre-
test counseling with so-called pre-test information; and whether it is justified to adopt an 
informed right of refusal approach, under which people are presumed to consent to HIV testing 
unless they explicitly withhold consent or “opt out” of testing. 
 
Those who answer this question in the affirmative generally argue that new approaches to testing 
that incorporate these elements are justified because they are necessary to increase the number of 
people being tested, and ultimately the number of people who contribute to prevention and 
treatment goals by changing their behaviors and seeking treatment. They also assume that few 
human rights abuses and other negative consequences will result from this approach. Finally, 
they assume that less rights-restricting alternatives such as increased VCT and/or PITC with an 
opt-in approach will not achieve these objectives. 
 
Increasing uptake 
There can be no question that introducing PITC in health facilities leads to increased uptake of 
HIV testing. A great number of studies, particularly in antenatal settings, but also in STI or TB 
clinics and other settings, has shown that making the offer of HIV testing and counseling routine 
and recommending testing makes patients more likely to undergo testing. There is also evidence 
from a small number of studies, particularly in resource-rich settings, that in antenatal settings 
 v
adoption of an opt-out approach leads to particularly high rates of HIV testing uptake. However, 
studies in a number of countries have shown that opt-in approaches can result in uptake rates that 
are comparable to those reached in jurisdictions using an opt-out approach. 
 
Importantly, with the exception of a few studies in antenatal settings, no studies have compared 
opt-in and opt-out approaches to PITC. Generally, studies suggest that, whether an opt-in or an 
opt-out approach to PITC is adopted, most people will accept the offer if providers recommend 
and encourage HIV testing. Studies also suggest that pre-test counseling and informed consent 
requirements do not necessarily pose barriers to implementation of PITC, even in resource-poor 
settings. 
 
Finally, while efforts to increase uptake of HIV testing are important, many studies suggest that 
more tests alone are not a sufficient achievement. For example, studies have shown that many of 
the pregnant women who accept HIV testing in antenatal settings in resource-poor settings do not 
obtain their results or take up perinatal HIV interventions. This suggests a need to link HIV 
testing policies with technologies that allow rapid testing, as well as a need to address the 
reasons why women do not get their results or face barriers to take up perinatal interventions. 
Another concern are low HIV-serostatus disclosure rates to sexual partners. Women often face 
greater difficulty than men in making the decision to test and share HIV test results with a 
partner. Efforts to increase access to, and uptake of, HIV testing therefore need to be 
accompanied by efforts to increase HIV-serostatus disclosure rates and support those who test 
positive, particularly women, through the HIV-serostatus disclosure process. In this context, it is 
worth studying whether some form of enhanced VCT that incorporated rapid testing and support 
with disclosure might result in higher rates of learning and disclosing one’s HIV status than the 
model of simplified PITC currently being proposed. 
 
Facilitating access to treatment 
One important benefit of scaled-up testing is the opportunity to identify people with HIV at an 
earlier stage. Where ART is available, maximum benefit in terms of reduced morbidity and 
mortality is obtained when HIV infection is diagnosed before end-stage immunodeficiency. Even 
in the absence of ART, when an HIV diagnosis is made earlier in the course of the disease, 
health benefits can accrue. Therefore, according to the 2007 WHO/UNAIDS guidance on PITC 
in health facilities, access to ART “should not be an absolute prerequisite” for the 
implementation of PITC. At the same time, there “should at least be a reasonable expectation 
that it will become available within the framework of a national plan to achieve universal access 
to antiretroviral therapy for all who need it”. 
 
Assisting HIV prevention 
There is evidence that people who seek voluntary testing, find out they are HIV-positive and 
receive counseling are more likely to take precautions to protect their partners than people who 
do not know their serostatus. There is also evidence that the nature and duration of prevention 
counseling might influence its effectiveness. But there is no evidence specifically about the value 
of pre-test counseling for prevention, and no studies have been concluded where testing provided 
with pre-test counseling was compared with testing without pre-test counseling or simplified pre-
test counseling. 
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In general, the existing evidence supports greater emphasis on efforts to increase the number of 
people who are aware of their HIV infection so that they can be counseled and supported to take 
precautions to reduce the spread of HIV to their sexual partners. However, a key question 
remains. Will the reductions in risk behaviors observed in the studies of people who have 
initiated VCT themselves be replicated among people who accept PITC, but may be less ready or 
motivated to disclose their status and change their behavior than people who initiate testing 
themselves? This is an important question as simply increasing uptake of testing may not be 
enough to effect changes in behavior absent efforts to make it possible for people testing positive 
to safely disclose their HIV status and take up prevention and treatment options. At the same 
time, access to evidence-based prevention measures needs to be scaled up, recognizing that many 
people, particularly in most-at-risk populations, are denied access to HIV prevention tools 
whether or not they test positive. 
 
Reducing stigma and discrimination 
Making testing more routinely available may help reduce the stigma related to HIV testing. 
However, this does not necessarily justify relaxing counseling and informed consent 
requirements. A policy of routinely offering and recommending opt-in testing may lessen the 
stigma of being tested as much as a policy of routine opt-out testing, as under both policies, 
testing is offered to everyone. 
 
Widespread testing may also contribute to reducing the stigma and discrimination related to 
HIV/AIDS, particularly if it is accompanied by widespread access to HIV treatment. Once HIV is 
perceived as a chronic but treatable condition, one of the factors that amplifies stigma – fear of 
contagion and inevitable death – is lessened. However, stigma is much more than fear of 
contagion. It is also related to the perception that HIV infection results from “immoral” behavior 
such as extra-marital sex, homosexuality, prostitution, or injecting drug use. Testing and 
treatment may thus be one component in helping overcome stigma and discrimination, but only 
further research will be able to tell the extent to which they can contribute to lessening stigma. 
 
Human rights abuses and other negative consequences following testing 
People who argue for more routine forms of HIV testing with reduced emphasis on pre-test 
counseling and informed consent assume that few human rights abuses and other negative 
consequences will result from this approach – or in any case that the benefits of HIV testing 
outweigh the prospect of such abuse. While more research will be needed to investigate whether 
relaxing informed consent and counseling requirements affects people’s experiences of abuse or 
other negative outcomes as a result of testing HIV-positive, the research that does exist suggests 
that concern about negative outcomes may be justified. With regard to potential negative 
outcomes for women, studies show that the majority of HIV-positive women report positive 
outcomes with disclosure of their HIV status, but that a significant minority report negative 
outcomes including blame, abandonment, violence, anger, stigma, and depression. Other 
populations most at-risk of HIV transmission, such as men who have sex with men, injecting 
drug users, sex workers, and prisoners, are also more susceptible to coercion, discrimination, 
violence, abandonment, incarceration or other negative concequences upon disclosure of an 
HIV-positive test result. 
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Conclusion 
Scaling up access to HIV testing and providing some form of PITC (in addition to scaled-up 
VCT services) is likely to have many benefits, particularly if people testing positive can benefit 
from treatment, including ART, have access to evidence-based prevention measures that enable 
them to reduce the risk of transmission to their partners, and the social and legal environment is 
such that people with or at risk of HIV: 
 
• feel comfortable about seeing a health worker and about getting tested for HIV 
• can learn how to maintain their HIV-free status or start working on keeping their health 
despite their HIV-positive status 
• can disclose their status without recrimination or discrimination 
• can live and work without discrimination for being HIV-positive or being at risk of it. 
 
Making testing more available might also help reduce the stigma related to HIV testing and 
ultimately contribute to reducing the stigma and discrimination related to HIV/AIDS – although 
reducing the stigma related to HIV testing does not automatically reduce the stigma against 
people and behaviors associated with HIV. 
 
In order to make it feasible for health-care providers to offer HIV testing to all their patients, in 
some settings it may also be justified to relax, to some extent, pre-test counseling requirements. 
Human rights and public health do not require cumbersome procedures for pre-test counseling. 
But human rights – and public health imperatives –require that regardless of whether persons are 
routinely offered an HIV test in a health care setting or whether they initiate HIV testing 
themselves, they are able to give informed and truly voluntary consent to testing. Established 
practice in HIV testing provides good models for obtaining informed consent without undue 
burden. 
 
WHO and UNAIDS, in their guidance on PITC, acknowledge that patients need to be able to 
make a voluntary and informed decision about whether to be tested or not, and specify the 
“minimum information for informed consent” that health care providers should provide patients 
when recommending HIV testing and counseling. 
 
However, a concern remains that adoption of an opt-out approach to testing, as recommended by 
WHO and UNAIDS, may in practice result in people being tested without their informed and 
voluntary consent. In settings where there is a power imbalance between test provider and client, 
the voluntary nature of HIV testing may be compromised, as the client may feel compelled to 
consent to the provider’s offer, particularly when the offer is communicated with the information 
that the test will be performed unless the client refuses.  Careful monitoring and training of 
health workers administering opt-out testing is essential to addressing this concern. 
 
One way of rapidly scaling up access to HIV testing that may be as effective as a matter of 
public health and more respectful of human rights would be to routinely offer and recommend 
opt-in HIV testing and counseling, rather than opt-out testing. Experience has shown that where 
implementation of such a policy is adequately supported, it can be as successful in increasing the 
number of people who test for HIV as adopting an opt-out approach. It also has the potential to 
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have an impact on access to care and treatment, prevention, and stigma similar to that of PITC 
using an opt-out approach. 
 
Ultimately, any form of PITC – whether opt-in or opt-out – needs to be carefully monitored and 
evaluated to ensure that, in practice, providers offer and recommend testing, but that patients 
give informed and voluntary consent to the test. 
 
Finally, scale-up of HIV testing must be adequately monitored and evaluated and accompanied 
by research, acknowledging that many of the discussions around HIV testing and counseling 
have occurred and continue to occur in the absence of empirical data, either from studies or from 
monitoring of existing programs. Outside the prenatal context, evidence about the impact of 
PITC remains limited and deeper research questions beyond simply the numbers of people 
getting tested have not been adequately addressed. 
 
Scaling up VCT and meeting the needs of most-at-risk populations 
Efforts to scale up access to HIV testing and counseling, which currently focus on PITC in 
formal health settings, need to devote greater attention to how client-initiated VCT services can 
be improved and scaled-up, particularly for socially marginalized groups. 
 
A large body of research demonstrates the effectiveness of VCT as part of comprehensive 
prevention, treatment and care strategies. VCT services that are responsive and sensitive to the 
communities served need to be adequately supported by resources and promoted and scaled up. 
Research studies undertaken in many countries and settings suggest ways in which uptake and 
acceptability of VCT can be increased. 
 
Scaling up access to VCT is particularly important because large numbers of people do not use 
formal health services and may need other ways to gain access to HIV testing and counseling, 
especially if they live in rural areas poorly served by the health care system, are mobile, or 
belong to vulnerable communities who face stigma and discrimination in health settings. For 
many of those who need testing the most – underserved and socially marginalized communities – 
PITC is unlikely to work precisely because they rarely use the health system. For sex workers, 
people who use drugs, or gay men, for example, health systems can be notoriously forbidding 
places. 
 
In their guidance document, WHO and UNAIDS do recognize that “strategies are needed to 
increase access to and uptake of HIV testing and counselling” for most at-risk populations, 
“particularly through innovative client-initiated approaches such as services delivered through 
mobile clinics, in other community settings, through harm reduction programmes or through 
other types of outreach”.  However, they also recommend that “consideration … be given to 
recommending HIV testing and counselling to all patients who attend [specific health services, 
such as acute care, STI or drug dependence treatment services] if this is epidemiologically 
appropriate and socially acceptable”.  
 
There is a concern that implementation of PITC in such settings may lead some people to avoid 
seeking care. In many countries, people belonging to most-at-risk populations have been 
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routinely subject to abuse in health care settings and may not feel that they have the power to 
decline a recommendation to be tested, because they may feel that they would suffer negative 
consequences if they did. The WHO/UNAIDS guidance recognizes these concerns and makes 
several recommendations aimed at addressing them, including that “additional discussion” take 
place in these settings of the right to decline HIV testing, of the risks and benefits of HIV testing 
and disclosure, and about social support needs. The guidance concludes that “an ‘opt-in’ 
approach to informed consent may merit consideration for highly vulnerable populations” and 
suggests that where PITC is implemented, most-at-risk populations and their advocates should be 
involved in the development of HIV testing and counseling protocols and in the monitoring and 
evaluation of PITC programs. 
 
Nevertheless, concerns remain that, unless dedicated financial and technical resources are 
devoted to ensuring that these recommendations can be implemented in practice, members of 
most-at-risk populations will continue avoiding health services or experiencing abusive 
treatment. Therefore, WHO and UNAIDS should provide more detailed guidance about the 
training and supervision required by health care providers in these settings, and specify what 
exactly the “additional discussion” of the right to decline HIV testing should entail. Pilot projects 
incorporating these elements should be funded and monitored and evaluated. Ultimately, efforts 
to scale up HIV testing and counseling for most-at-risk populations should continue to focus on 
strategies to increase access to and uptake of HIV testing and counseling through innovative 
client-initiated VCT services. 
 
HIV testing cannot be considered in isolation 
For the last 20 years, important barriers to HIV testing have included stigma, lack of access to or 
investment in VCT, lack of HIV treatment and care, and a belief held by health-care providers 
and patients alike that it was better “not to know” because of the lack of treatment and pervasive 
discrimination. Streamlining PITC within formal health settings does not address all of these 
barriers.  Contrary to what some have claimed, it was not the entrenching of the right to informed 
consent that caused low HIV testing uptake, but the poor implementation of VCT, and the fact 
that treatment options were limited and stigma and discrimination rampant. In recent years 
progress has been made on these fronts, but a move towards increasing access to HIV testing that 
is genuinely grounded in human rights and promotes public health demands that these issues now 
be addressed tangibly and urgently. 
 
HIV testing is never a goal in itself, but clearly linked to larger prevention and care, treatment 
and support goals. Consequently, the efficacy of testing policies and programs is, in turn, co-
determined by the availability of effective prevention and care, treatment and support programs. 
This means that testing programs and programs to scale up access to ART and to evidence-based 
prevention need to be coordinated and integrated. 
 
In addition, increasing testing and counseling must go hand in hand with much greater 
investment in real protection – in practice, and not just on paper – from HIV-related 
discrimination and abuse, particularly for women, children and adolescents, sex workers, men 
who have sex with men, people who use drugs, and prisoners. In their guidance on PITC, WHO 
and UNAIDS recognize that in addition to expanding access to HIV testing, “equal efforts must 
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be made to ensure that a supportive social, policy and legal framework is in place to maximize 
positive outcomes and minimize potential harm to patients”. But in practice, there have been few 
efforts to cost, budget and implement national programs that would secure legal and human 
rights protections for people living with, affected by, or vulnerable to HIV and AIDS. Despite 
vastly increased funding for global HIV and AIDS programs, there has been little investment in 
basic human rights initiatives. If scale-up of HIV testing is to reach its goals, HIV-related human 
rights must become a much higher priority. 
 
 1
Definitions 
 
The definition and interpretation of various terms used in the debate about routinizing HIV 
testing vary widely. It is therefore important to present first the most widely used terms and be 
clear about their meaning.  
 
 
HIV testing and counseling 
 
Client-initiated counseling and testing (also called voluntary counseling and 
testing, or VCT) 
VCT involves individuals actively seeking HIV testing and counseling services that involve the 
following elements (often referred to as the “three Cs”): both pre-and post-test counseling, 
informed consent, and confidentiality of test results. It has been the dominant, recommended 
model for HIV counseling and testing among individuals without symptoms of AIDS. VCT is 
conducted in a wide variety of settings, including health facilities, stand-alone facilities outside 
health institutions, through mobile services, in community-based settings and even in people’s 
homes. 
 
The VCT approach rests on: (a) governments and other care providers making HIV counseling 
and testing services available; (b) public awareness of that availability; (c) an individual’s 
decision to seek out a facility providing VCT services; and (d) the individual’s subsequent 
conscious choice to return to receive test results along with associated post-test counseling and 
referral. Significantly, in a traditional VCT approach, it is the individual, not the health system, 
that initiates action; she or he receives counseling and testing services only after having made an 
active decision to seek out a VCT service and be tested. VCT is especially oriented to self-
empowerment for the person seeking the test and the provision of prevention counseling tailored 
to the test result. 
 
Provider-initiated testing and counseling (PITC) 
PITC refers to HIV testing and counseling that is initiated by health care providers for persons 
attending health care facilities. According to the WHO/UNAIDS guidance on PITC in health 
facilities, guidance from health care providers is not neutral but recommends HIV testing and 
counseling “as a standard component of medical care” (WHO/UNAIDS, 2007). “The major 
purpose of such testing is to enable specific clinical decisions to be made and/or specific medical 
services to be offered that would not be possible without knowledge of the person’s HIV status” 
(ibid).  
 
PITC encompasses two scenarios in which health care providers in clinical settings initiate HIV 
testing and counseling: 
 
• In the case of persons presenting to health facilities with symptoms or signs of illness that 
could be attributable to HIV, heath care providers recommend HIV testing and counseling as 
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part of the patient’s routine clinical management. This includes recommending HIV testing 
and counseling to tuberculosis patients and persons suspected of having tuberculosis. 
• Provider-initiated HIV testing and counseling also aims to identify unrecognized or 
unsuspected HIV infection in persons attending health facilities. Health care providers may 
therefore recommend HIV testing and counseling to patients in some settings even if they do 
not have obvious HIV-related symptoms or signs. In such circumstances, HIV testing and 
counseling is recommended by the health care provider “as part of a package of services 
provided to all patients during all clinical interactions in the health facility” (WHO/UNAIDS, 
2007). 
 
WHO and UNAIDS are seeking to replace the term “routine offer of testing”, which they had 
employed in their 2004 policy statement on HIV testing and counseling (UNAIDS/WHO, 
2004),1 and also avoid terminology such as “HIV screening” and “routine recommendation” in 
favour of “provider-initiated HIV testing and counseling.” The two agencies emphasize that 
PITC is voluntary and that the “three Cs” “must be observed. They also highlight that PITC “is 
neither mandatory nor compulsory” and add that they “do not support mandatory or compulsory 
testing of individuals on public health grounds” (WHO/UNAIDS, 2007, at 20). 
 
Provider-initiated testing can be done using either an “opt-out” approach or an “opt-in” 
approach. 
 
• With an “opt-out approach”, testing is initiated by the provider of some (health) service and 
people are tested unless they clearly opt out and refuse to be tested. Some add other elements 
to the definition, saying that in opt-out testing regimes clients or patients receive only 
essential information about HIV, and there is greater emphasis on post-test, rather than pre-
test, counseling (see, e.g., De Cock, 2005, at 33). This is what is proposed in the 
WHO/UNAIDS guidance on PITC in health facilities, which – with some exceptions – 
recommends an “opt-out approach … including simplified pre-test information” 
(WHO/UNAIDS, 2007, at 5). What taking an opt-out approach to testing means in practice 
will vary widely. WHO and UNAIDS stress that, “when recommending HIV testing and 
counseling, service providers should always aim to do what is in the best interest of the 
individual patient. This requires giving individuals sufficient information to make an 
informed and voluntary decision to be tested (ibid, at 6). In contrast, the New York City 
health department recommends that physicians say to their patients, in advising them about 
all the blood tests that will be performed, “I am going to ... do an HIV test. Do you have any 
questions?” (New York City Department of Health and Mental Hygiene, 2006) 
 
• With an “opt-in approach”, testing is initiated by the provider, who offers an HIV test as a 
routine part of discussions with all patients in a given setting or meeting certain criteria (e.g., 
all pregnant women, all patients using STI health services), but the client must specifically 
agree to the test, rather than having to decline it. With “opt-out”, the default is testing; with 
“opt-in”, the default is no testing. 
 
1 The 2004 policy statement will be updated to reflect the terminology used in the 2007 guidance. 
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It should be noted that the terms “opt-in” and “opt-out” are generally avoided in the 
WHO/UNAIDS guidance, despite the fact that the document acknowledges that in some 
circumstances, such as in health facilities that serve highly vulnerable populations, “opt-in” 
approaches “merit consideration” (WHO/UNAIDS, 2007, at 20). Significantly, the document 
states that, “[w]hether patients “opt-in” or “opt-out”, the end result should be the same: an 
informed decision by the patient to accept or decline the health care provider’s recommendation 
of an HIV test” (ibid). 
 
Other terms 
In addition to these terms, other terms have often been used to describe more routine or 
involuntary forms of HIV testing, often without clearly stated definitions. 
 
Routine testing implies that everyone in a given setting or circumstance is tested without regard 
to individual consent.  
 
“Routine offer of testing” should, if used correctly, mean that everyone in a given setting or 
circumstance is routinely offered an HIV test, which test is done only if the offer is accepted by 
the patient. 
 
However, some have used the term “routine testing” carelessly and sometimes interchangeably 
with “routine offer of testing” (e.g., Metz, 2005), or with “opt-out testing” (e.g. Weiser et al, 
2006), even though there are important differences. It often becomes necessary to determine as 
best as possible from the context what a particular author means. 
 
Compulsory testing, also known as involuntary testing, is defined as testing without a voluntary 
element – i.e., without informed consent, at the behest of someone or some institution other than 
the person tested and, sometimes, with neither the fact of having been tested nor the result 
communicated to the person tested (Canadian HIV/AIDS Legal Network, Center for Health and 
Gender Equity, Gay Men’s Health Crisis, 2006). 
 
Mandatory testing is defined as testing that would occur as a condition for some other benefit, 
such as donating blood or bodily tissues, immigrating to certain countries, getting married, 
joining the military or as a pre-condition of other kinds of employment. 
 
The two terms “compulsory” and “mandatory” are often used, albeit inaccurately, as 
interchangeable.  Often people refer to “mandatory” testing when what they are really talking 
about is compulsory testing, and the intended meaning has to be deduced from the context.  
 
 
Types of HIV epidemics 
 
WHO and UNAIDS define different types of HIV epidemics as follows: 
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Generalized HIV epidemics 
HIV is firmly established in the general population. Although sub-populations at high risk may 
contribute disproportionately to the spread of HIV, sexual networking in the general population 
is sufficient to sustain an epidemic independent of sub-populations at higher risk of infection. 
Numerical proxy: HIV prevalence consistently over one percent in pregnant women 
(WHO/UNAIDS, 2007). 
 
Concentrated HIV epidemics 
HIV has spread rapidly in one or more defined sub-populations, but is not well-established in the 
general population. The future course of the epidemic is determined by the frequency and nature 
of links between the sub-populations with high rates of HIV and the general population. 
Numerical proxy: HIV prevalence is consistently over five percent in at least one defined 
subpopulation but is below one percent in pregnant women in urban areas (id.). 
 
Low-level HIV epidemics 
HIV has never spread to significant levels in any sub-population. Recorded infection is largely 
confined to individuals with higher risk behaviour, e.g. sex workers, people who inject drugs, 
men who have sex with men. Numerical proxy: HIV prevalence has not consistently exceeded 
five percent in any defined sub-population (id.). 
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Methodology and scope 
 
This background paper was commissioned by the Public Health Program of Open Society 
Institute (OSI) to inform discussions about an OSI position on HIV testing. Both were presented 
for discussion at a meeting of OSI’s Global Health Advisory Committee in October 2006. It was 
first revised in December 2006 following the release of the draft WHO/UNAIDS Guidance on 
Provider-initiated HIV Testing and Counselling in Health Facilities (WHO/UNAIDS, 2006). At 
the time, the paper was widely disseminated and served as the basis for extensive comments 
provided by OSI and others to WHO and UNAIDS on the draft guidance. The paper was revised 
again after the release of the final version of the WHO/UNAIDS guidance. 
 
Research included a review of existing materials – reports, position statements, policy 
documents, studies, critiques, advocacy materials, journal articles, and news clippings – on the 
issue of expanding HIV testing. A search of the published scientific literature was carried out 
using electronic databases. Conference abstracts were reviewed, and searches of the Internet 
were conducted. Attempts were made to obtain as much information as possible from low-and 
middle-income countries, particularly those that have been left out of the discussion on scale-up 
of HIV testing. The ‘grey’ literature was reviewed via a variety of sources including professional 
contacts, direct contact with known researchers and research centres and the Internet. 
 
In addition, the author worked with staff from OSI and the Soros Foundations Network to 
identify the implications of routine testing for OSI’s work, and to survey existing policy and 
practice on HIV testing in the countries in which OSI operates, with a focus on marginalized 
groups such as people who use drugs and sex workers. In order to do this, the author interviewed 
people from within and outside the OSI and Soros Foundations Network in a number of low- and 
middle-income countries, and obtained written comments from others. Informants were not 
compensated for their participation, and their names were sometimes withheld on request. 
 
A first draft of both this background paper and the position were peer reviewed by experts in the 
field, and both documents were revised taking their comments into account. 
 
The focus of both papers is on scaling up HIV testing in low- and middle-income countries, in 
the context of recent calls by the World Health Organization and other major opinion leaders on 
routinizing HIV testing. Policies, however, are also in transition in high-income countries, as 
evidenced in particular by the issuing of new recommendations on HIV testing and counseling in 
the United States and France during the drafting of the papers. While developments in high-
income countries are not the focus of the papers, they are nevertheless included inasmuch as they 
affect developments in low- and middle-income countries. In addition, much of the analysis in 
the papers also applies to high-income countries. 
 
As they are neither central to the current debate about routinizing HIV testing nor the motivation 
for OSI’s position paper, the papers do not deal in detail with some other important and 
controversial issues, such as pre-marital testing or testing of minors. 
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General background 
 
Key points 
• Global action to combat the HIV pandemic has increased markedly, with world leaders having 
committed to “pursuing all necessary efforts … towards the goal of universal access to 
comprehensive prevention programmes, treatment, care and support by 2010.”  
• By the end of 2006, more than 2 million people living with HIV in low- and middle-income 
countries were receiving life-prolonging antiretroviral treatment, compared to 1.3 million people 
at the end of 2005 and less than 500,000 people in 2003. 
• However, evidence-based and human rights-based policies and programs are being widely 
undermined.  At the same time, those most vulnerable to HIV and its impact continue to receive 
the least access to HIV prevention, care and treatment services. 
 
 
 
At the end of 2006 an estimated 39.5 million people were living with HIV and high numbers of 
new HIV infections continue to occur throughout the world. Sub-Saharan Africa remains the 
hardest-hit region with 24.7 million people living with HIV. Epidemics in Eastern Europe and 
Asia continue to grow (UNAIDS/WHO, 2006). 
 
In recent years, global action to combat the HIV pandemic has increased markedly. The world 
made an unprecedented commitment in the United Nations Millenium Declaration (2000) and 
during the United Nations General Assembly Special Session on HIV/AIDS in 2001 to halting 
and reversing the epidemic by 2015.  There has been global acknowledgement of the HIV/AIDS 
pandemic as not only a public health crisis but also a threat to societies and international 
security. The world’s leaders endorsed a set of specific global targets in combating HIV/AIDS 
(United Nations General Assembly, 2001). More recently, first in 2005 at the meeting of the 
“Group of Eight” nations and at the World Summit (United Nations General Assembly, 2005), 
and then at the 2006 High Level Meeting on AIDS, world leaders committed “to pursuing all 
necessary efforts … towards the goal of universal access to comprehensive prevention 
programmes, treatment, care and support by 2010” (United Nations General Assembly, 2006). 
 
As part of this effort, increased resources have been committed to fighting the epidemic. In 2001, 
the Global Fund to Fight HIV/AIDS, TB and Malaria (GFATM) was created. Three years later, 
the United States Leadership against AIDS, Tuberculosis and Malaria Act of 2003 (the U.S. 
Global AIDS Act), which authorized the U.S. President’s Emergency Plan for AIDS Relief 
(commonly known as PEPFAR), was enacted. The same year, WHO, the Joint United Nations 
Programme on HIV/AIDS (UNAIDS), and the GFATM launched the Treat 3 Million by 2005 (3 
by 5) Initiative, partly out of the recognition that HIV/AIDS was exacerbating inequities between 
rich and poor countries, and the conviction that the human rights to health and life should not be 
dependent on ability to pay for medicines (WHO & UNAIDS, 2003). At heart, 3 by 5 was a 
public health initiative, but it also aimed to lessen the inequity that exists in access to medicines 
between First and Third Worlds (Heywood, 2004). Although the ambitious target of 3 by 5 was 
not reached, by the end of 2005, an estimated 1.3 million people living with HIV in low- and 
middle-income countries were receiving ART, which was more than a three-fold increase in the 
number of people on ART two years previously (WHO/UNAIDS, 2006b).2 Within a few years, 
the question “should AIDS treatment programs be implemented in low income countries?” was 
replaced with a new question: “How can the ambitious and costly global AIDS treatment 
programmes be implemented in ways that are swift, affordable, feasible, efficient and ethically 
sound in the resource-poor countries most burdened by HIV/AIDS?” (Rennie & Behets, 2006, at 
52) 
 
At the same time, however, evidence-based and human rights-based HIV/AIDS policies and 
programs are being widely undermined, impeding efforts to scale up both HIV treatment and 
prevention. In the last 25 years, it has been shown time and again that HIV programs are most 
effective when based on people’s voluntary, informed and open engagement with health services.  
Such services should inform and educate people about HIV, support them to engage in behavior 
change and offer them a variety of prevention and care options that will fit in with the realities of 
their lives and allow them to choose what is most effective (Amon, 2006; Csete, 2005; Heywood, 
2004).  However, at the same time as the world witnesses a global regression in commitment to 
human rights more generally – as seen in political rhetoric and policies on terrorism, trade, 
migration, freedom of expression, etc. – there has been a recent trend to resort to punitive and 
coercive attempts at “HIV control”.    
 
• In many countries, governments are resorting to coercive methods of HIV prevention such as 
criminalization of “intentional” HIV transmission and mass HIV testing without informed 
consent (Amon, 2006; see also the 
many reports released by the Human 
Rights Watch’s HIV/AIDS & 
Human Rights program, available 
via www.hrw.org). Such policies 
have the potential to promote stigma 
against people living with HIV and 
to deter people from coming forward 
for needed health services. 
• In many countries that have fought hard
HIV-related services, there has been pre
implement only one or two narrow appr
on abstinence-based HIV prevention pro
access to sexual and life-skills education
about and control over their own sexuali
HIV information, condoms, and certain 
• Even though commercial sex is a contex
for both sex workers and clients (depend
many countries police confiscate condom
illegal prostitution, and sex workers are 
forced HIV testing and judgmental treat
                                                          
2 By the end of 2006, more than two million people l
receiving treatment, an increase of 54 percent since tThe push for more routine approaches to HIV testing is happening in 
a larger political context … which includes the undermining of 
evidence-based prevention measures, impediments to scaling up 
treatment, and coercive and punitive responses to AIDS.  Other policy 
shifts could occur following the move to making HIV testing more 
routine, such as more coercive approaches to partner notification. 
- Canadian HIV/AIDS Legal Network, Center for Health and Gender 
Equity, Gay Men’s Health Crisis, 2006  7
 to establish access to comprehensive and effective 
ssure, based on political or ideological orientation, to 
oaches (e.g., an exclusive or predominant emphasis 
grams).  This results in young people being denied 
; young women being denied access to information 
ty; and people being denied access to comprehensive 
reproductive and sexual health services. 
t in which vulnerability to HIV infection can be high 
ing on the conditions of work for sex workers), in 
s from sex workers and use them as evidence of 
deterred from seeking health services by the fear of 
ment by health workers.  In 2003, the United States 
iving with HIV in low- and middle-income countries were 
he end of 2005 (WHO, UNAIDS, UNICEF, 2007). 
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Congress passed a law requiring all recipients of U.S. global HIV/AIDS funding to adopt an 
explicit policy “opposing” prostitution – a requirement that placed a chilling effect on efforts 
to work respectfully with sex workers to prevent the transmission of HIV and provide care 
and treatment to sex workers. 
• There has been pressure by a small minority of countries on the United Nations and others to 
withdraw support from needle and syringe programs, despite incontrovertible evidence of the 
effectiveness of such programs for HIV prevention (WHO, 2004; National Academy of 
Sciences, 2006). Some of the most proven methods of preventing HIV among people who 
inject drugs – needle and syringe programs and opioid substitution therapies (WHO, 2005c) – 
remain restricted by law or policy in many countries. Even where these programs are legal, 
people who use drugs may fear using these programs because of the risk of arrest for 
possession of drug paraphernalia or controlled substances. Criminal laws and police practices 
that drive people who use drugs away from HIV and other health services, or into prison, 
have been shown to be counterproductive to efforts to respond to the HIV epidemic within 
this population (see, e.g., Wood et al., 2003; International Harm Reduction Association, 
2007). 
• In prisons, where HIV spreads rapidly through sex and injection drug use, access to 
condoms, sterile injecting equipment, and opioid substitution therapy remains restricted in 
many countries (Jürgens, Betteridge, 2005; WHO, 2007). Access to HIV treatment is also 
often limited (Jürgens, 2006; WHO, 2007b). Such restrictions effectively exclude an entire 
segment of the population from HIV services, making the goal of universal access impossible 
to attain.  They also represent unsound public health policy, given the links between 
prisoners’ health and broader community health. 
 
Ironically, human rights advocates have sometimes been blamed for the lethargic response of 
governments, particularly in adopting effective HIV prevention policies – the same human rights 
advocates who have been saying “for 25 years that we must have information, we must be 
protected from violence and property rights abuses, we must have condoms, clean needles and 
methadone” (Amon, 2006), and who have also been fighting for increased access to HIV testing 
and counseling and to treatment (Heywood, 2004; Heywood, 2005). As Amon has put it: “These 
are demands that are based both in human rights and in effective, science-based prevention, and 
the reason that we don’t have these things is not because activists haven’t been asking for them. 
It is because governments have refused to provide them.”  
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The debate about HIV testing and counseling: A brief 
history 
 
Key points 
• In recent years, there has been a call for a large expansion of HIV testing services and for moving 
away from a sole reliance on the voluntary counseling and testing (VCT) model, particularly in 
high-prevalence countries, but also in some high-income countries. 
• The current move to expanded HIV testing has been endorsed by a number of prominent leaders 
and is attributable to three main factors: (1) advances in ART have dramatically improved the 
clinical outcome of HIV infection, strengthening one objective of HIV testing: to make care 
available to HIV-positive people; (2) increasing the number of people who know they are HIV-
positive may have a positive impact on prevention efforts; (3) some believe that a change in 
testing strategies will contribute to the “normalization” of HIV. 
• Of all the documents released over the last years, the 2007 WHO/UNAIDS Guidance on Provider-
Initiated HIV Testing and Counselling in Health Facilities will likely have the biggest impact in 
shaping HIV testing policy and practice in low-and middle-income countries. 
• The guidance recommends an opt-out approach to provider-initiated testing and counseling, but 
also strongly support the continued scale up of client-initiated VCT. 
 
 
 
Background 
 
HIV testing has long been a focal point of concern for those committed to the struggle against 
HIV/AIDS (Canadian HIV/AIDS Legal Network, Center for Health and Gender Equity, Gay 
Men’s Health Crisis, 2006). In the early years of the epidemic, aggressive calls for punitive, 
forcible testing sparked widespread concern about the effects of such strategies on individual 
rights and the spread of the epidemic. Members of affected communities and public health 
professionals recognized that HIV testing must be voluntary and that informed choice was 
central to creating a climate of confidence and trust between the person being tested and service 
providers. The pressures that existed at the time to make HIV testing compulsory or mandatory 
were curbed as most public health professionals came to understand that VCT was the most 
effective and rights-based approach to HIV testing (Gruskin, 2005). HIV/AIDS, unlike some 
other infectious diseases, disproportionately affected populations who were already marginalized 
and attracted a deep social stigma that made traditional public health approaches unworkable.  
The pursuit of public health goals led to the HIV/AIDS epidemic being treated, for good reason, 
in ways different from previous public health emergencies – an approach later called “HIV 
exceptionalism” (Bayer, 1991; Bayer & Fairchild, 2006). 
 
Three underpinning principles of HIV testing (the “three Cs”) were established as norms, 
namely: 
∙ counseling and information about HIV/AIDS before and after the test;  
∙ consent to be tested given in an informed, specific and voluntary way by the person to be 
tested; and 
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∙ confidentiality of test results and of the fact of seeking a test. 
 
In recent years, however, HIV testing policies have started shifting. There has been a call for a 
large expansion of HIV testing services and for moving away from a sole reliance on the VCT 
model, particularly in high-prevalence countries (De Cock, Mbori-Ngacha, Marum, 2002; De 
Cock, Marum, Mbori-Ngacha, 2003; De Cock, Bunnell, Mermin, 2006). Some suggest that VCT 
is too slow or inefficient to help prevent the relentless spread of HIV, while others argue that 
client-initiated VCT will always have an important role to play in the response to HIV/AIDS but 
that it needs to be supplemented by some form of provider-initiated testing. 
 
At the same time, there have been calls in some high-income countries including the U.K. 
(Manavi & Welsby, 2005) and France (Conseil national du sida, 2006), but particularly the U.S. 
(Frieden, 2005; Feinberg, 2006; Bozzette, 2005; Beckwith et al., 2005; Bazell, 2006; Rietmeijer 
& Thrun, 2006; Koo et al., 2006; Simmons et al., 2006), for a revision of standard approaches, in 
an effort to identify a higher proportion of those people living with HIV who do not know their 
status – the so-called “hidden epidemic” (Schietinger, 2006). The call for a new paradigm in 
testing is being taken up in many countries by political authorities.  In some cases, AIDS experts 
who previously supported the idea that HIV testing was always to be completely voluntary and 
feature informed consent and pre-test counseling are now supporting measures that do not 
necessarily preserve these conditions. The proponents of this new paradigm often argue that 
AIDS should no longer be treated as an exceptional disease with respect to human rights 
protections in testing (see, e.g., Cameron, 2005; Cameron, 2006).  
 
The current move to expanded HIV testing is attributable to a number of factors (see, e.g., 
Schietinger, 2006; Gruskin, 2005). 
 
Firstly, advances in ART have dramatically improved the clinical outcome of HIV infection, 
particularly when it is initiated before people develop physical symptoms of HIV disease. This 
has strengthened one objective of HIV testing and counseling: to make care available to people 
who are seropositive. Yet, even in countries in which ART has been available since 1996, a 
significant proportion of people who live with HIV do not know their HIV status – 30 to 35 
percent in Western Europe, 25 to 35 percent in Oceania, and 25 to 30 percent in North America 
(Schietinger, 2006, with reference to Archibald, 2004; Branson, 2006). In developing countries, 
where treatment is finally starting to become more readily available, the percentage of people 
who are aware of their HIV status is even lower and has been estimated to be no higher than 10 
percent (UNAIDS and WHO, 2004). Surveys in twelve high-burden countries in sub-Saharan 
Africa showed that a median of just 12 percent of men and 10 percent of women in the general 
population had been tested for HIV and received the results (WHO, UNAIDS, UNICEF, 2007; 
see also Corbett et al., 2006, with reference to Measure DHS, 2006). This is one of the reasons 
why, even as ART becomes increasingly available, initial uptake has been slow – many 
individuals who might qualify for treatment simply do not know their HIV status. Without 
knowing who is infected, however, programs are unable to provide people with appropriate care, 
treatment, counseling, and support. Access to ART is unlikely to be successfully scaled up 
without a parallel expansion of HIV testing.  
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The identification of each HIV-positive person generally requires that a vastly larger number of 
persons be tested. Looking beyond 2005, WHO has estimated that up to 180 million people will 
need HIV testing and counseling every year (WHO, 2003, at 12).  Consequently, rapid expansion 
of effective HIV testing and counseling capacity has become a pressing operational and policy 
priority in many programs and countries (Nieburg, Cannell, Morrison, 2005). 
 
The push to extend ART has also fuelled calls for more aggressive testing measures, including 
“routine” testing of, or routine offers of HIV testing to pregnant women to enable the optimum 
use of tools to prevent mother-to-child transmission (Dabis et al., 2000; Chou et al., 2005b; 
Fennelly & Charles, 2006). 
 
Some argue that expanded HIV testing is justified and needed even when ART is not available, 
calling for “routine testing wherever basic HIV care and prevention are available” (De Cock, 
Bunnell, Mermin, 2006). According to them, this would allow infected persons to receive care 
such as cotrimoxazole prophylaxis, which is within the reach of even the poorest countries.  Of 
course, in addition to a change in testing strategies, other preconditions of successful testing 
scale-up include availability of affordable test kits and competent health-care staff (Vermund & 
Wilson, 2002).  
 
Secondly, there is some evidence that people who know they are HIV-positive are more likely to 
take precautions to protect their partners than people who do not know their serostatus (Marks, 
2005; Weinhardt, 1999). The importance of this for HIV prevention is enhanced in settings 
where ART is available, given the value of ART in reducing a person’s viral load. 
 
Thirdly, some believe that a change in testing strategies is needed as part of a larger effort to 
make the treatment of HIV similar to that of other diseases, and thereby contribute to the 
“normalization” of HIV and reduce HIV-related stigma (see, e.g., Cameron, 2006). 
 
In the words of WHO: 
 
Knowing their HIV status enables individuals to 
• initiate or maintain behaviours to prevent acquisition or further transmission of HIV 
• gain early access to HIV-specific care, treatment and support 
• access interventions to prevent transmission from mothers to their infants 
• better cope with HIV infection 
• plan for the future 
 
and helps communities to: 
• reduce the denial, stigma and discrimination that surround HIV/AIDS 
• mobilize support for appropriate responses (WHO, 2003b). 
 
 
Chronology of a shifting debate 
 
The following is a brief summary of some of the main events since 2001 that have influenced the 
discussion about routinization of HIV testing. 
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2001 
In December 2001, WHO held a consultation to begin to explore new approaches to delivering 
HIV testing and counseling services (WHO, 2002). At that consultation, participants endorsed 
the standard model of VCT as an effective way to address certain needs in certain settings. 
However, the participants also recognized the need for a greater variety of models in the 
provision of testing and counseling services that could be rapidly scaled up. They concluded that 
new models of HIV testing and counseling should retain their commitment to voluntariness and 
informed consent; should be adapted to different populations and service delivery settings; and 
should be capable of rapid expansion. 
 
2002 
In 2002, in a widely cited paper, Kevin De Cock (then with the Centers for Disease Control and 
Prevention in Kenya, and since March 2006 Director of WHO’s HIV/AIDS Department) and 
colleagues called for “routine HIV testing [that] should not require specific consent or pre-test 
counselling” and claimed that “human-rights based approaches to HIV/AIDS prevention might 
have reduced the role of public health and social justice.” (DeCock et al, 2002) In their view, 
particularly in high-prevalence settings, HIV testing should be the routine or default practice in 
health facilities, with people having the possibility to opt out of testing. In November, WHO 
convened another, larger consultation to consider strategies to increase access to HIV testing and 
counseling. Those at the consultation reconfirmed the commitment to voluntary HIV testing and 
counseling and explored new modalities by which to ensure informed consent. Participants urged 
that HIV testing and counseling be offered as standard best practice in the provision of 
prevention, care and treatment services whenever testing and counseling can benefit the health of 
those affected by HIV/AIDS. 
 
2003 
In 2003, the U.S. Centers for Disease Control and Prevention (CDC) began a new program 
(“Advancing HIV Prevention”) that included routinely encouraging HIV testing in certain health 
care settings as a part of medical care (Janssen et al., 2003).  
 
2004 
In the course of 2004, the charge towards a “new approach” to HIV testing gathered pace and 
supporters internationally. Botswana implemented a new policy of routine HIV testing under 
which all people in Botswana would automatically be offered an HIV test when they utilized 
health services. People receive a pre-test information session, have the right to “opt-out” of 
testing, and those who are tested receive post-test counseling (Kenyon, 2005; Ministry of Health, 
2004; Stegling, 2004; Weiser et al., 2006). Similar initiatives have since been under active 
discussion, or have been adopted, in a number of other countries (Alcorn, 2006).  
 
In February 2004, the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria 
(GBC), a corporate membership advocacy organization, launched its global “opt-out” campaign 
calling for dramatic scale up of HIV testing and counseling. The campaign was initiated by 
Richard Holbrooke (GBC President and CEO) and Dr. Richard Furman (Founder, World 
Medical Mission) when they published an opinion piece in the New York Times arguing that 
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“international policy on testing must be changed, not only in Africa but also in every nation that 
is threatened, including India, China and Russia and countries in the Caribbean.” They proposed 
redesignating VCT “as something like ‘Confidential and Recommended [or Routine] Counseling 
and Testing’.” But their recommendations went even further: “We believe that, at a minimum, 
testing should be required at three specific moments in a person’s life: at marriage, before 
childbirth and upon any visit to a hospital. At these moments (and, we hope, others), public 
health criteria legitimately take priority over the desire of an individual.” Finally, they proposed 
that “part of international and American financing for AIDS programs be set aside specifically to 
encourage and carry out testing; that new technologies, like a quick, cheap and reliable saliva 
swab test, be widely distributed in Africa and other highly affected areas; and that all public 
education programs be reoriented to stress the importance of testing” (Holbrooke & Furman, 
2004). Following the New York Times article, the GBC “worked aggressively to make the shift in 
HIV testing policy a reality” (GBC website, accessed on 15 September 2006; see also Global 
Business Coalition on HIV/AIDS, 2004) and Richard Holbrooke and the GBC have continued 
arguing strongly for a change in testing policy (see, e.g., Holbrooke, 2005; Holbrooke, 2006). 
Most recently, at the XVI International AIDS Conference in Toronto in August 2006, newly-
appointed GBC Executive Director John Tedstrom said that “it was impossible to engage in 
appropriate prevention, counselling and treatment programmes if millions of people carrying the 
virus had not been identified” (BBC News, 2006). 
 
Later in 2004, UNAIDS and WHO, partly in response to Botswana’s initiative and to concerns 
raised about that initiative, issued a policy statement reasserting the importance of maintaining 
“the three C’s” for all voluntary counseling and testing, but advocating for scaled-up HIV testing 
services, changes in the delivery of provider-initiated testing and counseling, and for the use of 
new testing technologies. One recommendation was that pre-test counseling be provided in 
group settings with individual follow-up in order to streamline the counseling process. Another 
recommendation was to use rapid test technologies. A third recommendation was to offer the 
HIV test to all patients in certain clinical settings along with pre-test counseling that is less 
involved than the standard counseling session recommended in VCT. A fourth recommendation 
was to have patients opt-out of provider-initiated testing rather than opt-in (UNAIDS and WHO, 
2004). In a plenary presentation at the XV International AIDS Conference in Bangkok, Jim Kim, 
then Director of WHO’s Department of HIV/AIDS, stated: 
 
With the possibility of treatment, we feel it is critical to routinely offer testing and counseling in all health 
care settings. Knowing your HIV status is one of the most powerful forces for behavior change and we have 
to be ambitious in our efforts to make testing and counseling widely available in every country. Of course, 
the more routine offer of HIV testing cannot come at the expense of human rights. It can only work with 
counseling, consent, confidentiality, community involvement and an aggressive effort to fight stigma and 
discrimination (Kim, 2004). 
 
2005 
In October 2005, prominent South African judge Edwin Cameron joined those calling for 
changes to HIV testing policy and practice, suggesting that the “legal protections burdening HIV 
testing require reconsideration and reform” (Cameron, 2005). He later clarified that, in his view, 
the diagnosis of HIV should be “re-medicalised,” by “making it a normal part of medical 
treatment, subject only to a patient’s deliberate and express refusal to be tested,” under three 
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conditions: ART must be available for offer to the patient; there must be assurance that the 
consequence of diagnosis will not be discrimination and ostracism; and the patient must be 
secure in the confidentiality of the testing procedure and its outcome (Cameron, 2006). He 
admitted that these conditions are still rare in Africa, but said that “where they do exist, we must 
move urgently to normalise the treatment and diagnosis of AIDS.” Cameron’s approach was 
criticized by Mark Heywood, Head of the AIDS Law Project, South Africa, who said that while 
people should be encouraged to test for HIV, Cameron was “trying to de-exceptionalise, when 
HIV remains an exception. For most people, HIV diagnosis remains full of dangers and access to 
treatment is far from guaranteed” (Beresford, 2006).  
 
Later in October 2005, in Montréal, Canada, persons living with HIV, representatives of AIDS 
service organizations, clinicians, researchers and representatives of development organizations 
and international agencies working on AIDS attended a Symposium on HIV Testing and Human 
Rights.  Participants considered the human rights and public health implications of HIV testing 
approaches that depart from traditional client-initiated VCT, as well as measures that may 
enhance human rights protections in all forms of HIV testing and considered their practical 
feasibility, and articulated research and policy needs related to these questions. They concluded 
that forms of HIV testing that omit or significantly curtail informed consent, counseling, and 
confidentiality are not acceptable as a matter of ethics and human rights (Canadian HIV/AIDS 
Legal Network, Center for Health and Gender Equity, Gay Men’s Health Crisis, 2006). 
 
On 1 December 2005, the Ministry of Health of Lesotho and the WHO announced a village-to-
village campaign to test every resident of Lesotho aged twelve and older for HIV by the end of 
2007 (WHO, 2005; Mills & Chong, 2006). The Lesotho operational plan for universal access to 
HIV testing states that “every household will be offered an HIV test” and that “communities will 
choose how HIV testing and counseling will be carried out for [their] members.” Independent 
oversight “to guarantee the rights of community members” will be provided by a three-person 
committee in each health center catchment area, with each center providing “at least a biannual 
written report” (Lesotho Ministry of Health and Social Welfare, 2005) The government is also 
creating a national telephone hotline. The government budgeted U.S.$11.7 million for testing, 
but only a small amount for post-test referral (Amon, 2006b, with reference to Lesotho Ministry 
of Health and Social Welfare, 2005). In practice, the door-to-door campaign to offer HIV testing 
began in July 2006 in certain regions and is currently being rolled out. Approximately 100,000 
people have been tested since the launch of the campaign, not only as part of the door-to-door 
testing initiative, but also in facility-based outreach testing (Richter, 2006). Doctors working in 
Lesotho have expressed concern about the program as there is currently a grave lack of medical 
personnel who can administer ART in Lesotho and insufficient support and infrastructure 
(Richter, 2006).  
 
2006 
In April 2006, former U.S. President Bill Clinton endorsed Lesotho’s program and suggested 
other countries and companies should launch extensive efforts to diagnose HIV. Clinton said he 
might support programs that went still further, explicitly requiring compulsory testing and even 
disclosure of positive HIV results to the partners of those found to be infected. Asked about the 
ethics of such compulsion, he argued that it could be justified in countries with high infection 
rates, on condition there was guaranteed diagnosis, treatment and anti-discrimination measures 
put in place. “In a population with extremely high rates of infection, [compulsory testing] 
overcomes other reservations,” he said (Financial Times, 2006). 
 
In July 2006, as part of the country’s goal of testing one million people by the end of 2007, 
Malawi began a weeklong nationwide HIV testing campaign, expected to reach 50,000 people 
between 14 and 49 (Agence France Presse, 2006). More than 240 testing sites, staffed by about 
1,000 counselors, were designated for HIV testing throughout the week. The campaign followed 
the revelation that only 15 percent of the country’s population of 12 million people have sought 
testing for HIV. 
 
Also in July 2006, WHO and UNAIDS held a consultation meeting to obtain initial feedback on 
a first draft of recommendations for PITC in health facilities (WHO & UNAIDS, 2006a).  
 
On 14 August 2006, during the XVI International AIDS Conference in Toronto, WHO and 
UNAIDS issued a statement on HIV testing and counseling that says that PITC “must be 
implemented in a manner that is consistent with human rights principles” and that “[a]ppropriate 
policy and legal frameworks to protect against stigma and discrimination must be in place before 
provider-initiated testing is implemented” (WHO & UNAIDS, 2006c). 
 
On 22 September 2006, the US CDC issued new recommendations for testing in health-care 
settings in the United States. Many aspects differ from previous recommendations (CDC, 2006, 
at 8): 
• “Opt-out screening” is recommended in all health-care settings for patients aged 13 to 64 
years. It is defined as “performing HIV screening after notifying the patient that (1) an HIV 
test will be performed and (2) the patient may elect to decline or defer testing.” 
• Consent may be assumed unless the patient expressly declines testing, and specific signed 
consent for HIV testing should not be required. General consent for medical care should be 
considered sufficient to encompass informed consent for HIV testing. 
• Persons at high risk for HIV should be tested for HIV at least annually. 
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The idea of making testing a routine part of medical care is clearly 
the thing to do, so long as we make sure to accompany that with care, 
treatment and counseling.  
Anthony Fauci, Director of the National Institute of Allergy and 
Infectious Diseases (NIAID) of the U.S. National Institutes of Health 
(NIH),  30 November 2006 
• HIV test results should be provided in the same manner as results of other diagnostic or 
screening tests. 
• Prevention counseling should 
not be required as a part of 
HIV screening programs in 
health-care settings. 
 
These recommendations go even 
further than those of WHO and UNAIDS (see below), because among other things they envisage 
opt-out testing in all health-care settings, not only “where there is a high HIV prevalence”.3 The 
                                                          
3 It should be noted that the U.S. Preventive Services Task Force, while strongly recommending that primary care 
clinicians screen all pregnant women as well as all adults and adolescents with identifiable risk factors for HIV, in 
2005 had made no recommendation for or against screening other patients, leaving the decision of whether to screen 
these individuals to the discretion of the primary care clinician. The Task Force had estimated that as many as 
11,000 non-high risk patients would have to be screened to prevent one clinical progression or death over three years 
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recommendations have been criticized by a number of organizations and individuals, including 
the American Civil Liberties Union (ACLU, 2006) the National Association of People with 
AIDS (NAPWA, 2006), and the New York State Health Commissioner, but have been supported 
by many editorials and opinion pieces published in the week following their release (see, Kaiser 
Daily HIV/AIDS Report, 29 September 2006) and by many of the participants at a CDC-
sponsored meeting on 29 November 2006 (Kaiser Daily HIV/AIDS Report, 30 November 2006). 
While supporting CDC’s objective of increasing the number of people tested for HIV, ACLU, 
NAPWA, and other organizations and individuals deplored the abandonment of the requirements 
of written consent and pre-test counseling and called on public health officials to develop and 
pilot new models to expedite and improve VCT services (see also Hilton Fisher, Hanssens & 
Schulman, 2006). New York State Health Commissioner Dr. Antonia Novello, a former U.S. 
Surgeon General, rejected the CDC’s recommendation as unwise.  In an op-ed, Dr. Novello 
argued that increased HIV testing “must not occur at the expense of adding problems to those 
who, unaware of their status, or in denial about their behavior, or in a situation where language 
barriers impede their comprehension, or in a situation where they fear violence or deportation, 
might not be able to cope with the newly acquired diagnosis” (Novello, 2006). Healthcare 
providers in India have also expressed “serious apprehensions” over the CDC recommendations, 
stating that they cannot be automatically adopted for India because of the prevalence of stigma 
and because “diagnosis, treatment and care are grossly inadequate” (Vijay, 2006). 
 
The CDC recommendations are similar to those offered earlier in 2006 by San Francisco City 
health agencies (Allday, 2006) and the New York City health department which recommended 
that the requirements for pretest counseling and written informed consent be eliminated and 
replaced with a requirement for consent with the right to opt out. In a circular about informed 
consent, the New York City health department recommends that physicians say to their patients, 
in advising them about all the blood tests that will be performed, “I am going to ... do an HIV 
test. Do you have any questions?” (New York City Department of Health and Mental Hygiene, 
2006) 
 
On 13 October 2006, an editorial entitled “AIDS Tests, Everywhere” in the New York Times 
called upon UNAIDS and WHO to “move quickly to endorse opt-out testing” (Editorial, 2006b). 
 
Also in October 2006, the Department of Health of South Africa released a draft of a new 
national policy on HIV counseling and testing which makes provision for the offer of counseling 
and testing to “any person motivated to know their HIV status who are 14 years of age and 
above” (Department of Health, 2006). The draft policy signifies a clear change from South 
Africa’s current policy on HIV testing of 2000, which is based almost exclusively on the VCT 
model. In particular, it provides that “[h]ealth providers recommend HIV counselling to all 
clients on a routine basis to ensure that all clients who would benefit from counselling and 
testing receive these services.” Groups that will be targeted by the routine offer also include 
clients diagnosed with or at risk of STIs or TB, “sexually active men and women with one or 
 
(Chou et al., 2005c). It concluded that “[g]iven the competing demands, the limited duration of the average primary 
care visit, and the very small likelihood that any 1 clinician would provide health benefits to an otherwise-undetected 
seropositive patient, the physician should consider whether this time might be better spent providing other preventive 
services … that carry the potential to improve outcomes for more patients” (Calonge & Petitti, 2005). 
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more sexual partners”, “vulnerable groups like pregnant women, commercial sex workers, 
migrant workers, substance users and long distance truck drivers and prisoners” and “women or 
couples considering pregnancy or concerned about transmission of HIV to their unborn child.” 
According to the draft, “counselling must always precede and follow testing”, “all clients should 
be given a choice to test or not to test”, and it is “highly recommended” to obtain a written 
consent before testing for HIV (Department of Health, 2006, at 10). A discussion paper by the 
AIDS Law Project, released on 31 October, supports the Department’s move towards “a more 
proactive and wide-ranging form of HIV testing” and states that “it is vital that the Department 
finalises the draft policy as a priority, but with wide consultation (Richter, 2006). 
 
On 23 November 2006, the French National AIDS Council released a report recommending 
changes to the “HIV testing paradigm” (Conseil National du Sida, 2006). In particular, the report 
suggests that the offer of an HIV test become routine in certain settings, including in health 
facilities in some regions of France where HIV prevalence is high, and that physicians be able to 
offer HIV testing without undertaking counseling “whenever counseling is a barrier to HIV 
testing” (ibid, at 8).  
 
On 28 November 2006, six months after the meeting at which a first draft was discussed, a 
revised draft of the WHO/UNAIDS “Guidance on Provider-initiated HIV Testing and 
Counselling in Health Facilities” was released (WHO/UNAIDS, 2006). WHO and UNAIDS 
sought further input before finalizing the guidance. The draft guidance elaborated upon the 2004 
joint policy statement on HIV testing and counseling (UNAIDS and WHO, 2004). Consistent 
with that statement, it recommended an opt-out approach to PITC in health facilities, but 
provided more detailed guidance on approaches to the implementation of PITC in generalized, 
concentrated, and low-level HIV epidemics (see the definitions section above for more 
information about the different types of epidemics), with options for phased implementation in 
priority settings where there are resource and capacity constraints. An HIV test was 
“recommended as a standard part of medical care for all patients attending health facilities in 
generalized HIV epidemics, and in certain settings in concentrated and low-level epidemics” 
(ibid, at 4). These settings included STI services, health services for most-at-risk populations and 
antenatal, childbirth and postpartum services (ibid, at 27). The guidance recognized that PITC is 
voluntary and the “three Cs” “must be observed” for PITC (at 5), but stated that individuals must 
specifically decline the HIV test if they do not want it to be performed” (at 4) and replaced pre-
test counseling with “simplified pre-test information” to obtain consent. It emphasized, however, 
that this “requires giving individuals sufficient information to make an informed and voluntary 
decision to be tested, including an opportunity to decline the test” (at 4), and specified minimum 
requirements for information that health care providers should give to patients as part of “pre-test 
information”. In addition, although it said that “access to antiretroviral therapy should not be an 
absolute prerequisite” for the implementation of PITC, the draft guidance document said that 
PITC “should be accompanied by a minimum set of HIV-related prevention, treatment, care and 
support services and implemented within the framework of a national plan to achieve universal 
access to antiretroviral therapy for all who need it” (at 6). Contrary to the first draft of the 
document, the “minimum set of prevention services” now included not only HIV prevention 
counselling for individuals and couples, promotion and provision of male and female condoms, 
and interventions to prevent mother to child transmission for pregnant women, but also “needle 
and syringe exchange (where permitted) and other harm reduction interventions for injecting 
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drug users” (at 30). In addition, the draft guidance said that at the same time as PITC is 
implemented, “efforts must be made to put in place a supportive policy and legal framework to 
maximize positive outcomes and minimize potential risks to the patient”, and that “national plans 
to achieve universal access to HIV prevention, treatment, care and support for all who need it 
should also address … broad social measures to protect the human rights of people living with 
HIV/AIDS and at risk of exposure to HIV” (at 7). As a result, contrary to the first draft, the 
guidance was consistent with the 2004 UNAIDS/WHO policy statement on HIV testing, which 
had been careful to link increased access to testing with access to prevention, care and treatment 
and to the creation of a more supportive legal and policy environment. The guidance concluded 
with a discussion of available testing technologies and of monitoring and evaluation of PITC. 
 
WHO and UNAIDS received approximately 170 sets of comments on the draft guidance, 
including from OSI, based on the extensive research undertaken for this paper. 
 
2007 
In June 2007, the final draft of the WHO/UNAIDS guidance document was released 
(WHO/UNAIDS, 2007). Among the many changes made to the document, the most significant 
are the following: 
• WHO and UNAIDS emphasize that VCT contributes significantly to helping people learn 
their HIV status, and that PITC programs are meant to complement, not replace, VCT. The 
document states that WHO and UNAIDS “strongly support the continued scale up of client-
initiated VCT”. 
• The document recognizes that innovative client-oriented approaches “such as services 
delivered through mobile clinics, in other community settings, through harm reduction 
programmes or through other types of outreach” are needed to increase access to and uptake 
of HIV testing and counseling for most-at-risk populations. In addition, it states that 
“consideration should … be given to recommending” HIV testing and counseling to 
members of most-at-risk populations at specific health services, such as acute care, STI or 
drug dependence treatment services. It acknowledges that an opt-in approach to informed 
consent “may merit consideration” for highly vulnerable populations. 
• The document no longer banalizes the risk of negative outcomes of HIV testing and 
disclosure, particularly for women, instead recognizing that these concerns need to be taken 
seriously. 
• The document states unequivocally that PITC “is neither mandatory not compulsory” and 
that WHO and UNAIDS “do not support mandatory or compulsory testing of individuals on 
public health grounds”. 
• The document recognizes that the evidence-base for scaling up PITC is more limited than 
had been suggested in the draft guidance, and emphasizes the need for monitoring and 
evaluation. 
 
Of all the different documents released over the last years, the WHO/UNAIDS guidance will 
likely have the biggest impact in shaping HIV testing policy and practice in low-and middle-
income countries. 
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Compulsory and mandatory HIV testing   
 
 
Key points 
• Mandatory and compulsory HIV testing occurs in many countries and contexts, in violation of 
ethical principles and basic rights of consent, privacy, and bodily integrity. 
• There is concern that making testing more routine – particularly by adopting approaches under 
which people are tested unless they specifically decline the test – may in practice result in even 
more instances of HIV testing without consent. In particular, official endorsement of such 
approaches by WHO and UNAIDS could be understood by some as an endorsement of a generally 
more coercive approach to HIV testing. 
• In the final version of their guidance, WHO and UNAIDS stress that they “do not support 
mandatory or compulsory testing of individuals on public health grounds”. In addition, they 
should undertake concrete activities to fight policy and practice requiring or permitting mandatory 
or testing. 
 
 
 
While the focus of this paper is on the current calls for “routinization” of HIV testing, many of 
those consulted in the course of drafting the paper and the position for OSI strongly 
recommended that compulsory and mandatory HIV testing be addressed as well. When asked 
what an OSI position on HIV testing should include, New York City’s commissioner of health, 
Thomas Frieden, said that, first and foremost, in the context of the countries in which OSI 
operates and the populations it works with, the statement should “strongly oppose mandatory 
testing” (interview on 14 September 2006). Generally, people consulted raised two concerns:  
 
• First, they said that for many of the populations they work with, mandatory or compulsory 
testing is a reality, whether they seek drug dependence treatment and are tested without their 
consent upon admission (and often rejected if they test positive), whether they are imprisoned 
and compulsorily tested upon incarceration, whether they work in the sex trade (and are 
subsequently criminalized further if they test positive), or whether they are listed for surgical 
procedures – and denied the procedures if they test positive (Malavade et al, 2002). 
Sometimes, such testing occurs because of policies or laws requiring it, but often it occurs 
surreptitiously, without the knowledge of the person being tested, in order to exclude people 
with HIV from access to certain services, or to impose restrictions on them. 
• Second, they expressed a concern that making testing more routine, particularly by adopting 
“opt out” models, would in practice result in even more instances of HIV testing without 
consent. They feared that official endorsement of opt-out PITC by WHO and UNAIDS 
would be understood by many as an endorsement of a generally more coercive approach to 
HIV testing. They said that, without a requirement for specific consent, testing would in 
effect become compulsory in many countries and in many situations.  
  
Others have cited similar concerns. In a recent press release, Human Rights Watch provided 
examples from around the world of existing or proposed HIV testing programs that violate 
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individual rights and contribute to neither HIV prevention nor treatment goals.  For example, in 
India, the state government of Goa has proposed mandatory premarital testing despite opposition 
by women’s groups and AIDS activists who recognize that empowering women to negotiate 
condom use and discuss AIDS with their partners and spouses is more important for their 
protection, before and during their marriage.  In Saudi Arabia, testing is mandatory for foreign 
workers, who are then confined to locked hospital rooms and deported if found to be HIV 
positive.  Human Rights Watch also pointed to proposals in the last few years in Malawi and 
Sierra Leone to test all journalists; in China to test all workers in the tourism sector and beauty 
parlors in the city of Guiyang; in Botswana to test all students applying for scholarships; and in 
India, to test all individuals wishing to obtain or retain a driver’s license in Punjab state (Human 
Rights Watch, 2006). 
 
In addition, many countries continue to apply universal HIV testing to people in certain 
institutions such as the military or prisons, or those undergoing certain evaluations, such as 
medical examinations when applying to immigrate or for insurance. For example, on 26 October 
2006, the Indian armed forces announced that HIV testing would become mandatory for those 
entering the armed forces (Anonymous, 2006). 
 
Crewe and Viljoen (2005) expressed a concern “that if ‘emergency’ measures such as routine 
opt-out or opt-in testing fail to reach the desired number of people, the next logical step under 
utilitarian principles might be to call for compulsory testing, either of selected groups (such as 
“high risk” groups) or for the population more generally.” An example of this slippery slope is 
evident in Zambia, where the National AIDS Council called for compulsory testing in hospitals 
and clinics as part of the program to place at least 100 000 people on ART by 2005 (Crewe and 
Viljoen, 2005, with reference). Other factors, such as inadequate training and intolerant attitudes 
of health care workers, may also see opt-out testing become compulsory in practice. “Faced with 
mounting pressure to treat large numbers of people with ARVs, policymakers or health care 
workers might confuse a call for increased HIV testing with a relaxation of the human right to 
consent” (ibid). 
 
As mentioned above, two of the most prominent and vocal proponents of changes to HIV testing 
policies, Richard Holbrooke and Bill Clinton, have already recommended widespread 
compulsory or mandatory testing, at least in some circumstances. Another proponent, Kevin De 
Cock, has stopped short of endorsing compulsory or mandatory testing. After providing many 
examples of how, in Africa, compulsory and mandatory HIV testing is widely practiced, he 
stated that “some of these examples of mandatory testing probably reduce HIV transmission, 
others yield little public health benefit but might further marginalise people infected with HIV.” 
He concluded that, 
 
if mandatory testing is practised, it should be based on scientifically supported rationales that apply to 
other infectious diseases, and should adhere to the same standards of provision of information, assurance 
of confidentiality, and referral for services and support as in voluntary testing. With a few exceptions, 
mandatory testing is likely to contribute fairly little to HIV prevention” (De Cock, Mbori-Ngacha, 
Marum, 2002, at 69). 
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However, he endorsed premarital testing, saying: “Unfortunately, premarital testing in 
industrialised countries did not have much effect, which has led to it being ignored in Africa’s 
high prevalence, heterosexual epidemic. For ethical and public health purposes, people should be 
strongly encouraged to learn the HIV status of prospective sex partners, undergo premarital 
testing, and notify their partners” (ibid, at 70). Calls for laws or guidelines to enforce mandatory 
HIV testing before marriage are becoming louder in some African countries and in practice, 
some religious leaders are asking people intending to get married to provide proof that they have 
had an HIV test (Opinion, 2006).  In October 2006, Dr Francois Venter, Head of the South 
African HIV Clinicians Society, argued that South Africa should institute mandatory HIV tests 
through employers, banks, and medical insurance programs, saying that all employers should 
insist on proof of an HIV test – but not the result – before offering a candidate a job, and that 
people should also be required to show proof of an HIV test to open a bank account, apply for a 
government grant, or deal in any way with bureaucracy (Quinn, 2006). 
 
According to the International Guidelines on HIV/AIDS and Human Rights drafted in 1996, 
“public health legislation should ensure that HIV testing of individuals should only be performed 
with the specific informed consent of that individual. Exceptions to voluntary testing would need 
specific judicial authorization, granted only after due evaluation of the important considerations 
involved in terms of privacy and liberty” (OHCHR & UNAIDS, 2006, at 27). International 
agencies working on HIV and public health authorities continue to reject compulsory or 
mandatory testing as unethical and a violation of human rights and as ineffectual in public health 
terms (WHO, 2003, at 9; UNAIDS/WHO, 2004). The one exception is HIV screening for blood, 
blood products and before all procedures involving transfer of bodily fluids or body parts, such 
as artificial insemination, corneal grafts and organ transplant, which is recommended by 
UNAIDS/WHO and is commonly required in national HIV policies, often legislatively. 
 
The August 2006 WHO and UNAIDS statement on HIV testing and counseling emphasizes that 
“provider-initiated testing and counselling should not be confused with mandatory testing” and 
that “testing must be voluntary and patients must retain the right to decline the test” (WHO & 
UNAIDS, 2006c). The WHO/UNAIDS guidance on PITC in health facilities also stresses that 
PITC “is neither mandatory nor compulsory” and that “WHO and UNAIDS do not support 
mandatory or compulsory testing of individuals on public health grounds” (WHO/UNAIDS, 
2007, at 20). 
 
Such statements should be welcomed. In addition, international agencies, particularly UNAIDS 
and WHO, need to demonstrate leadership on this issue by detailing what concrete activities will 
be undertaken to fight policy and practice requiring or permitting such testing, including: 
• developing model legislation that prohibits compulsory and mandatory testing 
• assisting governments to revise existing laws or policies requiring such testing 
• promoting government investment in scaling up accessible testing services, particularly for 
those most in need 
• developing a model code of conduct for health care providers and assisting with training 
testing providers and other health care providers on HIV and on human rights and ethical 
practice, and promoting the International Guidelines on HIV/AIDS and Human Rights 
(OHCHR & UNAIDS, 2006). 
No controversy: Need to scale up access to HIV testing 
 
 
Key points 
• There is complete consensus among AIDS activists and policy-makers in favour of vastly scaled 
up access to affordable and high-quality HIV testing. 
• Efforts to increase access are an important part of countries’ legal obligation to take steps to 
realize progressively every person’s human right to the highest attainable standard of health. 
• The real question is not whether HIV testing should be scaled up, but how it can best be scaled up, 
meeting the needs of different populations in different parts of the world, and what the right to 
health demands in terms of the testing services themselves. 
 
 
 
Today, it is undisputed that access to quality HIV testing is essential for an effective global 
response to HIV/AIDS, and there is 
complete consensus among AIDS 
activists and policy-makers in favour 
of vastly scaled up access to affordable 
and high-quality HIV testing. In his 
plenary speech at the XVI International AI
Grover of the Lawyers Collective HIV/AID
(Grover, 2006): 
 
Undoubtedly the vast majority of the people l
is in their interest to know that they are indee
appropriate treatment and also protect others.
There can be no two opinions on this proposi
 
Commentators have argued that the human
health, which essentially means the highes
services,4 underscores the need to increase
to non-discrimination, education, informat
of scientific progress and its applications. 
 
The authoritative comment on the right to hea
progress on attaining this right, suggests that 
HIV/AIDS-related health services, that are “s
as well as respectful of culture and medical et
 
WHO has stated: 
                                                          
4 International Covenant on Economic, Social and 
16 December 1966, article 12(1).  See also interpre
Cultural Rights.  General Comment No. 14: The rig
E/C.12/2000/4, 11 August 2000. 
5 General Comment No. 14 at pars 12c and 12d. Testing and counselling should be accessible to all and free of 
charge. This should be the central policy goal. 
- Canadian HIV/AIDS Legal Network, Center for Health and 
Gender Equity, Gay Men’s Health Crisis, 2006  22
DS Conference in Toronto in August 2006, Anand 
S Unit in India expressed this consensus as follows 
iving with HIV do not know that they are HIV- positive. It 
d HIV-positive so that they can protect themselves by taking 
 Therefore scaling up of testing is of the utmost necessity. 
tion.  
 right to enjoy the “highest attainable standard” of 
t attainable standard of health information, goods and 
 access to HIV testing and counseling, as do the rights 
ion and participation and the right to enjoy the benefits 
According to Csete & Elliott (2006): 
lth, from the UN committee that monitors governments’ 
the right to health includes basic services, including 
cientifically and medically appropriate and of good quality,” 
hics.5 We take this to include HIV testing.   
Cultural Rights.  United Nations General Assembly Res. 2200A, 
tation of this right in UN Committee on Economic, Social and 
ht to the highest attainable standard of health: Art 12 
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The right to health obligates governments to take legislative, budgetary and administrative steps towards 
the progressive realization of this right. The right to health includes the right to knowledge about one’s 
health status – in this case, knowledge of one’s HIV status through HIV testing and counselling. The right 
to health also includes the right to comprehensive care, treatment and support for health conditions, 
including for HIV/AIDS, and the medicines necessary to treat them. Since HIV testing is an essential first 
step to accessing such care, treatment and support, greater access to HIV testing should form a part of 
governments’ obligations to realize progressively the right to health. (WHO, 2003) 
 
While there is consensus on the need to scale up access to HIV testing, there are differing views 
on the essential elements of HIV testing and on the means by which greater access to HIV testing 
should be achieved. The real question is not whether HIV testing should be scaled up, but how it 
can best be scaled up, meeting the needs of different populations in different parts of the world, 
and what the right to health demands in terms of the testing services themselves. 
 
The General Comment on the Right to Health sets out the following conditions that should be 
applied to HIV testing as to any other form of health care: 
 
a. availability – sufficient quantity of sites, trained health professionals, testing kits 
etc 
b. accessibility – no discrimination in access (rural population, marginalized 
populations such as people who inject drugs, prisoners, migrants, youth, sex 
workers, men who have sex with men, etc), physically accessible, safe, affordable 
(if there is to be a cost), impartial information  
c. acceptability – respects medical ethics (including the right to confidentiality), 
sensitive to cultures, gender etc, information in local languages 
d. quality – reliable testing technology, quality of counseling 
 
Those interviewed in the process of writing this paper stressed the point that, while scale-up is 
needed everywhere, the discussion about scale-up has so far been driven primarily by the needs 
of countries in Sub-Saharan Africa most affected by the epidemic, in which there is also a real, 
concerted effort to also scale up access to ART. They emphasized that what may be ethical and 
work there may not be ethical and not work at all in other countries, particularly in countries in 
which the epidemic is concentrated among certain segments of the population that are often at 
the margins of society, and often have least access to ART and other treatment and care, as well 
as to evidence-based HIV prevention methods. 
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Making testing more routinely available: Agreements 
and disagreements 
 
Key points 
• For countries with a generalized HIV epidemic, there is consensus about the need to make testing 
more routinely available, and to combine scaled-up VCT with some form of PITC. 
• There is also consensus that efforts to increase access to HIV testing should not be limited only to 
countries with a generalized epidemic, but that certain forms of PITC should also be introduced in 
countries with low-level or concentrated HIV epidemics. 
• However, there is lack of agreement about a number of other issues concerning PITC and more 
generally, routinization of testing. In particular, there is a lack of agreement about whether and, if 
so, to what extent, the three underpinning principles of HIV testing (counseling, consent, and 
confidentiality) need to be or ought to be relaxed in an effort to increase HIV testing rates. 
 
 
 
Agreements 
 
While it will be important to continue – and scale up – efforts to improve and better resource 
VCT (see below, the chapter on voluntary counseling and testing services), this alone will not be 
sufficient to achieve vastly scaled-up access to HIV testing and counseling and, ultimately, 
universal access to prevention, care, treatment and support. 
 
The experience of ART roll-out has shown that when VCT and treatment are available and the 
community is mobilized around HIV testing, people do come forward voluntarily in larger 
numbers for testing.  One widely cited example is the Médecins Sans Frontières pilot project in 
Khayelitsha, South Africa, where, upon the widespread provision of ART, the number of people 
getting tested has also risen dramatically (Global HIV Prevention Working Group, 2004). 
Although in an earlier study, preceding more widespread availability of ART, only 14 percent of 
participants indicated they would be more likely to access VCT if ART became available (Day et 
al., 2003), more recent research in South Africa has confirmed a correlation between an increase 
in the uptake of VCT services and the availability of ART (Mfundisi et al., 2005). During a 
presentation at the XVI International AIDS Conference, Heywood referred more generally to the 
success of South Africa’s VCT scale up. Health facilities providing VCT have more than 
doubled from 1,500 in 2002/03 to 3,700 in 2004/05. The number of people counseled for testing 
in the public sector rose from 413,000 in 2002/03 to 691,000 in 2003/04 and 1,3 million in 
2004/05, and the total number of people tested rose from 247,287 in 2002/03 to 511,843 in 
2003/04 (Heywood, 2006). “Dramatically increased” demand for VCT has also been reported in 
settings such as Dar es Salaam, Tanzania (Maman et al., 2003; Maman et al., 2001). 
 
Nevertheless, for countries with a generalized HIV epidemic, there is consensus about the need 
to make testing more routinely available, and to combine scaled-up VCT with some form of 
PITC. There is also consensus that efforts to increase access to HIV testing should not be limited 
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only to countries with a generalized epidemic, but that certain forms of PITC should also be 
introduced in countries with low-level or concentrated HIV epidemics. As Heywood has stated 
(2005), a “commitment to the routine offer of testing has … become necessary because in most 
developing countries easy access to counseling, an HIV test, and information about AIDS in 
health facilities has been as scarce as access to anti-retroviral drugs.” Making HIV testing more 
routinely available can be expected to substantially increase the number of people who obtain 
HIV tests relative to approaches that rely on VCT alone (Metz, 2005).   
 
 
Disagreements 
 
However, while there is consensus that HIV testing should be more routinely available, there is 
lack of agreement about a number of other issues concerning PITC and more generally, 
routinization of testing. In particular, there is lack of agreement about: 
 
• whether or not pre-test counseling should be eliminated and replaced by some form of 
“simplified pre-test information” 
• what type of information provision is adequate to constitute true informed consent 
• whether or not PITC should be implemented using an “opt-in” or “opt-out” approach 
• the extent to which scale up of testing and counseling needs to be linked to availability of 
treatment, including ART, and evidence-based prevention information and tools 
• the extent to which scale-up of HIV testing needs to be linked to efforts to reduce stigma and 
discrimination, to protect women from gender-based violence, and to create supportive legal 
and social environments 
• the extent to which HIV/AIDS should be “normalized” and treated like other diseases and the 
role that expanding HIV testing can play in this, as well as the debate about whether 
routinizing HIV testing will or might reduce HIV-related stigma. 
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Human rights and the three Cs: counseling, informed 
consent and confidentiality 
 
Key points 
• In the early years of the epidemic, three underpinning principles of HIV testing (the “three Cs”) 
were established as norms: counseling and information about HIV/AIDS before and after the test; 
consent to be tested given in an informed, specific and voluntary way by the person to be tested; 
and confidentiality of test results and of the fact of seeking a test. 
• Some argue that the protections afforded by the three Cs are no longer justified and support 
models of HIV testing that eliminate or minimize specific, informed consent and counseling. 
Often, they do not adequately take into account the link between these elements and human rights. 
• In particular, informed consent has a clear foundation in ethics and in human rights law. 
International human rights law recognizes the individual right to withhold consent to medical 
treatment, including diagnostic tests.  Under international law, restrictions on rights can be 
justified, if certain conditions are met. 
• The question therefore is whether the conditions exist, particularly in countries with generalized 
HIV epidemics, to justify limiting or infringing the human rights protected by counseling and 
informed consent by relaxing the informed consent and counseling requirements of testing. 
Different conditions and populations may yield a different analysis. The burden of proof is on 
those who propose modifications to, or elimination of, the three Cs. 
 
 
 
As described above, in the early years of the HIV/AIDS epidemic, aggressive calls for punitive, 
forcible testing sparked widespread concern about the effects of such strategies on individual 
rights and the spread of the epidemic. Three underpinning principles of HIV testing were 
established as norms: 
 
∙ counseling and information about HIV/AIDS before and after the test; 
∙ consent to be tested given in an informed, specific and voluntary way by the person to be 
tested; 
∙ confidentiality of test results and of the fact of seeking a test. 
 
Central to the debate about routinization of HIV testing is whether and, if so, to what extent, 
these conditions should be relaxed. 
 
 
The approach taken in the WHO/UNAIDS guidance 
 
As mentioned above, the WHO and UNAIDS guidance on PITC in health facilities state that, “as 
in the case of client-initiated HIV testing and counselling, provider-initiated HIV testing and 
counselling is voluntary and the ‘three C’s’ – informed consent, counselling and confidentiality – 
must be observed” (WHO/UNAIDS, 2007, at 19). They specify that 
 
When recommending HIV testing and counselling, service providers should always aim to do what is in 
the best interests of the individual patient. This requires giving individuals sufficient information to make 
an informed and voluntary decision to be tested, maintaining patient confidentiality, performing post-test 
counselling and making referrals to appropriate services (ibid, at 6). 
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The emphasis on counselling around HIV diagnosis is unique in 
infectious diseases and merits discussion. Awareness of HIV/AIDS is 
now high in Africa, and evidence that more extensive pretest 
counselling is necessary for HIV than for other infections is lacking. 
What seems most necessary is to make access to information for HIV 
testing and prevention easily available, remove artificial barriers to 
testing, and provide appropriate information and medical and social 
support to infected people.  
De Cock, Mbori-Ngacha, Marum, 2002 
Nevertheless, the guidance recommends “simplified pre-test information” instead of pre-test 
counseling, and uses an informed “right of refusal” or “right to decline” approach to obtaining 
consent under which consent 
is assumed unless the patient 
expressly refuses or declines 
the test (i.e., “opt-out” 
routine testing). This is 
similar to the CDC’s revised 
recommendations on HIV 
testing in health-care settings 
(CDC, 2006). 
 
However, in a welcome development, WHO and UNAIDS have specified minimum 
requirements for “simplified pre-test information”. The guidance says: 
 
When recommending HIV testing and counselling to a patient, the health care provider should at a 
minimum provide the patient with the following information: 
 
• The reasons why HIV testing and counselling is being recommended 
• The clinical and prevention benefits of testing and the potential risks, such as discrimination, 
abandonment or violence 
• The services that are available in the case of either an HIV-negative or an HIV-positive test result, 
including whether antiretroviral treatment is available 
• The fact that the test result will be treated confidentially and will not be shared with anyone other than 
health care providers directly involved in providing services to the patient 
• The fact that the patient has the right to decline the test and that testing will be performed unless the 
patient exercises that right.  
• The fact that declining the test will not affect the patient’s access to services that do not depend upon 
knowledge of HIV status 
• In the event of an HIV-positive test result, encouragement of disclosure to other persons who may be  
at risk of exposure to HIV 
• An opportunity to ask the health care provider questions. (WHO/UNAIDS, 2007, at 36) 
 
The guidance adds that patients “should also be made aware of relevant laws in jurisdictions that 
mandate the disclosure of HIV status to sexual and/or drug injecting partners” (id). As mentioned 
above, it recognizes that “additional measures to ensure informed consent may be appropriate” 
for “some patient groups, such as populations most at-risk of HIV transmission and women” 
(ibid, at 37).  
 
In addition, the guidance states that “[a]t the same time as provider-initiated HIV testing and 
counselling is implemented, equal efforts must be made to ensure that a supportive social, policy 
and legal framework is in place to maximize positive outcomes and minimize potential harms to 
patients” (ibid, at 32). It continues by saying that the implementation of PITC is likely to require 
a major investment in training and ongoing supervision of health care personnel in the processes 
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of obtaining informed consent, maintaining confidentiality, counselling referral, and treating 
patients decently and without discrimination due to HIV status or perceived risk behaviours. 
 
One of the “basic elements” of the social, policy and legal framework required to support PITC 
is “an ethical process for obtaining informed consent”. The guidance states that 
 
Guidance and ongoing supervision must be provided to health care providers on the process of obtaining 
informed consent. Patients must receive adequate information on which to base a personal and voluntary 
decision whether or not to consent to the test, and be given an explicit opportunity to decline a 
recommendation of HIV testing and counselling without coercion. (ibid, at 33) 
 
 
Proposals to further relax or abandon counseling and informed 
consent 
 
In contrast to the WHO/UNAIDS guidance, the U.S. CDC recommendations for HIV testing in 
health-care settings in the U.S. state only that “patients should be informed orally or in writing 
that HIV testing will be performed unless they decline” and that “oral or written information 
should include an explanation of HIV infection and the meaning of positive and negative test 
results, and the patient should be offered an opportunity to ask questions and to decline testing” 
(CDC, 2006, at 7-8). Going even further, in a circular about informed consent, the New York 
City health department recommends that physicians say to their patients, in advising them about 
all the blood tests that will be performed, “I am going to ... do an HIV test. Do you have any 
questions?” (New York City Department of Health and Mental Hygiene, 2006). The French 
National AIDS Council seems to propose a similar approach, suggesting that in certain 
circumstances, if counseling is a barrier to testing because physicians do not have the time or the 
training necessary to undertake it, HIV testing may be offered without any counseling (Conseil 
national du sida, 2006, at 8, 21). It is not clear whether any form of pre-test information would 
still be required. 
 
At their crudest, proponents of routine testing have gone so far as to dismiss the ethical and 
human rights requirement that testing be voluntary: in 2004, before the recent changes to U.S. 
policy, Holbrooke and Furman asserted that “current United Nations and United States policy on 
testing simply does not work” and that “it is time to abandon this ethnocentric Western rhetoric, 
born in the 1980s in the United States under different circumstances, that led to the ‘V’ in 
V.C.T.” (2004). Others have argued that the protections afforded by the three Cs treated 
HIV/AIDS as exceptional, because it was exceptional in the early years of the epidemic, but that 
“the world has changed”, stigma has decreased, and treatment is now “widely available”. They 
suggest that, where treatment is available, “the exceptionalisation of HIV infection in the 
healthcare setting may be impeding its effective management” and that the “exceptional 
protections for HIV testing” in the healthcare setting should be relaxed (Cameron, 2006). With 
regard to the requirements of express and specific consent and pre-test counseling, Cameron 
states: 
 
These safeguards are intended for the protection of people with HIV; but today I suggest that they also serve 
to reinforce the inner fears and dread – the inner sense of self-contamination – of those who suspect they may 
have HIV… People shy away from being tested because the requirements relating to consent and counselling 
accentuate the differentness  and distinctness and horror of AIDS. They emphasise to the patient that this 
disease is exceptional, abnormal, unusual. As a result, rather than consenting to testing, many shy away. 
They prefer to ascribe their symptoms to causes other than HIV, when all too often the routine administration 
of a test will confirm the opposite, and will open the way to effective management of their condition” 
(Cameron, 2006). 
 
In a 2006 article, Csete and Elliott summarized the arguments made by proponents of relaxing or 
abandoning counseling and informed consent requirements as follows: 
 
∙ VCT, especially with counseling and informed consent, is too slow and costly to be a 
useful tool for a public health emergency on the scale of HIV/AIDS, especially in high-
prevalence countries 
∙ pre-test counseling has dissuaded physicians from offering the test because of the amount 
of time it takes and because it forces them to raise issues they may not feel comfortable 
discussing with their patients 
∙ pre-test counseling has dissuaded clients from taking an HIV test or created a barrier or 
impediment to testing when it provides an overload of information  
∙ HIV/AIDS awareness is already very high in most high-prevalence countries, and 
therefore there is less need for counseling (De Cock, Mbori-Ngasha, Marum, 2002) 
∙ the exceptional human rights protections related to HIV testing compared to those of 
other infectious diseases only add to stigma; normalizing HIV testing and less insistence 
on confidentiality or anonymity of testing will reduce stigma; and 
∙ VCT actually may undermine 
social justice in that it restricts 
people’s access to testing, 
which is essential to treatment 
and care.  
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Instead of arguing that the requirement of informed consent 
has not been raised to an unjustifiably high level for HIV care 
(“AIDS exceptionalism”), we should assert that it has been 
tolerated at a low level for other communicable diseases … 
Heywood 2005 
Some proponents of routinizing HIV testing argue that safeguards to protect human rights must 
be part of the universal offer of testing and counseling, but warn that procedures that safeguard a 
patient’s autonomy at the expense of his or her health and well-being undermine the moral and 
logical basis of human rights themselves (Heywood, 2005, at 15, with reference to Nieburg et al., 
2005). According to Heywood, 
 
this argument artificially pits a person’s right to autonomy against his or her right to health and well-
being – as if the two can be separated. It leads down a dangerous road – away from the principle that a 
human rights approach will complement and strengthen a public health approach. 
 
Indeed, as was pointed out above, HIV testing and counseling are properly seen as an aspect of 
the human right to the highest attainable standard of health. Heywood also points out that, 
contrary to what some have argued (e.g., Cameron, 2006) the requirement of informed consent 
has not been raised to an unjustifiably high level for HIV care. Rather, it could be said that it has 
been tolerated at an unjustifiably low level for other communicable diseases (Heywood, 2005).  
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The link between the “three C’s” and human rights 
 
Arguments in favour of models of HIV testing that eliminate or minimize specific, informed 
consent and counseling often do not adequately take into account the link between these 
elements and human rights. As Rennie and Behets (2006) have put it, “the difficulties and 
complexities associated with a genuine consideration of human rights, particularly in resource-
poor countries, are often downplayed by advocates of the new routine testing policies.”  
 
Central to the human rights calculus related to HIV testing is the notion of informed consent. 
Informed consent is defined as “a process of communication between a patient and physician that 
results in the patient’s authorization or agreement to undergo a specific medical intervention” 
(American Medical Association, 1998).  What constitutes sufficient information to ensure that 
consent is informed is contextual, determined by the nature and complexity of the condition at 
issue and the consequences of the diagnosis, and subsequent care and treatment that may be 
available. The patient should have an opportunity to ask questions for a better understanding of 
the treatment or procedure to allow an informed decision to proceed or to refuse a particular 
course of medical intervention. 
 
Informed consent has a clear foundation in ethics and in human rights law. International human 
rights law recognizes the individual right to withhold consent to medical treatment, including 
diagnostic tests.6 This right derives from the principle of individual autonomy, which has its 
roots in the inherent dignity of every individual7 and recognizes that an individual has the right 
and ability to make decisions on his or her person and private information, as opposed to a 
paternalistic approach in which the physician has the right and duty to make such decisions on 
behalf of the patient. Testing for HIV without informed consent represents an involuntary 
intrusion into bodily integrity, which is protected by the right to liberty and security of the person 
in article 9 of the International Covenant on Civil and Political Rights (ICCPR).8 
 
The ICCPR also protects the right to seek and receive information, which is central to informed 
consent.9 Pre-test counseling contributes to the fulfillment of these same human rights.  Post-test 
counseling also imparts information to which people have a right. Confidentiality of test results 
and of the fact of seeking an HIV test is part of respecting and protecting the right to privacy.10 
Finally, each of these rights should be viewed as part of appropriate and quality health care, 
which is protected under the right to the highest attainable standard of health in the International 
Covenant on Economic, Social and Cultural Rights. 
 
6 See, eg, UN Committee on Economic, Social and Cultural Rights, The Right to the Highest Attainable Standard of 
Health: CESCR General Comment 14, UN Doc. E/C.12/2000/4 (November 8, 2000), para 8 “The right to health 
contains both freedoms and entitlements.  The freedoms include the right to control one’s health and body, including 
... the right to be free from interference, such as the right to be free from ... non-consensual medical treatment and 
experimentation.” 
7 Universal Declaration of Human Rights arts 1 and 3. 
8 International Covenant on Civil and Political Rights. United Nations General Assembly Res. 2200A, 16 December 
1966, article 9(1). 
9 Ibid. at article 19(2). 
10 Ibid. at article 17(1). 
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Beyond the components of the testing process itself, governments have a responsibility to ensure 
that HIV testing, like all other essential health services, is not offered or provided in a way that 
discriminates against any person or group of people.11 The right to be free of discrimination and 
the right to security of the person, also require that in both HIV testing policy and practice, 
governments take into account the outcomes of HIV testing for people – including stigma, 
discrimination, violence and other abuse – and do all that they can to prevent human rights 
violations associated with this health service. As Csete, Schleifer, and Cohen (2004) have stated:  
 
AIDS-related human rights concerns encompass subordination of women and girls, stigma and 
discrimination faced by people living with HIV/AIDS and those at high risk, the right of all people to 
HIV/AIDS information and services, and the right to health of newborn children. Informed consent and 
confidentiality are linked to all these other rights, particularly in settings where HIV/AIDS still carries a deep 
stigma, and should not be considered in isolation. 
 
Restrictions on these rights can, of course, be justified. In 1985, a UN human rights body 
suggested conditions under which it may be justifiable for a society, including public health 
authorities, to limit or infringe upon human rights to some degree.  Among the conditions 
identified are the following: 
 
• when the limitation on human rights “responds to a pressing public or social need,”  “pursues 
a legitimate aim and is proportionate to that aim”; 
• when the limitation represents “no more restrictive means than are required for the 
achievement of the purpose of the limitation”; 
• when the limitation is not applied in an arbitrary or discriminatory manner; 
• when the limitation is provided for by law; and 
• when the limitation does not violate “non-derogable” rights, which include the right to life 
and freedom from medical or scientific experimentation without free consent.12 
 
The question therefore becomes whether the conditions exist, particularly in countries with 
generalized HIV epidemics and for most-at-risk populations in countries with low-level and 
concentrated HIV epidemics, to justify limiting or infringing upon human rights by relaxing the 
informed consent and counseling requirements of testing. Different conditions and populations 
may yield a different analysis. 
 
The burden of proof is on those who propose modifications to, or elimination of, the three Cs, to 
build a body of evidence showing that new models of HIV testing that relax the counseling and 
informed consent requirements do not violate the human rights of persons tested in the proposed 
testing process or contribute, in ways that could be avoided or minimized, to subsequent human 
rights violations experienced by people who get tested (Tarantola, 2005; Canadian HIV/AIDS 
Legal Network, Center for Health and Gender Equity, Gay Men’s Health Crisis, 2006). 
 
11 International Covenant on Economic, Social and Cultural Rights, article 2(2). 
12 UN Economic and Social Council, UN Sub-Commission on Prevention of Discrimination and Protection of 
Minorities.  Siracusa Principles on the Limitation and Derogation of Provisions in the International Covenant on 
Civil and Political Rights (Annex).  UN Doc E/CN.4/1984/4 (1984), articles I.A., II.D. 
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Can relaxation or elimination of counseling and 
informed consent requirements be justified? 
 
 
Is it justified to replace pre-test counseling with so-called pre-test information, and is it justified 
to adopt an informed right of refusal approach, under which people are tested unless they opt out 
of testing? 
 
Those who answer this question in the affirmative generally argue that new approaches to testing 
that incorporate these elements are justified because they are necessary to increase the number of 
people being tested, and ultimately the number of people who contribute to prevention and 
treatment goals by changing their behaviors and seeking treatment. They also assume that few 
human rights abuses and other negative consequences will result from this approach. Finally, 
they assume that less rights-restricting alternatives such as increased VCT and/or PITC with an 
opt-in approach will not achieve these objectives. 
 
These arguments have been made with regard to countries with generalized HIV epidemics, and 
with regard to high-income countries with “hidden HIV epidemics”, specifically the U.S., the 
United Kingdom, and France. In the WHO/UNAIDS guidance on PITC in health facilities, they 
have been expanded implicitly to most-at-risk populations in countries with low-level or 
concentrated epidemics, while recognizing that special protections may be needed to ensure that 
members of these populations do not suffer adverse consequences. The following sections 
examine these assumptions. 
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Increasing uptake of HIV testing  
 
Key points 
• A great number of studies has shown that making the offer of HIV testing and counseling routine 
and recommending testing makes patients more likely to undergo testing.  However, with the 
exception of a few studies in antenatal settings, no studies have compared opt-in and opt-out 
approaches to PITC.   
• Studies also suggest that pre-test counseling and informed consent requirements do not necessarily 
pose barriers to implementation of PITC, even in resource-poor settings. 
• Many studies suggest that more tests alone are not a sufficient achievement.  For example, studies 
have shown that many of the pregnant women who accept HIV testing in antenatal settings in 
resource-poor settings do not obtain their results or take up perinatal HIV interventions. Another 
concern is low HIV-serostatus disclosure rates to sexual partners. 
 
 
An increasing number of studies, the vast majority of which were undertaken in prenatal settings, 
show that various forms of routinizing HIV testing and counseling yield high rates of testing. 
 
Experience in high-income countries 
 
Prenatal settings 
Studies in high-income countries have shown that PITC in prenatal settings leads to high 
numbers of women being tested. Opt-out PITC (with the right to decline) has been associated 
with the highest proportions of individuals tested (Anderson, 2005; CDC, 2002; Jayaraman et al., 
2003; Walmsley, 2003; Mossman, 2002; Bitnun et al., 2004). 
 
Several factors appear to influence testing rates. One randomized trial undertaken in the United 
Kingdom in 1996/97 found that prenatal testing rates were significantly higher in women offered 
testing (35 percent) than in those not receiving a direct offer (6 percent), independent of whether 
a comprehensive or minimal pretest counseling protocol was used, but uptake varied widely 
between individual providers offering the test (Simpson et al., 1998). Testing rates were 
generally higher in places that used an “opt-out” approach (Chou et al., 2005b). While in 
Ontario, Canada, the opt-in testing and counseling policy for pregnant women delivers results 
comparable to most opt-out policies (Schietinger, 2006; Remis et al., 2003; Remis et al. 2004; 
Remis et al., 2006), in studies in the United Kingdom and the United States, the proportion of 
pregnant women undergoing prenatal HIV testing increased from 33 to 74 percent with the “opt-
in” strategy to 81 to 88 percent with the “opt-out” strategy (Stringer et al., 2001; Simpson et al., 
1998; Simpson et al., 1999a; Simpson et al., 1999b; Blott et al., 1999; CDC, 2002). In part, this 
increase may be explained by evolving attitudes among both women and providers, owing to 
increasing knowledge about effective treatment and considerable media exposure, but the 
magnitude of the increase nevertheless suggests that more women take up testing under the “opt-
out” approach. In Alberta, Canada, the implementation of an “opt-out” prenatal HIV testing 
policy also resulted in a “dramatic” increase in the number of women tested (Jayaraman et al., 
2003). However, even with the “opt-out” approach, many women may decline testing if their 
provider does not recommend and encourage HIV testing, suggesting that education and training 
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about the importance of recommending the test must be delivered to all prenatal care providers 
(Anderson et al., 2005). A number of studies confirms that strong provider endorsement of 
testing increases the number of pregnant women getting tested for HIV (Lindsay et al., 1991; 
Royce et al., 2001).  
 
A small number of studies explored what pregnant women think about the HIV test. In one 
study, most women (87.7 percent) answered yes to the question, “Do you think the HIV test 
should be a routine test like all the other blood tests during pregnancy (i.e., it’s done unless you 
say you don’t want it)?” (Simpson et al., 1999a). A small qualitative study suggested that routine 
testing would cause less anxiety to pregnant women because it would eliminate the stigma of 
saying yes to testing (Boyd et al., 1999). Other studies showed that policy and practice may 
differ greatly with respect to pre-test counseling and informed consent (Leonard et al., 2002; 
Leonard et al., 2001; Leonard, 2001; Leonard & Shap, 1999; Howard Research and Instructional 
Systems, Inc., 2001). In these studies, many pregnant women reported that they did not 
experience the offer to test as voluntary and did not feel that they had given their informed 
consent to be tested. Some women thought that HIV testing in pregnancy was mandatory, or that 
there were good reasons for not “making a fuss” about the testing offer before them, and most 
women went along with prenatal HIV testing in absence of any meaningful pre-test discussion 
(Csete & Elliott, 2007, with references). 
 
 
Outside the prenatal setting 
Outside the prenatal setting, a small number of studies have indicated that a high proportion of 
patients find PITC an acceptable intervention. 
 
• In a sexually transmitted infection clinic in the U.S., HIV was added to the list of tests 
offered to all patients, who were informed at registration and given a consent form to read 
and sign (Campos-Outcalt, 2006).  Each person who signed the form was provided 
counseling during the clinical encounter (which consisted of answering the patient’s 
questions regarding the test and providing general prevention information). Sixty-eight 
percent of patients accepted testing, and 5.6 percent of those tested were seropositive. 
• In a small study, 72 hospitalized patients in the U.S. were asked about how they would feel 
about an unsolicited HIV test. Only 11 percent had an unfavorable response (Greenwald JL, 
2006). 
• Studies of routine testing at genitourinary clinics in the United Kingdom also demonstrated 
that many patients will accept HIV testing and counseling when it is offered (Lee, 2005; 
Jones, Peterson & Watson, 2005) and that the uptake increases when an “opt-out” testing 
policy is adopted (Day et al., 2004). 
 
 
Experience in resource-poor settings 
A fairly large number of studies have been undertaken in African countries to compare HIV 
testing uptake under different testing strategies and to assess what other factors affect uptake of 
HIV testing. Many of these studies were undertaken in prenatal settings, but some focused on 
uptake of testing in other settings such as TB clinics or workplaces and others examined uptake 
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of testing at free-standing or clinic-based VCT centres. The results of these studies have been 
summarized as follows: 
 
Direct offer of HIV testing in a convenient location usually leads to high uptake in both health-care settings 
and community settings. Acceptance of provider-initiated testing can exceed 90% for antenatal clinic 
attendees and patients presenting with opportunistic infections, but with rates of return of only 45%–75% 
when a repeat visit is required. However, only a minority of African adults will make unsolicited visits to 
free-standing or clinic-based VCT centres. Major disincentives include fear of being seen, fear of breach of 
confidentiality, inability to cope or adverse life events if found to be positive, and a sense of futility if testing 
is not linked to HIV care. Accessibility and cost are also important. Making counselling and receipt of results 
available through home visits increased uptake of community-based VCT from 10%–12% to 37%–87% in 
four different African studies. Thus, the consistent finding is that relatively minor differences in accessibility 
translate into major differences in acceptability of [testing and counseling] in Africa. (Corbett et al., 2006, 
with many references) 
 
WHO/UNAIDS also note that evidence from resource-poor settings “indicates that the uptake of 
testing increases when testing is routinely discussed and offered, and when it is well-integrated 
into prenatal care” (WHO/UNAIDS, 2007, at 16, with many references). They continue by 
saying: 
 
Findings from a growing number of studies in settings other than pre-natal care are also encouraging. 
Comparisons of data collected before and after the introduction of provider-initiated HIV testing and 
counselling consistently show significantly higher uptake, as documented in post-partum wards in Botswana; 
pediatric wards in Zambia; tuberculosis clinics as well as Ugandan pediatric wards, maternity ward and STI 
clinics. In Mbarara hospital in Uganda, increased uptake of HIV testing appeared to be associated with 
clinical benefits for patients. People diagnosed HIV-positive after provider-initiated HIV testing and 
counselling was introduced were at an earlier clinical stage and had higher CD4 counts than those identified 
beforehand, and were therefore more likely to be referred to treatment at an appropriate time. (ibid) 
 
However, while there are many studies about various forms of HIV testing, including PITC with 
an opt-in approach, only a few studies examine PITC with an opt-out approach. A number of 
studies that have been cited as evidence of the fact that opt-out approaches in resource-poor 
settings show results similar to those obtained in the U.S., Canada, or the United Kingdom 
(WHO/UNAIDS, 2006, at 14, notes 39, 42 and 43), and also “cause less anxiety for women than 
an ‘opt-in approach’ (at 14, note 42), are not studies about opt-out approaches at all. Instead, two 
of the studies analyzed the effect of testing approaches under which the offer of HIV testing 
became a part of routine antenatal care, but women were tested only after group and individual 
counseling and if they opted in to testing (Etiebet et al., 2004), or after counseling and accepting 
the HIV test (Shankar et al., 2003). The third study analyzed factors influencing acceptability of 
VCT in a district of Uganda with a view to suggesting measures for increasing uptake (Nuwaha 
et al., 2002). Ultimately, only a few studies suggest that opt-out approaches may indeed lead to 
increased uptake of HIV testing among pregnant women in resource-poor settings: 
 
• A study presented at the XVI International AIDS Conference in Toronto in August 2006 
showed that in Malawi, in the 9 months between April and December 2005, 14,495 (98.3 
percent) women at prenatal clinics were counseled and 14,491 (98.3 percent) were tested 
after the government adopted new guidelines recommending an opt-out strategy in antenatal 
clinics – compared to 15,343 women who came to clinics in the 9 months between July 2004 
and March 2005, of whom 11,689 (76.2 percent) were counseled and 11,674 (76.1 percent) 
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were tested. Under the new guidelines, women receive group pre-test counseling and are then 
tested for HIV unless they specifically request to not be tested (Zimba et al., 2006).13 
• Another study, undertaken in Zimbabwe, suggested that an opt-out strategy would be 
acceptable to pregnant women if it was implemented (Perez et al., 2006). It warned that the 
“possible negative impacts in the implementation of this strategy should not be neglected” 
and suggested that close monitoring of issues such as whether such a strategy would deter 
women from seeking prenatal care or result in fewer women returning for their test results 
would be necessary. Preliminary results from the pilot phase of the implementation of the 
new strategy showed a significant increase in counseling and testing rates in both urban and 
rural settings (99.9 percent of antenatal clinic bookings tested versus 65 percent under the 
traditional VCT model and 95 percent versus 54 percent, respectively). At the same time, the 
introduction of routine testing did not seem to have any negative effects on post-test 
counseling rates or the delivery of ARV prophylaxis (Miller et al, 2006).  
 
However, studies in a number of countries have shown that opt-out approaches may not be 
necessary to obtain high uptake of HIV testing. When the offer of HIV testing and counseling 
was integrated into routine antenatal services, up to 97 percent of women accepted the offer and 
opted in to HIV testing (see, e.g., Malonza et al., 2003; Etiebet et al., 2004; Shankar et al., 2003; 
Kiarie et al., 2000). 
 
More information on these studies and other studies undertaken in low- and middle-income 
countries outside Africa can be found in Appendix 1.  
 
Information about the only country-wide program of PITC using an opt-out approach, introduced 
in Botswana in 2004, also remains limited. However, it is known that the number of people 
tested for HIV in Botswana has increased substantially since the program was introduced and 
that most people express support for the program: 
 
• It has been reported that the number of people tested for HIV increased by 134 percent in 
2005, that only 10 percent of those who were offered the test did not go ahead with it, and 
that 41 percent of those tested were HIV-positive (Alcorn, 2006; Steen et al., 2007; 
Rajaraman & Surender, 2006).  
• A study of antenatal clinics in Francistown showed that in the first three months of routine 
opt-out testing, 90.5 percent of pregnant women were tested for HIV, compared with 75.3 
percent during the final four months of opt-in testing (Seipone et al., 2004). Attendance at 
antenatal clinics remains high at more than 95 percent (Steen et al., 2007). However, the 
success of the policy was mitigated by the fact that many of the women who were tested 
failed to return for their results – 29.4 percent during the opt-in period and 33 percent during 
the first three months of routine testing (a statistically insignificant difference: Seipone et al., 
2004). 
• A population-based study in Botswana indicated that most people (81 percent) reported being 
extremely or very much in favour of routine testing (Weiser et al., 2006). It should be noted 
that almost half of the people interviewed in the study had never heard about the routine 
13 According to newspaper reports, however, some women are shunning hospitals “fearing that they will be forced to 
undergo an HIV test” (Kumwenda, 2006). 
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testing policy and responded to questions about routine testing after the policy was explained 
to them by the researchers. In addition, only 15 percent of those tested had actual experience 
with routine testing. 
 
Increasing uptake: Summary and discussion 
The research about uptake of HIV testing can be summarized as follows: 
  
• There can be no question that introducing PITC in health facilities leads to increased uptake 
of HIV testing. A great number of studies, particularly in antenatal settings, but also in STI or 
TB clinics and other settings, has shown that making the offer of HIV testing and counseling 
routine and recommending testing makes patients more likely to undergo testing. 
• There is also evidence from a small number of studies, particularly in resource-rich settings, 
that in antenatal settings adoption of an opt-out approach leads to particularly high rates of 
HIV testing uptake. However, studies in a number of countries – both in high-income 
countries and resource-poor settings – have shown that opt-in approaches can result in uptake 
rates that are comparable to those reached in jurisdictions using an opt-out approach. 
• With the exception of the studies in antenatal settings, no studies have compared opt-in and 
opt-out approaches to PITC. 
• Generally, studies on PITC suggest that, whether an opt-in or an opt-out approach to PITC is 
adopted, most people will accept the offer if providers recommend and encourage HIV 
testing. 
• Studies also suggest that pre-test counseling and informed consent requirements do not 
necessarily pose barriers to implementation of PITC, even in resource-poor settings. In fact, 
in many of the studies, these requirements were not relaxed. High HIV testing uptake rates 
were found 
• in settings in which group pre-test information was provided, but also in settings in which 
both group and individual pre-test counseling were provided; and 
• in settings in which consent to testing was assumed unless the patient expressly refused 
the test, but also in settings in which people had to sign written consent forms. 
• A study that compared various pre-test counseling protocols found that “neither anxiety nor 
dissatisfaction increased with the amount of information given, lending no support to 
previous suggestions that comprehensive discussion may have an adverse impact” (Simpson 
et al., 1998). 
• One study found that HIV testing acceptance rates of pregnant women who are routinely 
offered HIV testing can be further increased when women: 
• understand the modes of vertical transmission and the role of medication in preventing 
transmission; 
• believe that prenatal identification of HIV infection can promote the health of the mother 
and child; and 
• perceive their providers as strongly endorsing prenatal testing (Fernandez et al., 2000). 
 
According to the authors, these points can be woven into a pre-test counseling message and 
made a routine component of prenatal care with little additional burden on providers. They 
point out that it may take longer than what some providers currently provide in terms of pre-
test counseling, but is shorter than what is required by many existing counseling and testing 
guidelines; and that it would also provide a foundation for a pregnant women who tests HIV-
positive to accept treatment for herself and her baby (Fernandez et al., 2000, at 468). The 
study suggests that pre-test counseling requirements may be somewhat relaxed, but that it 
would be counterproductive and ultimately reduce the number of people who take up HIV 
testing if that relaxation goes too far and if providers fail to provide people with information 
that will help them make an informed decision. As Hilton Fisher, Hanssens and Schulman 
(2006) point out, “health care providers committed to increasing HIV testing can do so 
efficiently and effectively while respecting their patients’ fundamental right to informed 
consent”.14 They continue by saying: 
 
Nearly all people offered HIV testing in a thoughtful, careful way — even people in the midst of a 
medical trauma — accept the offer. The few who do not accept it typically have good reason not to at 
that particular time; skilled counselling could ensure they return to test when the time is right for 
them.  State legislatures can be assured that there is no basis to abandon the fundamental legal right of 
patients to informed consent in order to make HIV testing more “routine. (ibid) 
 
 
Increasing uptake of HIV 
testing is not enough 
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Just the fact of having been tested may not necessarily be a positive 
outcome if the extra margin of people who are routinely tested includes a 
significant number who were not well prepared for testing, who do not 
have adequate information to understand what their test result means for 
their lives and those around them, who may have irrational fears of HIV 
because they have had little information about the disease, or who may 
not know how to begin to disclose their status to sexual or drug-using 
partners. 
Csete and Elliott, 2006, at 6-7 
Efforts to increase uptake of HIV 
testing are important, but many 
studies suggest that more tests 
alone are not a sufficient 
achievement. 
 
Uptake of HIV interventions 
Importantly, although 75 to 97 percent of pregnant women in sub-Saharan Africa accept HIV 
testing in antenatal settings offering counseling and testing, between 25 and 55 percent of 
women consenting to the test do not obtain their results (Cartoux et al., 1998). From a public 
health perspective, this suggests a need to link HIV testing policies with technologies that allow 
rapid testing (in which people can learn their test results on the spot), as well as a need to address 
the reasons why women do not get their results. A randomized trial undertaken in Kenya 
demonstrated that pregnant women randomly assigned to rapid HIV testing were more likely to 
obtain their results than women randomly assigned to conventional ELISA testing (96 versus 73 
percent: Malonza et al., 2003). However, although rapid testing was associated with a 
significantly increased rate of obtaining results, there was no significant difference in the overall 
uptake of perinatal HIV interventions between the women in the two groups: significantly fewer 
                                                          
14 Hilton Fisher, Hanssens & Schulman (2006) describe a pilot program to increase HIV testing of pregnant women 
by offering counseling and rapid HIV tests to women in active labor who did not have HIV tests already in their 
records, implemented in Illinois, US, since 2005 (Collins & Haufle, 2005). One year after the program began, the 
percentage of women accepting HIV testing rose from 86.7 to 97.1. By early 2006, that percentage had risen to 97.9 
(Garcia et al., 2006; Collins & Haufle, 2005). They continue by saying: “Similar results have been obtained in 
similar programs in other states, such as California. In fact, contrary to the CDC’s and others’ interpretation that the 
U.S. perinatal testing experience demonstrates that informed consent prior to HIV testing is dispensable, perinatal 
transmission of HIV has been all but eliminated in this country with informed consent in most states.  Data from the 
Perinatal Guidelines Project further supports the experience of Illinois — i.e., that the vast majority of women 
accept HIV testing if it is recommended by their health-care provider”. 
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HIV-positive women who received rapid testing accepted referral for perinatal HIV interventions 
than women who received conventional testing. According to Malonza et al. 
 
women may have been unable to cope with the HIV/AIDS information on the same day as receiving their 
HIV-1 test results. With rapid HIV-1 testing, there may be limited time for women to comprehend the 
implications of a positive diagnosis and to decide on what action to take. In contrast, conventional testing 
provides ample time for women to decide on their readiness to receive HIV-1 results, and those who 
choose to get their results are prepared to accept the diagnosis, the implications of a positive test, and 
referral for perinatal HIV-1 interventions. 
 
More broadly, this study and many other studies showing low rates of uptake of perinatal HIV 
interventions (see Appendix 2), suggest that policies that may increase uptake of testing may not 
be enough to ensure increased uptake of perinatal HIV interventions – despite preliminary 
evidence from the pilot phase of the introduction of routine HIV testing in antenatal clinics in 
Zimbabwe, which resulted in “increases in the percentages of HIV-infected women and their 
infants receiving ARV prophylaxis in the majority of health facilities” (Miller et al., 2006). 
“Girls and women may feel intimidated or obliged to comply with the health care providers’ 
request to be tested, but at the same time perceive too many risks in actually learning their status 
and in acting upon that knowledge” (Nieburg, Cannell, Morrison, 2005, at 13). Ultimately, “one 
wonders whether the women … who failed to return for their test results were committed to 
knowing their HIV status, or whether they were channelled into testing” (Rennie & Behets, 
2006, at 54). 
 
Rates of HIV-serostatus disclosure 
Low rates of HIV-serostatus disclosure to sexual partners represent another concern. In sub-
Saharan Africa, reported rates of serostatus disclosure to sexual partners vary widely. Studies 
have found that between 16.7 and 86 percent of HIV-positive individuals share HIV test results 
with their sexual partners (Maman et al., 2003, with further references). Women face greater 
difficulty than men in making the decision to test and share HIV test results with a partner. The 
most salient barrier to disclosure described by women is fear of a partner’s reaction and a 
partner’s negative attitudes toward HIV testing (Maman et al., 2001). The lowest rates of HIV 
serostatus disclosure are reported in studies among pregnant women (Kilewo et al., 2001; 
Anterman et al., 2001). 
 
The discrepancy in disclosure rates between populations of women who are tested in VCT clinics 
and within the context of antenatal care in the same city at the same time may be explained by 
the fact that women who come to VCT clinics to test for HIV typically think about HIV testing 
for a long period of time, often talk to their partner about their decision to test, and often have a 
high perception of risk for HIV that motivates them to seek VCT services (Maman et al., 2001). 
In contrast, women who are offered HIV testing within the context of antenatal care may not 
have had time to psychologically prepare themselves for HIV testing and may not have had a 
chance to talk to their partner before deciding to test for HIV, and so the barriers to disclosure 
they face may be more formidable (Maman et al., 2003). 
 
The low rates of disclosure seen in many of the studies have many implications (Medley et al., 
2004): 
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• First, disclosure of HIV status between women and their sexual partners is necessary to 
initiate discussions about HIV/AIDS that raise both partners’ awareness of the risk of 
infection and may ultimately lead to behavior change to reduce HIV risk. 
• Second, disclosure plays an important role in women’s uptake of prevention of mother-to-
child transmission (PMTCT) programs and in their participation in treatment and care and 
support programs. In order to benefit from interventions that can reduce HIV perinatal 
transmission, women must be willing to be tested for HIV, and if they are HIV-positive they 
must be willing to accept and adhere to PMTCT prophylaxis. The optimal uptake and 
adherence to PMTCT programs is difficult for women whose partners are either unaware or 
not supportive of their participation. 
• Finally, it has been well documented in Africa that women often lack the power to make 
independent decisions with regard to their own health care and that of their children (Medley 
et al., 2004, with reference to Molyneux et al., 2002; Guinan & Leviton, 1995; Manhart et al., 
2000). It is therefore difficult for HIV-positive women to seek social and medical support 
from care and treatment programs for themselves and their infants without first disclosing 
their HIV status to their partners. 
 
Efforts to increase access to, and uptake of, HIV testing therefore need to be accompanied by 
efforts to increase HIV-serostatus disclosure rates and support those who test positive, 
particularly women, through the HIV-serostatus disclosure process. Great caution needs to be 
taken to ensure that new, more routine forms of testing result not only in increased uptake of 
HIV testing, but also in increased disclosure rates. Moreover, it is worth studying whether some 
form of enhanced VCT that incorporated rapid testing and support with disclosure might result in 
higher rates of learning and disclosing one’s HIV status than the model of simplified PITC 
currently being proposed. 
 
In this context, it is of concern that current proposals de-emphasize pre-test counseling. Studies 
have suggested that new HIV counseling approaches to support women through the testing and 
HIV-serostatus disclosure process are needed (Maman et al., 2003), and that, in order to increase 
rates of HIV serostatus disclosure to sexual partners, repeated opportunities for counseling on 
disclosure should be used in HIV testing programs.  
 
DeRosa and Marks (1998) found that rates of disclosure among clients in the U.S. increased with 
the number of times that a health official at the HIV clinic where they received care discussed 
the issue of HIV disclosure. It has therefore been suggested that, “at a minimum, raising the issue 
of disclosure during both the HIV pre-test and the post-test counseling session is necessary in 
order to address the barriers and plan for disclosure to sexual partners” (Maman et al., 2003). 
Multiple opportunities for discussion of disclosure are also important from the counselors’ 
perspective in order to assess whether clients have the social support they need to cope with the 
diagnosis (ibid). Medley et al. (2004) also concluded that standard protocols for HIV testing and 
counseling do not dedicate sufficient time to considering the challenges of HIV status disclosure 
that are faced by many clients, particularly women. They suggested that “standard counselling 
protocols need to be enhanced for HIV-infected women, concentrating on barriers to partner 
notification, and additional counselling needs to focus on helping women identify the pros and 
cons of disclosure” (ibid.).  
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Enough awareness of HIV/AIDS? 
 
 
Key points 
 
• Another of the arguments used to justify relaxing pre-test counseling and informed consent 
requirements is that awareness of HIV is now high, at least in Africa, reducing the need for 
extensive pre-test counseling. 
• However, this argument fails to take into account the fact that awareness is not the same as 
knowledge and understanding, much less behavior change. 
 
 
Another of the arguments used to justify relaxing pre-test counseling and informed consent 
requirements is that awareness of HIV is now high, at least in Africa, reducing the need for 
extensive pre-test counseling (De Cock, Mbori-Ngacha, Marum, 2002, at 69). However, this 
argument fails to take into account the fact that awareness is not the same as knowledge and 
understanding, much less behavior change. Heywood (2004, at 9) points out that 
 
High levels of HIV/AIDS awareness are often accompanied by high levels of misunderstanding, myth, 
and denial. High awareness does not lead to health-seeking behaviour – and the deterrent is not the 
human rights approach. It is important to understand pre-test counselling as both a public health 
intervention intended to transfer knowledge about HIV to the patient and an ethical and human rights 
obligation compelling the health worker to respect patient autonomy. 
 
Heywood also notes that in South Africa, which has some of the continent’s largest and most 
expensive HIV prevention campaigns, there is evidence that these campaigns may create 
awareness of an ephemeral existence of HIV, but not of one’s own risk. A survey carried out by 
the Reproductive Health Research Unit (RHRU) of the University of the Witwatersand found 
that 85 percent of the nearly 12,000 young people surveyed were aware of HIV/AIDS. But: 
 
Among sexually active young people 67% continue to think of themselves as being at low risk for HIV 
infection. 54% of young people who indicated never using a condom with their last sexual partner feel 
that they are at low risk of HIV infection…. Despite the high prevalence of HIV in this young age group 
(10.2%), the vast majority of HIV positive youth do not know that they are infected as 67% reported that 
they had never been tested. (Pettifor et al., 2004, at 56-57) 
 
According to Heywood, 
 
the RHRU’s findings beg the question why so-called at-risk populations are not seeking HIV testing – 
which brings us back to the issue of human rights and stigma! If anything, this emphasizes the importance 
of counselling rather than the opposite. 
 
Some of the people consulted in the process of writing this paper suggested that knowledge and 
understanding of HIV is even lower in many other countries, particularly in Asia and Eastern 
Europe and the former Soviet Union. They pointed out that misconceptions about HIV and AIDS 
remain high, and that many people do not know the difference between HIV and AIDS, know 
little if anything about ART, and have rarely received adequate prevention information. 
 
 42
In addition, they pointed out that, contrary to UN policy recommendations (UNAIDS, 2002b) 
and the International Guidelines on HIV/AIDS and Human Rights (OHCHR & UNAIDS, 2006, 
Guideline 4), countries continue to introduce specific criminal offences against the deliberate and 
intentional transmission of HIV, or even against failing to take reasonable steps to prevent HIV 
transmission to one’s partner – a trend that must be taken into account in the context of expanded 
HIV testing with simplified counseling. In practice, this means that as soon as a person finds out 
that he or she is positive, they have to tell their partner or face criminal penalties. 
 
In this context, it is important to note that women, who are more likely to be tested for HIV than 
men under an approach that makes HIV testing a more routine part of using health services, may 
be disproportionately exposed to the risk of criminalization in instances of not disclosing to a 
sexual partner and not using precautions – when it is precisely because women too often lack 
autonomy in their sexual relations as a result of violence, cultural norms and/or economic 
subordination that they may be unable to disclose or to negotiate safer sex. 
 
“For testing to be part of a comprehensive, effective and human rights-based prevention effort, it 
should provide the people tested the opportunity to understand and ask questions about 
HIV/AIDS transmission and care and treatment and to get help on the difficult matter of 
disclosing their HIV status” (Csete and Elliott, 2006, at 7). As noted in the WHO/UNAIDS 
guidance (2007, at 36), it should also counsel people about potential legal liability for not 
disclosing HIV-positive status to their partners, as well as other legal issues such as protection 
from HIV-related violence and discrimination. While there is “no doubt that the absence of 
qualified counsellors has been a bottleneck at various times, particularly in heavily affected 
communities”, this is “a question of resources and program priorities”, and “many low-income 
countries have shown that relatively rapid training of HIV counsellors is possible when resources 
are available” (id). 
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Facilitating access to ART 
 
Key points 
 
• One important benefit of wider testing is the opportunity to identify people with HIV at an earlier 
stage.  This has led to debate over whether ART availability should be a precondition for 
routinizing HIV testing, or whether this is unwarranted given that HIV testing has health benefits 
short of ART.  
• According to the WHO/UNAIDS guidance, access to ART “should not be an absolute 
prerequisite” for the implementation of PITC, but there “should at least be a reasonable 
expectation that it will become available within the framework of a national plan to achieve 
universal access to antiretroviral therapy for all who need it”. 
• There is increasing evidence that shortage of medical staff, rather than low uptake of HIV testing, 
is hindering rapid scale-up of treatment, at least in some resource-poor settings. 
 
 
 
Proponents of relaxing pre-test counseling and informed consent requirements have argued that 
some curtailment of the right to informed consent may be justified to ensure that new medical 
advances, particularly ART, will reach people living with HIV on a large scale. This was the 
main justification for the Botswana program, which stated that “earlier identification through 
routine testing of HIV-positive patients will allow earlier [ART] enrolment”. The Botswana 
Minister of Health justified routine testing with reference to the right of access to care, referring 
to a “right not to die before your time because a doctor did not perform relevant tests and 
diagnostics” (Crewe and Viljoen, 2005, with reference). In a population-based study in Botswana 
undertaken 11 months after the introduction of routine testing in Botswana, 93 percent of 
participants believed that this policy would increase access to ART, but 43 percent also believed 
that it would lead people to avoid going to the doctor for fear of being tested without consent 
(Weiser et al., 2006). 
 
One important benefit of wider testing is the opportunity to identify people with HIV sooner 
after infection. Where ART is available, maximum benefit in terms of reduced morbidity and 
mortality is obtained when HIV infection is diagnosed before end-stage immunodeficiency. In 
the absence of PITC, many people start treatment very late when they are already experiencing 
wasting, and very advanced disease and low body mass index are repeatedly associated with 
poor response to ART in African studies. Researchers in Uganda looked at the effects of 
introducing “routine testing” on the clinical profile of HIV-positive patients in their care, and 
found that over the course of a year, routine testing shifted the profile strongly towards 
asymptomatic patients who needed less intensive clinical management when they started 
treatment. Prior to “routine testing” 65 percent of patients had CD4 counts below 200 and three-
quarters were symptomatic. After routine testing was introduced, the proportion with CD4 counts 
below 200 fell to 45 percent and the proportion that were symptomatic fell to 55 percent. 
Although the clinic that shifted to “routine testing” had more patients under care as a result of 
“routine testing”, these patients were likely to have a better chance of success when they began 
treatment (Alcorn, 2006, with reference to Andia et al., 2006).  
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Crewe and Viljoen (2005) suggest that the “goal of greater access to ARV medicines is 
unimpeachable,” but “the assumption that earlier identification of HIV cases through routine 
testing will achieve that goal, or is necessary to achieve that goal, is debatable.”  While routine 
testing may indeed identify more asymptomatic patients, the reality is that in most low- or 
middle-income countries, there is far from a guarantee that the tested person will receive ART, 
due to the unavailability or unaffordability of these medications in many settings. In most 
countries, treatment rollout programs are not nearly universal, often with more coverage in urban 
areas and little or no coverage in rural settings. Often, some of the most vulnerable populations, 
such as people who inject drugs, prisoners, and children, have little or no access to ART (WHO, 
UNAIDS, UNICEF, 2007). Even where ART is widely available, the general requirement is that 
usually only HIV positive people with a CD4 count of less than 200 qualify for ART and 
therefore a positive test does not necessarily mean immediate access to treatment. Finally, in 
some resource-poor settings at least, there is increasing evidence that shortage of medical staff, 
rather than low uptake of HIV testing, is hindering rapid scale-up of treatment (Médecins sans 
Frontières, 2007). Current testing and treatment scale-up campaigns often neglect to make this 
clear: 
 
Often the uninformed person living with HIV may find themself in a place of having to deal with an 
unexpected load of repeated testing and challenges that they were initially not fully aware of as a result of 
the simplified counselling. One lady in Botswana expressed the view that had she been fully informed of 
the implications of HIV testing before testing she would probably have opted out as knowing her status 
has caused her more anxiety than not knowing.15 
 
While some people clearly indicate that ART availability should be a necessary precondition for 
routinizing HIV testing (e.g., Cameron, 2006), others have advocated that the use of routine 
testing should not be restricted to settings in which ART is available (De Cock, Bunnell, 
Mermin, 2006). They believe that routine testing would be justified “wherever basic HIV care 
and prevention are available,” and say that this “would improve efforts at prevention, allow 
infected persons to receive care such as cotrimoxazole prophylaxis, and normalize HIV testing” 
(id). According to the WHO/UNAIDS guidance on PITC in health facilities, access to ART 
“should not be an absolute prerequisite” for the implementation of PITC, but there “should at 
least be a reasonable expectation that it will become available within the framework of a national 
plan to achieve universal access to antiretroviral therapy for all who need it” (WHO/UNAIDS, 
2007, at 8). In addition, the guidance states that PITC “should be accompanied by a 
recommended set of HIV-related prevention, treatment, care and support services”, including 
 
education, psychosocial and peer support for management of HIV; periodic clinical assessment and 
clinical staging; management and treatment of common opportunistic infections; co-trimoxazole 
prophylaxis; tuberculosis screening and treatment when indicated, preventive therapy when appropriate; 
malaria prevention and treatment, where appropriate; STI case management and treatment; palliative care 
and symptom management; advice and support on other prevention interventions, such as safe drinking 
water; nutrition advice; infant feeding counselling; and antiretroviral treatment, where available. (ibid, at 
31) 
 
15 PLWHA in Botswana speaking at Press Conference ARASA/BONELA Consultative meeting on HIV Testing 
Gaberone Botswana 13 March 2006. 
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There is no question that, when an HIV diagnosis is made earlier in the course of the disease, 
health benefits can accrue for persons testing HIV positive even in the absence of ART. But, as  
Rennie & Behets (2006) say, treatment availability “cannot be used as an argument in favour of 
implementing routine testing in African or Asian countries where antiretroviral treatment 
coverage is currently dismal, and where it may take years before accessible and appropriate 
treatment, care and other services become widely available.” Mentioning the example of the 
Democratic Republic of Congo, where only two percent of patients with symptoms of AIDS 
have access to ART (WHO & UNAIDS, 2005b), they ask: 
 
How should the issue of routine HIV-testing policies be approached in such circumstances? With little 
prospect of treatment, would a VCT approach be ethically more appropriate, even in areas of high 
prevalence, despite the known shortcomings of VCT? To what extent does access to treatment have to be 
‘assured’ (nationally, regionally or locally) before a routine HIV-testing policy is justified on human 
rights grounds? (Rennie & Behets, 2006) 
 
According to Metz (2005), only policies of routinely offering HIV testing with an opt-in 
approach, but not opt-out approaches, are ethically justified when testing does not serve as a 
gateway to treatment and when ART “is unaffordable or otherwise unavailable.” 
 
Those consulted in the course of writing the paper agreed with WHO and UNAIDS that access to 
ART should not be an absolute prerequisite for the implementation of PITC, but highlighted that, 
even if there is a reasonable expectation that ART will become available in a particular country, 
some populations may be left out. Speaking about people who inject drugs, Kasia-Malinowska 
Sempruch, Director of OSI’s International Harm Reduction Program, referred to WHO’s own 
statistics according to which in eastern Europe and central Asia, people who inject drugs account 
for more than 70 percent of HIV cases but represent only about 24 percent of the people 
receiving ART (WHO/UNAIDS, 2006b). She added: “The reality is that if people who use drugs 
are tested, it often happens against their will or even without their knowledge. And it is not done 
to benefit them, but to exclude them. Those people who are on drugs who do receive treatment 
are the first to suffer if there are interruptions in the supply of medications – they are the bottom 
of everyone’s priorities.” 
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Assisting HIV prevention  
 
Key points 
 
• There is evidence that people who seek voluntary testing, find out they are HIV-positive, and 
receive counseling are more likely to take precautions to protect their partners than people who do 
not know their serostatus. 
• There is also evidence that the nature and duration of prevention counseling might influence its 
effectiveness. But there is no evidence specifically about the value of pre-test counseling for 
prevention, and no studies have been undertaken where testing provided with pre-test counseling 
was compared with testing without pre-test counseling or abbreviated pre-test counseling. 
• It is not known whether the reductions in risk behaviors observed in the studies of people who 
have initiated VCT themselves will be replicated among people who accept PITC.  It is also self-
evident that HIV testing cannot be an effective gateway to prevention unless people who test 
positive can safely disclose their HIV status and gain access to a full range of prevention options. 
 
 
Proponents of relaxing pre-test counseling and informed consent requirements also argue that it 
is justified because, as more people learn their HIV status, this will assist HIV prevention efforts. 
 
Review of the evidence 
 
Reducing the risk of HIV in infants 
ART combined with HIV and infant-feeding counseling is highly effective in reducing the risk of 
HIV in infants (Chou, 2005b). Although combination ARV regimens, given during pregnancy, 
labor and in the postpartum are most effective, in resource-limited settings, ARV prophylaxis at 
the time of labor and/or to the infant shortly after delivery has also been shown to reduce mother-
to-child transmission (MTCT) (WHO & UNAIDS, 2006; Jackson et al., 2002). With these 
interventions and through safe infant feeding measures, new HIV infections in children are 
becoming increasingly rare in several parts of the world. These advances in the prevention of 
MTCT have increased the benefits of HIV testing during pregnancy, leading many to 
recommend routine opt-out testing for all pregnant women (Institute of Medicine, 1999; 
American Academy of Pediatrics & American College of Obstetricians & Gynecologists, 1999; 
CDC, 2006). 
 
The impact on HIV testing and counseling on HIV transmission rates 
There is also some evidence that people who know they are HIV-positive are more likely to take 
precautions to protect their partners than people who do not know their serostatus (Weinhardt et 
al., 1999; Wolitski et al., 1997; Higgins et al., 1991; The Voluntary HIV-1 Counseling and 
Testing Efficacy Study Group, 2000; Glick, 2005, with further references), thus limiting the 
number of secondary infections compared to individuals who are unaware of their HIV 
serostatus. The importance of this for HIV prevention is enhanced when factoring in the value of 
ART in reducing a person’s viral load. Because viral load is the chief biological predictor of HIV 
transmission (Quinn et al., 2000; Tovanabutra et al., 2002; Castilla et al., 2005; Pedraza et al., 
1999), reduction in viral load through timely initiation of HAART might reduce transmission 
even for HIV-infected patients who do not change their risk behavior (Sanders et al., 2005). 
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These findings have supported the recent focus on identifying people who are not yet aware of 
their HIV infection and on developing prevention programs for people who are HIV-positive 
(Schietinger, 2006). 
 
Weinhardt et al. (1999) conducted a meta-analysis of 27 published studies of HIV counseling 
and testing interventions promoting reductions in sexual risk behavior. Consistent with the 
findings of Wolitzki et al. (1997), they concluded that HIV counseling and testing can facilitate 
behavior change among individuals found to be seropositive as well as among serodiscordant 
couples, but is not an effective primary prevention strategy for uninfected participants 
(Weinhardt, 1999). This has more recently been confirmed by studies in Africa (Motovu et al., 
2005). Those who were seropositive and discordant couples reported more behavior change 
(reduced unprotected intercourse and increased condom use) than those who learned they were 
HIV-negative. In fact, HIV-negative participants reported no more change in sexual behavior 
than participants who were not tested at all. 
 
More recently, it was reported that VCT has been associated with a reduction in non-regular 
partner numbers and an increase in condom use over six months of follow-up, especially among 
HIV-positive individuals, among a sample of 5200 individuals who had undergone VCT in 
Rwanda. Condom use doubled with non-regular partners (Mukabarisi et al., 2006). Finally, 
Marks et al. conducted a meta-analysis of U.S. studies comparing high-risk sexual behavior 
among people who are either aware or unaware that they are infected with HIV. They found that 
the prevalence of unprotected anal or vaginal intercourse with uninfected partners was on 
average 68 percent lower for HIV-positive persons who were aware of their status than it was for 
HIV-positive persons who were unaware of their status. They did note a number of methodologic 
limitations of the primary studies (Marks et al., 2005). Most importantly, the studies used self-
reported sexual behavior. Self-reports are open to socially desirable responding, and some HIV-
positive persons may underreport unprotected sex with at-risk partners (Catania et al., 1990). 
Glick (2005) notes further limitations: follow-up periods in many studies are too short – often 
just several months – to gauge long-term impacts; and study results may reflect self-selection 
into VCT of individuals who are predisposed to make behavior changes, suggesting the need to 
interpret the results of the studies “with a good deal more caution than has been the case”. Glick 
concludes: 
 
Reductions in risk behaviors reported in these studies may have limited relevance for inferring the 
outcomes from a scaled-up program that attempts to achieve broad coverage. Even individual-level 
randomized trials may have low external validity, and hence they may not provide meaningful estimates 
of behavioral outcomes under an expanded program. A key problem is that expansion is likely to be 
associated with significantly reduced costs (broadly defined) to using the service, and this will draw in 
new participants who are likely to respond differently than existing ones who presumably value the 
service more highly. 
 
No clinical trials have evaluated the impact on transmission rates of testing and counseling 
compared with no testing and counseling on HIV transmission rates. One prospective U.S. study 
of 144 serodiscordant heterosexual couples who received counseling and reported reduced risky 
behaviors found no seroconversion after 193 couple-years of follow-up (Padian et al., 1993). A 
prospective African study found that the rate of seroconversion among uninfected female 
partners of HIV-positive men was 6 to 9 per 100 person-years, compared with 22 per 100 
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person-years in women with untested partners (Allen et al., 1992). Two observational studies 
found that testing plus counseling was associated with a moderate (about 33 percent) decrease in 
sexually transmitted diseases among those who tested positive but that it increased the risk 
among those who tested negative (relative risk, 1.27 to 2; Chou, 2005b with reference to Otten et 
al, 1993; Chamot et al., 1999). Two randomized trials found that more interactive counseling was 
more effective than standard counseling in reducing sexually transmitted disease rates among 
HIV-positive women (Wingood et al., 2004) and seronegative heterosexual persons (Kamb et al., 
1998b), although there were too few new HIV infections to detect differences in HIV rates. 
However, the first randomized trial to report HIV incidence under different VCT strategies in 
Africa found no significant difference in HIV incidence among HIV-negative employees under 
two randomly allocated, workplace-based VCT strategies, despite a major difference in 
acceptability and the fact that VCT acceptors received counselling with personalized risk 
reduction planning (Corbett et al., 2007). 
 
Finally, a number of cross-sectional studies found that HIV-positive people who use drugs report 
less risky behaviors than untested or HIV-negative people who use drugs (Desenclos, 1993; 
Schlumberger, 1999; Celentano, 2001), but one randomized trial (Calsyn et al., 1992) and one 
prospective study (McCusker et al., 1994) found that testing plus counseling was not associated 
with decreased risk behaviors among people who use drugs (Chou et al., 2005b).  
 
Despite evidence that knowledge of HIV-positive status reduces some high-risk behaviors, the 
U.S. Preventive Services Task Force concluded that “there is insufficient evidence with which to 
accurately estimate the effects on transmission rates” (Chou et al., 2005, at 66). However, in a 
widely cited study, Marks, Crepaz & Janssen estimated that sexual transmission of HIV in the 
US from persons who are unaware of their infection is 3.5 times higher than among persons who 
are aware of their infection (Marks, Crepaz & Janssen, 2006). They concluded that, if all people 
unaware of their infection could learn of their serostatus, and the prevalence of unprotected anal 
or vaginal intercourse with at-risk partners declined by 57 percent (based on the data from their 
earlier meta-analysis: Marks et al., 2005), then the overall number of new sexual HIV infections 
in the US could, theoretically, be reduced by 31 percent per year (Marks, Crepaz & Janssen, 
2006). Baggaley et al. (2006) modeled the impact of ART use in resource-poor settings, 
concluding that “HIV epidemics in sub-Saharan Africa are not amenable to control through 
treatment, regardless of the extent of roll-out, and must be integrated with prevention methods. 
In the absence of substantial behaviour change of treated patients through extensive counselling, 
prevalence is likely to increase.” 
 
The call for routinization of testing in the context of prevention 
De Cock and colleagues have argued that in high prevalence settings, especially in Africa, “a 
stated goal for prevention should be for every citizen, including sexually active adolescents, to 
know their HIV status, and for repeat testing to occur at regular intervals, and in case of risky 
behaviour or impending life decisions” (De Cock, Mbori-Ngacha, Marum, 2002, at 70). 
According to them, “this approach would demystify HIV/AIDS, place the responsibility for 
avoidance of acquiring or transmitting HIV on every individual, and empower the community to 
take charge of its own health.” One of the motivations of the routine HIV testing program in 
Botswana was that it would “identify the HIV-negative population, which will help to target 
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prevention strategies better and help people stay negative” (Crewe and Viljoen, 2005, with 
reference).  
 
Clearly, the fact that the majority of HIV-positive people in low- and middle-income countries 
do not know their HIV status and may transmit HIV sexually (or through sharing of injecting 
equipment) to their partner(s) raises the issue of whether more routine forms of testing are 
justified to protect those who are uninfected. One person consulted in the process of writing this 
paper put the question in the following terms: “We have always protected the right of the person 
to refuse testing, but don’t those who are not infected have a right to health or not to be 
infected?”  
 
However, while implementing more routine forms of HIV testing would likely increase the 
number of people aware of their HIV status, some have speculated that HIV testing that includes 
neither quality pre-test counseling nor truly informed consent may lose at least some of its power 
as a prevention tool. For example, Crewe and Viljoen (2005) have said that it is “striking that 
routine testing proposals de-emphasize the one thing that is likely to assist people in adopting 
safer sex practices …, full pre-test counselling and information.” They conclude that, for testing 
to succeed as a prevention strategy, information and counseling are essential, and that there is 
scant likelihood that a routine opt-out testing approach that de-emphasizes counseling will have a 
more beneficial impact on HIV prevention than increased access to VCT programs. Similarly, 
Kenyon (2005, at 22) says that 
 
behavioral change is the product of understanding and ownership of one’s health and a sense of 
responsibility to protect the health of others. These changes occur not from the act of testing blood alone, 
but from the pre-test counselling, the information given, and the informed and voluntary consent that 
accompany them. For RHT [routine HIV testing] to be successful in Botswana and elsewhere in its public 
health goals, it must not dilute the participation of patients in their own health care or neglect individuals’ 
rights to autonomy, dignity, and information. 
 
According to Koo et al. (2006), however, “a close look at published studies evaluating combined 
counseling and testing programs challenges the belief in a benefit of pretest counseling [for 
prevention]”. They speculate that the fact that finding out one is HIV positive reduces risk 
behaviors, but finding out one is negative does not necessarily result in the same outcome, 
despite the fact that pretest counseling is offered in both cases, “suggests that discovering one is 
HIV-infected and the subsequent counseling around this diagnosis explains the reduced risk 
behavior, rather than pre-test counseling”. They continue by saying that “pretest counseling is 
not risk-reduction counseling but rather informational counseling with a focus on assessing 
readiness to test”, and conclude that “counseling might best be conducted after the patient knows 
their status, allowing for tailored messages dependent on serostatus”. 
 
A recent systematic review of the literature (Chou et al., 2005) found that some (Rotheram-Borus 
et al., 2004; Rotheram-Borus et al., 2001; Wingood et al., 2004; Fogarty et al., 2001; Kalichman 
et al., 2001; EXPLORE Study Team, 2004), but not all (Coates et al., 1989; Cleary et al., 1995; 
Patterson, Shaw & Semple, 2003; Richardson et al., 2004) randomized trials found that 
counseling that was tailored to participant needs or was more intensive was associated with 
greater reductions in risky behaviors than standard or less intensive counseling. But counseling 
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methods varied greatly across the trials and it is therefore difficult to draw definitive conclusions 
about the added value of pre-test counseling for prevention. 
 
More generally, it is essential to bear in mind that “motivating individuals to change their HIV 
risk behaviours is best achieved by comprehensive efforts that provide for repeated intervention 
contacts across multiple settings using a range of intervention strategies and messages”; and that 
the “ultimate goal of these efforts should be to change the behaviours and norms of entire 
communities in a manner that will perpetuate the reinforcement of HIV risk-reduction and help-
seeking practices of at-risk community members.” (Wolitski et al., 1997, p. 65). A systematic 
review of studies of HIV prevention interventions for people living with HIV (Schietinger, with 
reference to Crepaz, 2006) determined that the interventions associated with reducing sexual risk 
behaviors:  
• were based on behavioral theory 
• were specifically focused on HIV transmission risk behaviors (more than 2/3 of sessions) 
• provided skills building (e.g., correct condom use, problem-solving) 
• delivered by health care providers or professional counselors 
• delivered to individuals on a one-to-one basis 
• delivered in an intensive manner (more than 10 sessions or 20 hours total) 
• delivered over a long duration (greater than 3 months) 
• delivered in settings where people with HIV receive services 
• addressed a myriad of issues related to coping with one’s serostatus,  medication 
adherence, and HIV risk behavior. 
 
 
Conclusion 
In conclusion, there is evidence that people who seek voluntary testing, find out they are HIV-
positive and receive counseling are more likely to take precautions to protect their partners than 
people who do not know their serostatus. There is also evidence that the nature and duration of 
prevention counseling might influence its effectiveness. But there is no evidence specifically 
about the value of pre-test counseling for prevention, and no studies have been undertaken where 
testing provided without pre-test counseling (or simplified pre-test counseling) was compared 
with testing with pre-test counseling. There are also no studies that have isolated client versus 
provider initiation or opt-in versus opt-out PITC approaches as variables affecting 
prevention/behavior change. 
 
In general, the existing evidence supports greater emphasis on efforts to increase the number of 
people who are aware of their HIV infection so that they can be counseled and supported to take 
precautions to reduce the spread of HIV to their sexual partners.  However, a number of 
questions remain. 
 
One of them is whether the reductions in risk behaviors observed in the studies of people who 
have initiated VCT themselves will be replicated among people who accept PITC, but may be 
less ready or motivated to disclose their status and change their behavior than people who initiate 
testing themselves (Glick, 2005). More broadly, this relates to the fact that – as discussed above 
– increasing uptake of testing is not enough, and efforts need to focus equally on making it 
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possible for people testing positive to safely disclose their HIV status and take up prevention and 
treatment options. 
 
Indeed, even knowledge and disclosure of HIV status does not begin to address the range of 
structural and human rights issues that affect individuals’ ability to protect themselves and others 
from HIV – issues that must be factored into the costs and benefits of relaxing requirements of 
consent and counseling for HIV testing. People interviewed in the process of writing this paper 
cautioned against overstating the value of testing and counseling for HIV prevention in settings 
where other barriers may exist that make it difficult if not impossible for people to disclose their 
HIV status and/or change their behaviors once they find out that they are HIV-positive. This is 
especially true for women. Evelyn Serima, HIV/AIDS Technical Specialist, ILO Sub Regional 
Office for Southern Africa, said: 
 
In the African context, where women are often denied any rights, how often will a woman who finds out she 
is HIV-positive feel safe to disclose to her partner or insist on taking precautions? Simply testing people will 
make little difference, particularly if we don’t counsel them and support them appropriately at the time of 
testing. 
 
In studies in Papua New Guinea, Jamaica, and India women reported that bringing up the issue 
of condom use, with its inherent implication that one partner or the other has been unfaithful, can 
result in violence (Gupta, 2002, with reference to George & Jaswal, 1995; Jenkins, 1995; Wyatt 
et al., 1992). As Gupta says, 
 
To protect women from HIV infection we must find ways to empower them. This means implementing 
policies and programmes that increase women’s access to education and information and to productive 
resources, such as land, income, and credit. It also means providing women with HIV prevention 
technologies that they themselves can control. … We must also increase social support for women by 
facilitating their opportunities to meet in groups and organise, allowing them to draw strength from numbers 
and to derive practical solutions from each other. Simultaneously, we must promote sexual and family 
responsibility among young boys and men and enable them to examine the damaging effects of prevalent 
notions of masculinity and male power. Finally, we must recognise that violence against women is a gross 
violation of women’s rights that has important implications for the health of women and communities. If we 
are to contain the HIV epidemic, we must tackle its root cause – gender inequality. (Gupta, 2002; see also 
Gupta, 2000; American Foundation for AIDS Research, 2005) 
 
Talking about a different context, people from Eastern Europe and Central Asia interviewed in 
the process of writing this paper highlighted that the vast majority of injecting drug users in 
countries in the region do not even have access to clean injecting equipment and to drug 
treatment. They pointed out that in theory HIV testing may help prevention, but that most people 
in the region who test positive cannot even get access to the prevention tools that would enable 
them to protect their injecting partners – and that those who live where there is one of the few 
needle exchange programs risk being arrested because police regularly harass them if they go to 
such a program. 
 
Another context in which people are often denied access to any HIV prevention tools, even 
including condoms, is prisons. A recent WHO report acknowledges that “[k]nowledge of HIV 
status alone is not sufficient to prevent HIV transmission when the means that would enable a 
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person to take steps to reduce that risk, short of being able to stop the behaviour that creates the 
risk, are not accessible in prison” (WHO, UNODC, UNAIDS, 2007). 
 
Generally, there is a concern that discussions about routinizing testing do not sufficiently take 
into account the often disempowering context in which people have to deal with information 
about their HIV status, a context that may be characterized by poverty, patriarchy, prejudice, 
stigma and/or homophobia (Crewe and Viljoen, 2005); as well as a concern that the emphasis on 
HIV testing could eclipse prevention programs that have proven their worth but have not been 
introduced in many settings or scaled up appropriately in others (Rietmeijer & Thrun, 2006). 
While one could argue that HIV testing is equally important to these interventions, the point is 
that the effectiveness of testing should not be assumed when weighing the costs and benefits of 
relaxing consent and counselling requirements. 
 
Finally, as discussed above, if governments want to maximize the usefulness of testing as an 
HIV prevention strategy, focusing on mainstreaming testing within clinical settings may have 
relatively limited impact. During early infection (the two-and-a-half month period after HIV 
seroconversion), the average rate of HIV transmission via heterosexual intercourse is five- to 
twelve-fold higher than during established infection. More than 40 percent of people with newly 
acquired HIV infection transmit it to their partners within approximately five months (Wawer et 
al., 2005; see also Pilcher et al., 2004). Specific efforts need to be made to identify primary HIV 
infection in order to reduce the spread of HIV that might otherwise occur during the acute phase 
of HIV disease. Many of the people who have sex or inject drugs rarely if ever see health-care 
providers. This means that for prevention purposes, it would be a mistake to focus on PITC 
without also scaling up interventions outside the health system. Rather, it will be important to 
find ways to encourage sexually active people, particularly men, to be tested, and to make testing 
and counseling easily accessible to them, for example by providing mobile VCT units at places 
wherever sex, alcohol, or cigarettes are sold and served, and also in work settings.  
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Reducing stigma and discrimination  
 
Key points 
 
• Making testing more routinely available may help reduce the stigma related to HIV testing.  
However, a policy of routinely offering and recommending opt-in testing may lessen the stigma of 
being tested as much as a policy of routine opt-out testing – under both policies, testing is offered 
to everyone. 
• Testing may also contribute to reducing the stigma and discrimination related to HIV/AIDS, 
particularly if treatment is accessible and HIV is increasingly perceived as a chronic but treatable 
condition.  However, this is unlikely to change the perception that HIV infection results from 
“immoral” behavior such as extra-marital sex, homosexuality, prostitution, or injecting drug use. 
• Testing and treatment may thus be one component in helping overcome certain forms of stigma 
and discrimination, but only further research will be able to tell the extent to which they can 
contribute to lessening stigma overall. 
 
 
Those who support more routine forms of HIV testing and propose relaxing the counseling and 
informed consent requirements also argue that this is justified because when testing and 
counseling is offered to everyone, individuals do not feel singled out as “at risk” for HIV. Thus, 
the stigma of being tested will be lessened if everyone is offered the test and many people are 
tested (Schietinger, 2006, at 61). This is borne out in the population study undertaken in 
Botswana 11 months after introduction of the routine opt-out testing program, in which 60 
percent of respondents felt that routine testing reduces the stigma of getting tested (Weiser et al., 
2006). Interviews with most persons tested anonymously in a mobile VCT program in 
marketplaces in Zimbabwe mentioned the stigma of being tested as a factor discouraging HIV 
testing (Morin, 2006). However, this does not necessarily justify relaxing counseling and 
informed consent requirements, as suggested by those favoring a policy of routine opt-out 
testing. A policy of routinely offering and recommending opt-in testing may lessen the stigma of 
being tested as much as a policy of routine opt-out testing – under both policies, testing is offered 
to everyone. 
 
Proponents of routine testing also suggest that with widespread testing more people learn their 
HIV status and can access ART, and that HIV/AIDS will then come to be perceived as yet 
another chronic, manageable illness (Castro & Farmer, 2005). In this sense, proponents of 
routine testing depart from the school of AIDS “exceptionalism,” which argues that AIDS is a 
uniquely stigmatized disease requiring specific human rights protections.  In the words of the 
Botswana Minister of Health, “[i]n a highly infected society … there is simply no place for 
exceptionalism that feeds stigma, induces fear, and curtails standard diagnostic care” (Crewe and 
Viljoen, 2005, with reference). However, as stated by Csete and Elliott (2006), 
 
Whether routine testing without consent or counselling would reduce stigma and discrimination by treating 
HIV/AIDS more like other diseases is an empirical question that has not been tested in research.  It would be 
difficult to test such a hypothesis in ethical ways. In countries where certain categories of people – such as all 
people who enter military service, all prisoners, or all immigrants – are subjected to mandatory or 
compulsory HIV testing, there is no evidence that suggests that the routinization of testing reduces stigma 
and discrimination. 
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HIV/AIDS does remain exceptional among infectious diseases in the degree to which it is 
associated with severe, even demonizing, stigma in the public mind and abusive responses from 
individuals and communities.  There remains relatively little investment in most countries in real 
protection from HIV-related discrimination and abuse.   
 
It is true that once HIV is perceived as a chronic but treatable condition, one of the factors that 
amplifies stigma – fear of contagion and inevitable death – is lessened.  However, stigma is 
much more than fear of contagion. It is also related to the perception that HIV infection results 
from “immoral” behavior such as extra-marital sex, homosexuality, prostitution, or injecting 
drug use (Crewe & Viljoen, 2005). It is a tool used by cultures to exclude those felt to have 
broken extant rules. The dominant stereotype of people living with HIV is a stigmatizing one that 
casts them as immoral (Stanley, 1999). While downgrading HIV to the status of a “manageable 
disease” may go some distance towards addressing HIV/AIDS-related stigma, it is unlikely on its 
own to alter deeply-rooted perceptions of the moral stature of people living with AIDS (Furber et 
al., 2004). 
 
Testing and treatment may thus be one component in helping overcome stigma and 
discrimination, but only further research will be able to tell the extent to which they can 
contribute to lessening stigma. In the population-based study undertaken in Botswana, Wolfe et 
al. (2006) found that perceived access to ART was strongly and significantly related to not 
holding stigmatizing attitudes and to not having “anticipated stigma” (belief that adverse social 
consequences would arise should they test positive and disclose their status to others). On the 
other hand, they found significant ongoing stigmatizing attitudes and anticipated stigma, 
suggesting that treatment access may be a necessary but not sufficient part of stigma reduction.  
The fact that there is still significant HIV stigma in countries where there is good access to 
treatment also suggests that access to treatment is not enough to eliminate stigma. Testing and 
treatment cannot be expected to end the stigma that is deeply located in social structures, in the 
history of the response to the HIV/AIDS pandemic, in the ways in which health systems are 
structured and in the ways in which health care workers often behave towards people living with 
HIV (Chingore, forthcoming). In order to effectively reduce stigma, as research increasingly 
shows, it is necessary to engage with institutions, attitudes, culture and beliefs (UNAIDS, 
2002/03; Burris, 2002). 
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Human rights abuses and other negative consequences following 
testing 
 
Key points 
 
• People who argue for more routine forms of HIV testing with reduced emphasis on pre-test 
counseling and informed consent assume that few human rights abuses and other negative 
consequences will result from this approach – or in any case that the benefits of HIV testing 
outweigh the prospect of such abuse. 
• More research will be needed to investigate this, but the research that does exist suggests that 
concern about negative outcomes may be justified. 
• With regard to potential negative outcomes for women, studies show that a significant minority 
report negative outcomes with disclosure of their HIV status, including blame, abandonment, 
violence, anger, stigma and depression. 
• In many countries, populations most at-risk of HIV transmission are also more susceptible to 
coercion, discrimination, violence, abandonment, incarceration or other negative concequences 
upon disclosure of an HIV-positive test result. 
 
 
 
Finally, people who argue for more routine forms of HIV testing with reduced emphasis on pre-
test counseling and informed consent assume that few human rights abuses and other negative 
consequences will result from this approach – or in any case that the benefits of HIV testing 
outweigh the prospect of such abuse. For example, while De Cock and colleagues (2002) 
recognized that some women refuse HIV testing because of “stigma, discrimination, and 
potential consequences such as domestic violence, abandonment, or murder,” they noted that the 
frequency of these events is uncertain. In response, Csete, Schleifer, and Cohen (2004, with 
reference to Human Rights Watch, 2003) pointed out that 
 
Indeed, the frequency of domestic violence in particular will always be uncertain since it is a hidden crime 
and is aggressively prosecuted in very few places. But our work and that of other investigators indicate that 
women frequently face spousal violence when they reveal that they are HIV positive or even show interest in 
learning their status or obtaining care.  Such violence is deeply rooted and underpinned in many societies by 
inequitable laws on property, inheritance, and divorce that keep women economically dependent on their 
spouses and limit their choices in leaving dangerous unions.  To trivialise or minimise HIV/AIDS-linked 
violence and abuse against women only risks perpetuating this abuse and also the stigma associated with 
AIDS, which is itself a major impediment to fighting the epidemic. 
 
Clearly, more research is needed to investigate whether relaxing informed consent and 
counseling requirements affects people’s experiences of abuse or other negative outcomes as a 
result of testing HIV-positive. The research that does exist suggests that concern about negative 
outcomes may be justified. In the population-based survey in Botswana, 14 percent of 
participants believed that the policy of routine opt-out testing could increase gender-based 
violence related to testing. Among participants who had been tested, two percent of those tested 
at VCT centers, but six percent of those tested by routine testing reported poor treatment from 
others related to testing (Weiser et al., 2006). A review of 17 studies from Africa and Southeast 
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Asia concluded that four to 28 percent of women reported negative outcomes following the 
disclosure of their status, including blame, abandonment, violence, anger, stigma and depression 
(Medley et al., 2004). Of these women, between 2.5 percent and 14.6 percent reported having 
faced violence as a reaction to disclosure of their HIV status. In another, more recent study in 
Zambia, 28 percent of women who tested HIV-positive reported adverse social events, including 
physical violence, verbal abuse, divorce or separation (Semrau et al., 2005). 
 
The highest rates of negative outcomes have been reported by women tested in antenatal clinics, 
and the lowest rates by women tested at VCT sites. It has been suggested that women who are 
tested at antenatal clinic sites are less likely to have a chance to think about testing or prepare 
themselves or their partners for testing; therefore they are both less likely to disclose results to 
their partners and more likely to be victims of violence when they do (Amon, 2006b). 
 
In a survey of women in Tanzania three months after they received testing and counseling, the 
women who were HIV positive reported more violence from their current partners than the 
women who were HIV negative (Maman, 2002). 
 
Studies thus show that a significant minority of women report negative outcomes following 
disclosure of their HIV-positivity. At the same time, they show that the majority of HIV-positive 
women surveyed report positive outcomes with disclosure of their HIV status, including less 
anxiety, fewer symptoms of depression, increased social support and, in many cases, a 
strengthening of the relationship with their partners (USAID/Synergy, 2004). This finding may 
suggest “that the considerable scaling up of counseling and testing programs now underway may 
pose a lower risk of negative outcomes of disclosure for HIV positive women – and suggest that 
there will be greater support for women – than expected, even by the women themselves” (ibid, 
at 24). However, 
 
Women who currently disclose do so selectively, choosing to whom they disclose and when to disclose, 
likely based on how they anticipate that their partner will react. While a relatively small proportion of 
women report negative outcomes, this may represent a large absolute number of women as more women 
learn that they are HIV positive and disclose their status to others. (ibid) 
 
Thus, it will be important not to banalize the risk of negative outcomes and instead find 
strategies for the scale up of HIV testing “that will allow women to maximize the beneficial 
outcomes and minimize the harmful aspects of disclosing their HIV serostatus” (ibid). It will also 
be critical to compare negative outcomes among women who test positive in a VCT setting with 
the negative outcomes among women who test positive in an opt-out PITC setting. 
 
There are four specific opportunities to integrate a focus on violence within HIV testing and 
counseling, including: 
 
• violence as a barrier to women seeking HIV testing and counseling services 
• violence as a barrier to women disclosing HIV test results to their sexual partners 
• violence as a barrier for women to negotiate HIV risk reduction with partners and 
• the post-test support needs of women living in violent relationships (WHO, 2006, at 36). 
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It has been suggested that “awareness about gender and violence” be incorporated into testing 
and counseling for HIV (Heise, 2006) and that some screening of women most at risk of negative 
outcomes of disclosure – as well as targeted, intensive counseling to help such women, 
especially those already exposed to domestic violence and sexual coercion – could help women 
minimize abuse following disclosure (Medley et al, 2004, at 305). Other researchers have noted 
that if the two partners in a sexual relationship can be counseled together – which costs more in 
outreach time and is not always possible – abusive situations may be effectively defused 
(Voluntary HIV-1 Counseling and Testing Efficacy Study Group, 2000). However, a number of 
studies point to a strong reluctance on the part of many to test with their partners (Glick, 2005, at 
348). Typically, few couples come in for testing, despite efforts to encourage couples to test. One 
barrier to more couple testing may be that many women who would like to have themselves and 
their partners tested lack the power to get their partners to go along. In addition, in a recent 
study, there were no significant differences in reported adverse social events between couple- 
and individual-counseled women (Semrau et al., 2005). 
 
In almost all low- and middle-income countries, unequal gender relations are reflected in the 
HIV epidemic. Women and teenage girls are infected at higher rates than men and have 
significantly less social and economic power to take measures to protect themselves from 
infection (Gupta, 2002). They are also frequently blamed for the infection of their partners and 
suffer from extreme forms of retribution.  In many cases, they have no inheritance rights, are 
subjected to wife inheritance and other forms of oppression and generally carry the main 
responsibility for care and support of family members who are living with HIV and AIDS.  As 
stated by Crewe & Viljoen (2005), the 
 
ways in which routine testing can further disadvantage women must be recognized…. Far from being a 
means of ‘empowerment,’ routine testing and possible disclosure may make the position of women much 
more precarious.  Not only is confidentiality of test results often breached, but as women are more likely 
than men to come into contact with the health system (largely because of antenatal services), routine 
testing may reinforce stereotypes about women being the principal bearers of HIV infection.  Women 
may thus suffer very greatly from routine testing – emotionally, physically and economically.  Unless 
tests are offered in an environment of establishing first what ongoing support the woman will need, what 
kind of support it is possible the woman may have and, in the absence of family or community support, 
who she will be able to turn to – the basic fundamentals of good pre test counselling – she should not be 
offered the test. In addition, for many women the option to ‘opt out’ of HIV testing in the face of pressure 
from a medical professional will not be realistic. 
 
In their guidance on PITC in health facilities, WHO and UNAIDS acknowledge the concern that 
“in some settings increased knowledge and disclosure of HIV status may be accompanied by 
increased stigma, discrimination, abandonment and violence” (WHO, UNAIDS, 2007, at 16). 
According to them, these concerns “underscore the importance of adequate training and 
supervision for health care providers, particularly in the processes of counselling, obtaining 
informed consent and maintaining confidentiality of HIV test results” (ibid, at 17). In addition, 
“close monitoring and evaluation, especially in the implementation stages, will be needed to 
ensure that provider-initiated HIV testing and counselling is implemented in a way that 
minimizes adverse outcomes and maximizes benefits for patients” (id). 
 
Generally, Csete and Elliott (2006) comment: 
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While measures may be taken to mitigate negative outcomes of HIV testing, it is clear that even where 
the three Cs are respected as a matter of policy, access to such measures is bound to be limited.  In 
addition, for some people, such as women in violent relationships, the only action that may reduce the 
harm they face from being known to be HIV-positive may be leaving the relationship, which may be 
impeded by factors that counselling and information cannot address.   
 
As Rennie and Behets point out, “there should be a sober recognition that while needs have been 
identified and policies have been formulated, many programmes to reduce stigma and provide 
psychosocial support for women and girls in low-income countries are currently non-existent, in 
the design phase, overburdened or underfunded (2006, at 55). They conclude that in the current 
circumstances, routine opt-out HIV-testing policies could expose women and girls to risks of 
significant harm. 
 
People interviewed in the process of writing this paper expressed particular concern about abuses 
that sex workers, men who have sex with men, people who use drugs, and prisoners could suffer 
in many countries if those countries were to implement PITC with an opt-out approach. WHO 
and UNAIDS recognize these concerns, saying that “populations most at-risk of HIV 
transmission may be more susceptible to coercion, discrimination, violence, abandonment, 
incarceration or other negative concequences upon disclosure of an HIV-positive test result” 
(WHO/UNAIDS, 2007, at 25). As discussed in more detail below, they further recognize that 
innovative client-initiated approaches are needed to increase access to and uptake of HIV testing 
and counselling for these populations, such as services delivered through mobile clinics or in 
community settings. While they say that “consideration should … be given to recommending” 
HIV testing and counseling to all patients attending specific health services for most-at-risk 
populations, such as acute care, STI or drug dependence treatment services, they also suggest 
that 
 
• health care providers “will usually require special training and supervision to uphold 
standards of informed consent and confidentiality for these populations” 
• “additional discussion of the right to decline HIV testing, of the risks and benefits of HIV 
testing and disclosure, and about social support needs may be required” 
• an opt-in approach to informed consent “may merit consideration for highly vulnerable 
populations” (id). 
 
People consulted in the process of writing this paper said that introducing PITC with an opt-out 
approach for such marginalized populations in such settings would be “the wrong priority” and 
could lead to unintended, negative consequences. They were concerned that this would be just 
another reason for them to stay away from the care they need. Mariya Savchuk, Public Health 
Program Director at the International Renaissance Foundation in Ukraine, added: “With all the 
abuse they already suffer in so-called care settings, making it even easier for people to test them 
without their consent is not the way to go. We need to find ways to encourage IDUs to seek 
VCT, in settings they know and trust. We need to allow nurses to work at needle exchanges and 
drop-in centres to do tests – currently the law in our country does not permit that, but it would be 
the best way to get people to know their status.” Raminta Stiukyte, Director of the Central and 
Eastern European Harm Reduction Network, said that it would send out the wrong message to 
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prison authorities if routine opt-out testing was recommended: “Often, [prisoners] have no access 
to VCT during incarceration – the prisons say they don’t have the funds for it, nor the staff. That 
is the problem. That’s what [WHO and UNAIDS] should be calling for, not for routine opt-out 
testing that would turn into automatic testing of all prisoners.” She was also concerned about 
what this would mean for sex workers, who already now are often subjected to testing without 
their consent. “It would mean even more involuntary testing, even greater barriers to the care and 
treatment they need to stay healthy – and to protect their customers.” 
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Conclusions 
 
 
Making testing more routinely available is likely to have many benefits, particularly if people 
testing positive can benefit from treatment, including ART, have access to prevention measures 
that enable them to reduce the risk of transmission to their partners, and the social and legal 
environment is such that people with or at risk of HIV: 
 
• feel comfortable about seeing a health worker and about getting tested for HIV 
• can learn how to maintain their HIV-free status or start working on keeping their health 
despite their HIV-positive status 
• can disclose their status without recrimination or discrimination 
• can live and work without discrimination on the ground of being HIV-positive or being at 
risk of it (Buchanan, 2005). 
 
Making HIV testing more available may in some contexts also help reduce the stigma related to 
HIV testing and ultimately contribute to reducing the stigma and discrimination related to 
HIV/AIDS, though this needs to be carefully studied. In order to vastly increase the number of 
people who have access to HIV testing, it will be necessary to move towards a model of HIV 
testing that combines VCT with some form of PITC. 
 
In order to make it feasible for health-care providers to offer HIV testing to all their patients, in 
some settings it may also be justified to relax, to some extent, pre-test counseling requirements.  
Human rights and public health do not require “cumbersome procedures for pretest counseling 
and written informed consent” (Gostin, 2006). But human rights – and public health imperatives 
– do require that regardless of whether persons are routinely offered an HIV test in a health care 
setting or whether they initiate HIV testing themselves, they are able to give informed and truly 
voluntary consent to testing. 
 
 
Scaling up access to HIV testing while retaining informed consent 
Great caution needs to be taken to ensure that even simplified forms of pre-test counseling allow 
people to understand the benefits and risks associated with HIV testing, as well as its voluntary 
nature; and that the actual practice of how providers go about offering the test allows people to 
give informed and truly voluntary consent. What it means to provide an “opportunity to refuse” a 
test should be clearly outlined in a code of conduct for health workers and implemented with 
thorough training and oversight. 
 
This is particularly important in settings where the benefits of testing are still limited because 
access to ART is not guaranteed or even unlikely in the near future, necessary prevention 
measures are scarce or unavailable, or negative consequences or human rights abuses are 
widespread and protection against discrimination not provided by legislation or unenforceable in 
practice. But even in resource-rich countries, the risks and benefits of HIV testing remain 
complex and health providers need to secure specific consent for HIV testing – general consent 
by definition covers only those procedures whose risks and benefits are generally well-known. 
 
Obtaining informed consent without undue burden 
Established practice in HIV testing provides good models for obtaining informed consent 
without undue burden and recommendations to forgo specific informed consent for HIV tests 
rest primarily on “a critical faulty assumption: that the process of securing informed consent 
presents a substantial barrier to busy health care professionals who would otherwise offer HIV 
testing to their patients” (Hilton Fisher, Hanssens, Schulman, 2006). It may be more convenient 
for providers to undertake testing without counseling. However, experience in many settings 
shows that health care providers committed to increasing uptake of HIV testing (and supported 
by policy and professional guidelines), can do so efficiently and effectively while respecting 
their patients’ fundamental right to informed consent. For example, in Cape Town, a number of 
STI clinics offer HIV testing to all people who attend the clinic and require written consent from 
the patient, but have reduced the amount of time spent on counseling. Data from the first quarter 
of 2006 show a major increase in the number of people who test for HIV at the clinics (Richter, 
2006). 
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When I got pregnant at 16 I knew nothing. I didn’t know I had a choice 
not to be tested. You can’t just ‘opt-out’.  
Member of the International Community of Women Living with 
HIV/AIDS (ICW) from South Africa. ICW press release, XVI 
International AIDS Conference 
Those who 
mischaracterize the 
informed consent 
requirement as a dated 
response to a past time 
when stigma and the lack 
of effective treatment warranted “special treatment” for HIV, seem to forget that the informed 
consent requirement is not a response to HIV but an established tenet of ethical and quality 
health care that emerged long prior to the appearance of HIV/AIDS. Ultimately, counseling and 
informed consent requirements 
 
do more than merely reflect the past and continuing reality of HIV stigma and its practical consequences.  
They incorporate the evolving understanding of a patient’s right to information and autonomy in making 
treatment decisions, a right undermined by proposals for a reversion to the outdated “doctor knows best 
— you don’t need to know” approach (ibid). 
 
Acknowledging that patients need to be able to make a voluntary and informed decision 
about whether to be tested or not, WHO and UNAIDS, in their guidance on PITC in health 
facilities, specify the “minimum information for informed consent” that health care 
providers should provide patients when recommending HIV testing and counseling 
(WHO/UNAIDS, 2007, at 36).  They add that, depending on the local conditions, pre-test 
information can be provided in the form of individual information sessions or in group 
health information talks; and that “verbal communication is normally adequate for the 
purpose of obtaining informed consent” (id).  In addition, they recommend that, at the same 
time as PITC is implemented, health facilities should develop codes of conduct for health 
care providers and methods of redress for patients whose rights are infringed; and that 
“consideration should be given to the appointment of an independent ombudsman or patient 
advocate to whom breaches of HIV testing and counselling protocols and codes of conduct 
can be reported” (ibid, at 34). 
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The fact that the guidance specifies minimum requirements for pre-test information sessions is a 
welcome development, as is the recommendation to develop codes of conduct and methods of 
redress. Yet, whether these minimum requirements are sufficient to ensure true informed consent 
remains to be seen. 
 
WHO and UNAIDS should develop a model code of conduct and minimum standards for 
training and accredited trainers, and assist countries in implementing and overseeing such a code 
and in training health care personnel in the process of obtaining informed consent. In order to 
increase the capacity to undertake counseling, changes to scopes of practice may be necessary to 
allow lay counselors to carry out HIV counseling and testing, after receiving adequate training. 
 
In addition, when countries considering the implementation of PITC adapt the WHO/UNAIDS 
guidance document to local conditions, they should acknowledge that other, additional 
information may have to be provided during pre-test information or counseling sessions. In 
particular, as has been discussed above and recommended elsewhere, in some settings it will be 
important to incorporate awareness about gender and violence into pre-test sessions, and to 
undertake some screening of women most at risk of negative outcomes of disclosure, as well as 
targeted, intensive counseling, including referral to legal services, to help such women. Finally, 
while group sessions may be adequate to provide some of the basic pre-test information, people 
should be given an opportunity to ask questions not only in the group, but also individually. 
 
Could adoption of an opt-out approach to testing result in more people being tested 
without informed consent? 
Ultimately, a legitimate concern remains that adoption of an opt-out approach to testing, as 
recommended by WHO and UNAIDS, may in practice result in people being tested without their 
informed and truly voluntary consent, unless they realize they can say no to an HIV test and have 
the confidence and power to make that choice.  
 
In settings where there is a power imbalance between test provider and client, the voluntary 
nature of HIV testing may be compromised, as the client may feel compelled to consent to the 
provider’s offer, particularly when the offer is communicated with the information that the test 
will be performed unless the client refuses. The recent population-based study in Botswana, in 
which 68 percent of participants who where tested (either by VCT or by routine testing) 
responded that they believed that they could not refuse the HIV test, and 43 percent of 
respondents believed that the HIV testing policy would lead people to avoid going to the doctor 
for fear of testing, also suggests that many may not fully understand the voluntary nature of 
testing (Weiser et al., 2006). Evelyn Serima, one of the people interviewed for this paper, said: 
“In Botswana, most of the people don’t understand what the policy is. Because the president said 
that people should be tested, they don’t think they can opt out from testing.” 
 
Preliminary data from another study, undertaken in Kinshasa, Democratic Republic of the 
Congo, indicate that most nurses, HIV counselors and TB patients prefer routine, opt-out HIV 
testing at TB clinics over opt-in HIV testing with referrals onsite or offsite. But 41 percent of TB 
nurses and HIV counselors believed it would be difficult for patients to opt-out of an offer of 
routine testing, as did 33 percent of patients (Corneli et al., 2005). A study of private 
practitioners’ communications with patients around HIV testing in Pune, India, showed that “in 
the majority of cases, pre-test communication is extremely limited and informed consent 
practically non-existent”(Datye et al., 2006). In cases where HIV testing is considered “routine”, 
as with antenatal attendees or pre-operative patients, patients are not informed that they are being 
tested. Generally, “communication with their patients around HIV is prescriptive rather than 
shared, and falls considerably short of best-practice standards around consent, counselling and 
confidentiality as upheld in national guidelines” (Datye et al., 2006). 
 
Another of the people interviewed in the process of writing this paper (Claude Cahn, Programs 
Director, European Roma Rights Centre), also talked about the fact that health-care providers in 
many countries do not ask what patients want, or even tell them what they do. He said that 
patients in many countries would unlikely be able to opt out of HIV testing: “Very few people in 
Central and Eastern Europe decide freely about their medical care. The attitude of providers is so 
paternalistic.” In his presentation at the XVI International AIDS Conference, Anand Grover 
(2006) cautioned that “if opt-out routine testing is recommended globally the clear message for 
all the medical fraternity in the developing world would be to test all persons without consent, 
i.e. mandatory testing.” 
 
Just how serious this concern needs to be taken was shown by a letter published on 6 December 
2006 by Russian physicians in the Annals of Internal Medicine (Vlassov & Denisov, 2006). The 
letter points out that “Russia inherited from the USSR the system of extensive testing of citizens 
without a barrier of consent: blood donors, pregnant women, all inpatients etc.” It suggests that 
the “efficacy of the Russian … system was de-facto recognized by the U.S. Centers for Disease 
Control and Prevention recommendations calling for routine HIV testing without specific 
consent”. It concludes by saying that the U.S. recommendation “is mimicking the Russian style” 
and that “WHO recently is also supporting the Russian style system by its recommendation of 
provider-initiated testing”. While the letter gets most of the facts wrong, it nevertheless 
highlights the danger that support for more routine forms of testing may be misinterpreted.  
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[Some of the proponents of routine opt-out testing] create an artificial 
and unwarranted polarity between human rights, social justice, and 
public health. They claim to find a new AIDS paradox in their assertion 
that human rights advocates deter HIV testing by insisting on autonomy 
via informed consent, and they conclude that ‘failure to prevent HIV 
transmission constitutes an infringement of human rights that hampers 
Africa’s human and social development’. 
 
Contrary to what [they] suggest, human rights both encompass and 
demand social justice and public health. The problem is that bad or 
corrupt governance by First and Third World governments prioritizes 
neither social justice nor public health in many developing countries. 
This is manifest in the fact that it is the lack of access to health care 
services, including voluntary counselling and testing (VCT), and 
prophylactic or curative medicines that is the greatest deterrent to 
health seeking behaviour. As recognized by the WHO, community 
mobilization around HIV/AIDS is necessary to demand the supply of 
VCT and other HIV-related services, as well as to create the demand in 
the community. Although [the proponents of routine opt-out testing] 
would not believe it, the reality is that the human rights principles of 
confidentiality and informed consent are still widely ignored in health 
settings in Africa – and are therefore not the kind of obstacles they are 
claimed to be. 
– Heywood, 2004, with reference to De Cock, Mbori-Ngacha, Marum, 
2002) 
 
The alternative: Routinely 
offering and recommending opt-
in HIV testing 
One way of rapidly scaling up 
access to HIV testing that may be 
as effective as a matter of public 
health and more respectful of 
human rights would be to routinely 
offer and recommend opt-in HIV 
testing and counseling in clinical 
settings, rather than opt-out 
testing. While generally 
recommending an opt-out 
approach to PITC in health 
facilities, WHO and UNAIDS 
acknowledge that an opt-in 
approach “may merit consideration 
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for highly vulnerable populations” (2007, at 5). 
 
Routinely offering and recommending opt-in HIV testing and counseling would recognize that 
providers should do more than just offer the HIV test to their patients, but emphasize that the 
actual practice of how providers go about offering the test needs to allow people to give 
informed and truly voluntary consent. Experience has shown that where implementation of such 
a policy is adequately supported, it can be as successful in increasing the number of people who 
test for HIV as adopting a “right of refusal” approach (Schietinger, 2006) – particularly, if 
accompanied by other necessary efforts to remove barriers to HIV testing, such as provision of 
adequately supported VCT services, social mobilization campaigns to encourage people to seek 
testing and to combat stigma and discrimination, as well as legislative and policy reforms to 
eliminate existing discrimination and other barriers to health services and to protect against such 
denial of human rights. It may also result in fewer people avoiding going to seek health care for 
fear of being unable to decline testing. It has the potential to have an impact on access to care 
and treatment, prevention, and stigma similar to that of routine opt-out testing. Finally, it takes 
into account that knowledge and understanding of HIV often remain low even where awareness 
of HIV is high, emphasizing the importance of providing people with the information they need, 
allowing them to ask questions, and preparing them for the result of the test.  
 
Admittedly, if a doctor “recommends” something, it could be difficult for patients, particularly 
women (especially given likelihood of gender and/or class differences between the female 
patient and the physician), to decline the test – so in effect it risks being similar to an opt-out 
system, unless care is taken to respect and ensure patients’ autonomy.  But at the same time 
providers should not simply offer an HIV test to their patients, but explain the potential benefits 
of testing and recommend testing, regardless of whether or not patients consider themselves at 
risk or not. 
 
According to WHO and UNAIDS, “whether patients ‘opt-in’ or ‘opt-out’, the end result should 
be the same: an informed decision by the patient to accept or decline the health care provider’s 
recommendation of an HIV test” (2007, at 20). Ultimately, any form of PITC needs to be 
carefully monitored and evaluated to ensure that, in practice, providers offer and recommend 
testing, but that patients give informed consent to the test. In addition, community mobilization 
efforts should be undertaken to encourage people to seek testing, while clearly explaining the 
policy so that people do not stay away from health facilities for fear that they will be tested 
without their consent. 
 
In the short-term, testing policies that encompass these elements may be more costly than simply 
providing routine, opt-out testing, and it will require scaling up of the capacity of health systems 
both to respect people’s right to consent to a medical procedure that has great consequences in 
people’s lives, and to give them as much information as possible to protect themselves from 
abuses that may accompany the knowledge of their HIV status. But these elements are essential 
to an effective HIV/AIDS response, and are human rights obligations of governments (Csete, 
Elliott, 2006, at 9). It is a positive duty of the state and the international community to provide 
the resources and personnel for scaling up HIV testing that incorporates these elements. 
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The need for more research 
The research undertaken for this paper has clearly demonstrated that deeper research issues 
beyond simply the numbers of people getting tested are not being addressed enough. In order to 
be able to assess whether increased uptake of testing allows countries to achieve prevention and 
treatment goals, more information is needed about the number of people who: 
 
• obtain their test results 
• disclose their HIV status 
• ultimately change their sexual and/or drug using behaviors and 
• access care and treatment, including ART. 
 
Research is also needed to capture the experience of HIV testing and that of people who may be 
at risk of adverse outcomes. Questions such as the following should be addressed: 
 
• What is the experience of people being tested as a result of approaches in which HIV testing 
is more routine? In particular, to what extent do people still experience counseling and 
testing as voluntary, and how will a shift away from “voluntariness” affect responses to 
prevention messages? 
• Would more routine forms of HIV testing under which people are tested unless they opt out 
lead to a greater chance of negative consequences including human rights abuses, particularly 
against women, than forms of HIV testing under which testing is routinely offered and 
recommended, but people have to opt in to testing? 
• Would such forms of HIV testing “normalize” HIV and reduce HIV-related stigma to a 
greater extent than forms of HIV testing under which people are offered the test, but tested 
only if they opt in, or than massively increased investment in VCT and anti-stigma 
campaigns? 
• Would such forms of testing result in greater uptake of ART, or might they result in lesser 
uptake than forms of HIV testing under which people are offered the test, but tested only if 
they opt in, given that they have the potential to deter people who are anxious about knowing 
their HIV status from seeking health care? 
• Under what conditions are such forms of testing likely to deter patients seeking care 
(including antenatal care)? 
• Would such forms of testing increase the number of people who are tested for HIV 
significantly more than routine offer of testing, and would this extra margin be prepared to 
know their HIV status, disclose it to their partner(s) and engage in positive behavior change? 
• To what extent is the ability to scale up treatment currently being restricted by a “testing gap” 
rather than by other factors?  
• Do more routine forms of testing lose some of the preventive value of testing and counseling, 
and would this be offset by the greater number of people who may take up testing (and find 
out their status)?   
• What is the impact of rapid point-of-care testing on counseling and the consent process? 
• Do the jurisdictions that have adopted such routine forms of testing have universal or even 
good access to treatment, condoms and other prevention measures? (Csete & Elliott, 2006; 
Schietinger, 2006; Alcorn, 2006).  
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The WHO/UNAIDS guidance document recognizes that “monitoring and evaluation should form 
an essential and ongoing part” of programs to implement PITC (WHO/UNAIDS, 2007, at 47). 
The document recommends that routine monitoring be complemented with focused evaluations 
on specific aspects of implementation and encourages health facilities “to partner with non-
governmental organizations and civil society groups in monitoring and evaluating provider-
initiated testing and counselling to ensure service quality and acceptability, including the 
maintenance of high ethical standards and human rights norms”. More detailed guidance on 
monitoring and evaluation of HIV testing and counseling, including PITC, is being developed by 
WHO and will be available later in 2007.  
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Voluntary counseling and testing services 
 
Key points 
• A large body of research demonstrates the effectiveness of VCT as part of comprehensive 
prevention, treatment and care strategies. 
• Scaling up access to VCT is particularly important because large numbers of people do not use 
formal health services and may need other ways to gain access to HIV testing and counseling, 
especially if they live in rural areas poorly served by the health care system, are mobile, or belong 
to vulnerable communities.  Vulnerable groups may be further deterred from seeking formal 
health care if opt-out PITC is perceived as a form of forced testing. 
• The WHO/UNAIDS guidance recognizes these concerns and makes several recommendations 
aimed at addressing them. WHO/UNAIDS should provide more detailed guidance about the 
training and supervision health care providers need in these settings, specifically around 
vulnerable groups’ “right to decline” testing. 
• Efforts to scale up HIV testing and counseling for most-at-risk populations should continue to 
focus on strategies to increase access to and uptake of HIV testing and counseling through 
innovative VCT services. 
 
Current efforts to scale up access to HIV testing and counseling focus on new models of 
providing counseling and testing and devote little attention to how client-initiated VCT services 
can be improved and scaled-up. 
 
WHO and UNAIDS continue to promote and “strongly support” the continued scale up of VCT 
(WHO/UNAIDS, 2006c; WHO/UNAIDS, 2007) and point to existing guidance on VCT 
(WHO/UNAIDS, 2007, at 18, with reference to WHO Regional Office for South-East Asia, 
2004; WHO Regional Office for Africa, 2005). Nevertheless, the clear focus of current efforts to 
increase access to HIV testing is on PITC, and some of those consulted in the process of writing 
this paper expressed the concern that VCT might not receive enough support and funding if 
resource-poor countries and funders continue shifting their emphasis to PITC. According to 
them, this would be of particular concern in countries where access to voluntary HIV testing and 
counseling remains limited, the epidemic is concentrated among marginalized populations, and 
few of those most at risk have access to or use health services. For a number of reasons, scaling 
up access to HIV testing and counseling should not only “not exclude” scaling up VCT, but has 
to include a greater emphasis on also scaling up VCT. 
 
 
The experience with VCT 
 
There is a large body of research, including case studies, 16 that demonstrates the effectiveness of 
VCT as part of comprehensive prevention, treatment and care strategies (Voluntary HIV-1 
Counseling and Testing Efficacy Study Group, 2002; UNAIDS, 2001; WHO & UNAIDS, 2001). 
In particular, VCT has been shown to be effective in increasing understanding of risks, providing 
                                                          
16 See, e.g., the VCT “success stories” at 
http://www.usaid.gov/our_work/global_health/aids/TechAreas/voluntarycounsel/vct_success.html. 
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a supportive environment in which to learn one’s HIV status, encourage acceptance of and 
coping with HIV (TASO Uganda, 1995), facilitating behavioral change for prevention 
(particularly among serodiscordant heterosexual couples and those testing HIV-positive), and 
increasing access to support. When it has been widely implemented in a context of community 
mobilization, it has also helped to open up the epidemic; decrease stigma and discrimination; 
increase opportunities for counseling for couples; and involve greater numbers in the response 
(UNAIDS, 2002). Because it has been confidential and has been non-threatening with regard to 
testing, VCT has tended to attract those who might otherwise shy away from HIV intervention. 
From a public health perspective, VCT has therefore served to connect many people to paths 
related to prevention and care (WHO, 2003, at 9). VCT has been identified as one of the most 
cost-effective HIV/AIDS interventions in Africa (Creese et al., 2002), including in reducing 
sexual transmission of HIV (Sweat et al., 2000). 
 
There have been many challenges in implementing VCT, and many VCT services are far from 
being perfect. Testing often occurs with little counseling and informed consent (see, e.g., 
Kawichai S et al., 2006). However, these do not add up to the “failure” of VCT. Critics of VCT 
often fail to acknowledge that in many settings VCT has not been adequately funded or 
promoted. An international survey of VCT in 11 cities in West, East and South Africa and 
Thailand undertaken in 1997 found that of 8 cities with more than 2 million inhabitants each, 
four had only one VCT center available for the entire population (Cartoux et al., 1998). In South 
Africa, one of the countries hit hardest by the HIV/AIDS epidemic, it took until 2000 before the 
government made VCT a priority and effective implementation was initially impeded by a 
number of factors at the level of policies, infrastructure and provisions (Swanepoel, 2006). As 
Csete and Elliott (2006, with reference to Attaran and Sachs) have pointed out, 
 
[o]ver the decade from 1988 to 1998, when sub-Saharan Africa should have been building HIV counselling 
and testing capacity, official development assistance for all HIV/AIDS programs, including testing, was 
scandalously low and actually declined on a per-HIV-positive-person basis. In this period, with so little hope 
of offering effective treatment for HIV/AIDS, it is unsurprising that many countries tended to invest in 
general education programs or promotion of condom use rather than pushing people to be tested. 
 
As WHO and UNAIDS have pointed out, uptake of VCT “has been hampered by many of the 
same factors that limit uptake of other HIV-related services, including stigma and discrimination, 
limited access to treatment, care and health services in general, as well as gender issues” 
(WHO/UNAIDS, 2007, at 14). Other factors affecting uptake of HIV testing via VCT services 
include: 
 
• In many countries, VCT is available only in urban centres. 
• VCT is often under-resourced, and counselors may be overworked and unable to spend 
sufficient time with those being tested. 
• The availability of VCT is often not well publicized; in some countries, many people learn 
about VCT only after they have already been informed of their HIV-positive status. 
• There has been a focus on creating discrete “VCT services” rather than VCT capacities 
integrated into prevention and care practice. (Canadian HIV/AIDS Legal Network, Center for 
Health and Gender Equity, Gay Men’s Health Crisis, 2006) 
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Some have suggested that the VCT model has not been given a fair chance, and pointed out that 
the VCT approach itself was not the major factor in low HIV testing uptake: 
 
The problem was in its poor implementation and the fact that treatment options were few and inadequately 
applied. The prevention and management of opportunistic infections through the use of simple and cheap 
drugs, even before the advent of ARV therapy, had been shown to impact significantly on the duration and 
quality of life of people living with HIV. Yet, no developing country established such schemes on a national 
scale, and successful projects remained few and with limited outreach. (Tarantola, 2005) 
 
It has been only since 2002, the year in which the debate about routinization of HIV testing 
picked up speed (De Cock, Mbori-Ngacha, Marum, 2002), that greater flows of HIV/AIDS 
assistance through mechanisms such as the GFATM have opened the possibility for large-scale 
building of counseling capacity as well as expansion of treatment access. As Csete and Elliott 
(2006) have stated, the growing hope of access to ART 
 
should be seen as highlighting the need for urgent scale-up of counselling capacity to ensure that HIV testing 
has the preventive value and the strong link to treatment and care that it should have.  Scale-up of testing is 
urgently needed and, with appropriate investment, that scale-up could minimize HIV-related abuse and 
encourage confidence in the health system that is needed for long-term treatment and care. 
 
 
 
The need for supporting, promoting, and scaling up VCT 
 
Therefore, rather than giving up on them, VCT services that are responsive and sensitive to the 
communities served need to be adequately supported by resources and promoted and scaled up. 
As Tarantola (2005) has pointed out, “to enhance this capacity is neither easy nor inexpensive, 
but doing so has been shown to be highly cost-effective with potential long-term public health 
benefits” (Voluntary HIV-1 Counseling and Testing Efficacy Study Group, 2000; Holtgrave, 
Reiser, Di Franceisco, 1997; Kamb et al., 1998). Research studies undertaken in many countries 
and settings, summarized below, suggest ways in which uptake and acceptability of VCT can be 
increased. At a minimum, the delivery of VCT needs to be better coordinated with other health 
services and integrated in services for most-at-risk populations. Better links are required between 
VCT and health services such as those provided for STIs and other sexual and reproductive 
health, and for directly-observed therapy for TB.  Consideration should be given to one-stop 
sexual health services – this would help to reduce stigma or at least minimize the degree to 
which HIV-related stigma may impede access to HIV testing and health services if these are 
delivered through separate, identifiable sites – and to mobile VCT services. VCT should also be 
included in harm reduction services and low-threshold services for other most-at-risk 
populations. Finally, serious investigations should continue to be undertaken to streamline VCT 
in order to make it less resource-intensive and time-intensive, while preserving its benefits. As 
stated by Alcorn, in some settings “there simply aren’t enough counsellors to scale up to do 
traditional VCT” and “HIV programmes may have no choice but to abandon lengthy pre-test 
counselling” (Alcorn, 2006). However, it may be possible to ensure confidentiality, consent and 
counseling in alternative, streamlined models of VCT, rather than only seeing these components 
as barriers (Canadian HIV/AIDS Legal Network, Center of Health and Gender Equity, Gay 
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Men’s Health Crisis, 2006), which is how they have too often been dismissed (e.g., DeCock et al, 
2002). 
 
 
Maximizing the prevention potential and meeting the needs of 
vulnerable communities 
 
Scaling up access to VCT is particularly important because – although PITC in medical facilities 
will clearly play a large role in identifying people who are likely to need treatment soon (due to 
the fact that medical facilities mainly see sick people), large numbers of people do not use formal 
health services and may need other ways to gain access to HIV testing, especially if they live in 
rural areas poorly served by the health care system, are mobile workers such as truck drivers, or 
belong to vulnerable communities. 
 
If governments want to maximize the usefulness of testing as an HIV prevention strategy, 
waiting for people to show up in clinical settings is going to have relatively limited impact. 
More than 40 percent of people with newly acquired HIV infection transmit it to their 
partners within approximately five months (Wawer et al., 2005). This means that it will be 
important to find ways to encourage those who rarely visit health facilities – young, sexually 
active people, particularly men – to be tested, and to make testing and counseling easily 
accessible to them, for example by providing mobile VCT units at places wherever sex, 
alcohol, or cigarettes are sold and served, but also in work settings (Akuno et al., 2006).  
 
For many of those who need testing the most – underserved and socially marginalized 
communities – PITC is also unlikely to work precisely because they rarely use the health system. 
For sex workers, people who use drugs, or gay men, for example, health systems can be 
notoriously forbidding places. These populations require other sources of HIV testing that are not 
provider-initiated and are offered in a peer-driven and non-judgmental manner. Concerted efforts 
should be undertaken to developing human-rights based policies reflecting the needs of these 
populations and to implementing and promoting safe, voluntary, and accessible HIV testing and 
counseling options for them. A more promising route than PITC might be to reach them with 
mobile clinics (see, e.g., Liang et al., 2005) or “where they are” (see, e.g., Tsu et al., 2002) by 
empowering community-based organizations to provide HIV tests to their peers—in widows’ 
groups and youth clubs, brothels, bathhouses (Spielberg et al., 2003) and gay bars. For people 
who use drugs, VCT may be offered at needle and syringe programs, drop-in centres, or through 
outreach programs, which may require changes to laws and policies in order to allow such 
practice. For prisoners, it should mean having access to VCT at any time during incarceration, 
and not being pressured to submit to “voluntary,” routine, or even compulsory testing upon 
incarceration, recognizing that this is a particularly stressful time, that some prisoners may go 
through withdrawal from drugs on which they are dependent, and that prisoners should have 
access to testing at the time they choose.    
 
As mentioned above, WHO and UNAIDS do recognize that “strategies are needed to increase 
access to and uptake of HIV testing and counselling” for most at-risk populations, “particularly 
through innovative client-initiated approaches such as services delivered through mobile clinics, 
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in other community settings, through harm reduction programmes or through other types of 
outreach” (WHO/UNAIDS, 2007, at 24-25).  However, they also recommend that “consideration 
… be given to recommending HIV testing and counselling to all patients who attend [specific 
health services, such as acute care, STI or drug dependence treatment services] if this is 
epidemiologically appropriate and socially acceptable” (ibid).  
 
There is a concern that implementation of PITC in specific health services for most-at-risk 
populations may lead certain people to avoid seeking care, and that these settings are less 
appropriate venues for HIV testing than peer-based settings such as needle and syringe programs 
and drop-in centers.  In many countries people belonging to these populations have been 
routinely subject to abuse in health care settings and may not feel that they have the power to 
decline a recommendation to be tested, because they may feel that they would suffer negative 
consequences if they did. For example, stigma and discrimination against people who use 
injecting drugs has been documented in health care services as well as in communities. In a study 
in Ireland of the experiences of hospitalized people with HIV, those who used drugs perceived 
more stigma and judgment from nurses than other people with HIV. Respondents reported that 
nurses blamed them for their illness and made disparaging remarks when they requested pain 
medication (Schietinger, 2006, with reference to Surlis, 2001). In Ukraine, where injecting drug 
use is a major factor in the spread of HIV, people who use drugs report that they frequently face 
police violence and abusive treatment in the health care system (HRW, 2006). Persons who use 
drugs report avoiding drug treatment and other services because official registration 
requirements can lead to being exposed to the police, losing employment, and being mistreated 
in hospitals; these reports are confirmed by the observations of service-providers. More often, 
drug treatment is simply forced. Men who have sex with men also continue to experience stigma 
and discrimination because of their sexual orientation, particularly in jurisdictions in which 
homosexuality is illegal, which creates a significant barrier to testing and counseling. Similar 
issues arise for other most-at-risk populations. 
 
The WHO/UNAIDS guidance recognizes these concerns, acknowledging that “[p]opulations 
most at-risk of HIV transmission may be more susceptible to coercion, discrimination, violence, 
abandonment, incarceration or other negative consequences upon disclosure of an HIV-positive 
test result” (WHO/UNAIDS, 2007, at 25). The guidance recommends that: 
 
• plans for PITC in health services for most-at-risk populations “should prioritize the 
implementation of a supportive social, policy and legal framework” 
• health care providers receive special training and supervision to uphold standards of 
informed consent and confidentiality for these populations 
• “additional discussion” take place of the right to decline HIV testing, of the risks and benefits 
of HIV testing and disclosure, and about social support needs  
• “mechanisms are in place for referral to prevention, care and support services provided by 
community-based organizations and civil society groups” (ibid, with reference to WHO, 
2005c; WHO, 2005d; WHO/UNAIDS, 2004). 
 
The WHO/UNAIDS guidance concludes that “an ‘opt-in’ approach to informed consent may 
merit consideration for highly vulnerable populations” and suggests that “[i]nvolving most-at-
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risk populations and their advocates in the development of HIV testing and counselling protocols 
and in the monitoring and evaluation of provider-initiated HIV testing and counselling 
programmes will help to ensure that the most appropriate and acceptable practices are followed” 
(ibid). 
 
These are good recommendations, but concerns remain that, unless special efforts are made to 
ensure they will be implemented, in practice members of most-at-risk populations will continue 
avoiding health services or experiencing abusive treatment. WHO/UNAIDS should provide more 
detailed guidance about the training and supervision of health care providers in these settings, as 
well as about what exactly the “additional discussion” of the right to decline HIV testing should 
entail. Pilot projects incorporating these elements should be undertaken and evaluated.
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HIV testing policies cannot be considered in isolation 
 
Key points 
 
• HIV testing is never a goal in itself, but clearly linked to larger prevention and care, treatment and 
support goals. Because the efficacy of testing policies and programs depends on the availability of 
effective prevention and care, treatment and support programs, all of these efforts must be 
coordinated and integrated. 
• Increasing testing and counseling must go hand in hand with much greater investment in real 
protection from HIV-related discrimination and abuse, particularly for women, children and 
adolescents, sex workers, men who have sex with men, people who use drugs, and prisoners. 
• Efforts to cost, budget, and implement national programs that would secure legal and human rights 
protections for people living with, affected by, or vulnerable to HIV and AIDS need to become a 
priority. 
 
 
 
Lessons from Botswana 
 
When Botswana adopted its routine testing policy, it was because enrolment in its HIV treatment 
program was slow, which was thought to be due in part to underutilization of HIV testing (de 
Korte, Mazonde, Darkoh, 2004; Center for Strategic and International Studies, 2004). An 
October 2006 editorial in the New York Times said that the “simple change in the rules for AIDS 
testing” in 2004 allowed HIV testing rates and, ultimately, the countries’ program of provision of 
ART to “soar” (Editorial, 2006), suggesting that it was only through “routinizing” HIV testing 
within its health system and testing everyone unless they “opt out” that Botswana was able to 
achieve an increased uptake of testing and ART. Botswana has since been hailed as the global 
model for PITC. 
 
In fact, Botswana’s turn-around coincided with a massive investment in ART in the country.  
When other African nations were slow to respond to HIV/AIDS, Botswana was devoting 
substantial national resources to HIV and securing international funding to increase access to 
ART.  In addition to changing its HIV testing policy, the government launched a massive 
community-based communications program to encourage people to be tested, both in hospitals 
and in VCT centres. Botswana now has 16 testing centres (called Tebelopele), operating 15 
satellite clinics, and 80 percent of the country’s population live within 50 km of a testing centre. 
In 2003 the national HIV program began using mobile testing caravans to offer testing in more 
remote areas, and by December 2004 had carried out 176, 805 tests. Mobile testing caravans 
were particularly effective at reaching people who had never tested before; over 90 percent of 
those who took a test at a mobile caravan were doing so for the first time, and they accounted for 
14 percent of all HIV tests carried out in Botswana in 2005 (Alcorn, 2006). The country’s 
president, Festus Mogae, publicly speculated he might be HIV-positive and had his own blood 
drawn for an HIV test, breaking much of the stigma and silence that deters people from testing. 
All of this activity occurred in a country that enjoys the highest GNP per capita in sub-Saharan 
Africa, a record of democratic governance, and a health infrastructure in which 75 percent of the 
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population (including 95 percent of women receiving antenatal care) have regular access to 
health care (Nieburg, Cannell & Morrison, 2005). A “simple change in the rules” on HIV testing 
does not capture this complexity. According to Alcorn, 
 
The success of Botswana’s efforts to promote universal testing has been ascribed to strong political 
leadership and a strong social marketing campaign which explained the benefits of testing - and the process - 
to the population. Batswana have been encouraged to ‘take a loved one for testing’, but it’s important to 
remember that this campaign is occurring in the context of the most comprehensive roll out of treatment 
anywhere in Africa (Alcorn, 2006). 
 
Indeed, the population-based study undertaken in Botswana indicates that knowledge that 
treatment was available was a key factor in encouraging testing for two-thirds of those tested, as 
was confidentiality of the test results, especially for men, and the national media advertising 
campaign – 69 percent of respondents said they were convinced by advertising messages of the 
need to test (Weiser et al., 2006). 
 
In addition to showing that more needs to be done to increase testing uptake than “simply 
changing the rules for testing,” Botswana’s experience also highlights some areas of concern, as 
has been highlighted by the population-based study. As mentioned above, 68 percent of 
participants who were tested for HIV in Botswana responded that they believed they could not 
refuse their HIV test, and 43 percent believed that the HIV testing policy would lead people to 
avoid going to the doctor for fear of testing (Weiser et al., 2006). Parts of the Botswana 
legislative framework “raise questions as to whether there exists an enabling and protective 
environment for those living with the virus. For example, … laws protecting women from 
domestic violence and marital rape have not been passed yet” (Stegling, 2006). 
 
The population-based study concluded that, 
 
Whenever HIV testing policies are implemented, human rights must be protected by ensuring that 
patients have all the information necessary to make an informed and free decision about being tested, by 
providing protection for women against violence related to HIV status, and by ensuring total 
confidentiality. (Weiser et al., 2006, editor’s summary) 
 
 
 
Time to act on other priorities 
 
More broadly, it is important to recognize that, for the last 20 years, important barriers to HIV 
testing have included stigma, lack of access to VCT, and a belief held by health-care providers 
and patients alike that it was better “not to know” because of the lack of treatment and pervasive 
discrimination. Contrary to what some have claimed, it was not the entrenching of the right to 
informed consent that caused low HIV testing uptake, but the poor implementation of VCT, and 
the fact that treatment options were limited and stigma and discrimination rampant. While in 
recent years progress has been made on these fronts, a move towards increasing access to HIV 
testing that is genuinely grounded in human rights and promotes public health demands that 
these issues now be addressed tangibly and urgently. 
 
HIV testing is never a goal in itself, but clearly motivated by prevention and care, treatment and 
support goals. Consequently, the efficacy of testing policies and programs is, in turn, also co-
determined by the availability of effective prevention and care, treatment and support programs. 
A lack of coordination and integration between testing programs and ART access and access to 
evidence-based prevention programs would be to treat the individuals tested “merely as a 
means,” a violation of the ethical principle of respect for persons, and would threaten “to 
sabotage the desired convergence between human rights aspirations and public health goals” 
(Rennie & Behets, 2006).  
 
Even as world leaders have committed to the goal of universal access to comprehensive 
prevention programs, treatment, care and support by 2010, and even as vastly increased financial 
resources have become available, those most vulnerable to HIV and its impact continue to 
receive the least access to HIV prevention, care and treatment services: 
 
• In many countries, young people are those who have the highest rate of infection and yet 
most do not receive access to sufficient HIV information, education and sexual education, 
nor do they have independent access to HIV testing and counseling or to treatment. 
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I fear that some of the calls for routine testing see diagnosis without access to 
care or other services, as an end in and of itself – it’s public health on the 
cheap. Some people are saying: let’s get everyone tested, we’ll worry about the 
rest later. … Let’s make testing easier, simpler, more routine, but let’s not put 
“the rest” on the back burner, let’s keep more women from being raped or 
beaten now, more kids from turning to … heroin … 
Gregg Gonsalves, email to HIV testing policy discussion group, 24 July 2006 
• Children living with HIV are not receiving treatment nor has there been development or 
distribution of 
paediatric 
formulations. Most 
orphans do not 
receive the care and 
support they need, 
and are often 
victims of sexual abuse, discrimination and property-grabbing by relatives. 
• Women continue to provide most of the care for the ill and for the children left behind.  
Their work is not counted, valued or remunerated. 
• People who use drugs represent the smallest fraction of individuals receiving anti-
retroviral treatment in many countries, despite accounting for a majority of people living 
with HIV. 
• Sex workers often cannot access to HIV services due to punitive approaches to sex work 
and prostitution, including sexual violence and discrimination practiced against sex 
workers. 
• Men who have sex with men face widespread violence and discrimination around the 
world, and often cannot access HIV services for fear of arrest, discrimination or violence. 
• Prisoners in many countries have little or no access to voluntary HIV testing and to 
treatment, and are often denied access to HIV prevention. 
 
Increasing testing and counseling capacity must therefore go hand in hand with increasing 
capacity for treatment (including ART), care, and prevention, and with much greater investment 
in real protection – in practice, and not just on paper – from HIV-related discrimination and 
abuse, particularly for women, children and adolescents, sex workers, men who have sex with 
men, people who use drugs and prisoners. Even proponents of more routine approaches to HIV 
testing accept that stigma and discrimination against people living with HIV, and human rights 
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abuses against particularly vulnerable groups that are compounded by HIV-related stigma, 
remain serious challenges. Simply increasing the number of people tested will not be effective in 
combating the wide range of forms and instances of HIV-related discrimination and abuse. 
Women, in particular, continue to report negative outcomes following disclosure of their HIV 
status. Well funded measures for protection of HIV-positive women and girls from abuse are 
needed. These include short term measures such as emergency help-lines, safe shelters for 
battered women, and training of police and social service providers on AIDS-related violence 
against women, and longer-term efforts such as ensuring effective prosecution of perpetrators of 
sexual violence, reform of legislation to criminalize marital rape, and school-based awareness 
programs for girls and boys (Csete, Schleifer, Cohen, 2004). 
 
The need for some of these measures is acknowledged in the WHO/UNAIDS guidance on PITC 
in health facilities, which says that “at the same time as provider-initiated testing is implemented, 
equal efforts must be made to ensure that a supportive social, policy and legal framework is in 
place to maximize positive outcomes and minimize potential harms to patients” 
(WHO/UNAIDS, 2007, at 9). The guidance adds that “optimal delivery of provider-initiated HIV 
testing and counselling in the long term requires that laws and policies against discrimination on 
the basis of HIV status, risk behaviour and gender are in place, monitored and enforced” (id). 
 
While the guidance says that these measures “may not be prerequisites for the implementation of 
provider-initiated testing”, it adds that “they should be addressed as part of national plans to 
scale up HIV testing and counselling and to achieve universal access to HIV prevention, 
treatment, care and support” (ibid, at 34). The fact that WHO and UNAIDS recognize that 
expansion of testing will require adequate resources to address these issues should be welcomed.  
In the past, the need for such measures has often been acknowledged on paper in national and 
international plans or statements, but real action and leadership to address them has continued to 
be missing. International financial institutions and bilateral donors must make vastly increased 
commitments in these areas. 
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Appendix 2: 
Studies on Uptake of HIV Testing and Counseling  
 
 
As mentioned above (see the chapter on “Can relaxation or elimination of counseling and informed 
consent requirements be justified?), a fairly large number of studies have been undertaken, mainly in 
African countries, to compare HIV testing uptake under different testing strategies and to assess what 
other factors impact on uptake of HIV testing. The results of these studies have been summarized as 
follows: 
 
Direct offer of HIV testing in a convenient location usually leads to high uptake in both health-care settings 
and community settings. Acceptance of provider-initiated testing can exceed 90% for antenatal clinic 
attendees and patients presenting with opportunistic infections, but with rates of return of only 45%–75% 
when a repeat visit is required. However, only a minority of African adults will make unsolicited visits to 
free-standing or clinic-based VCT centres. Major disincentives include fear of being seen, fear of breach of 
confidentiality, inability to cope or adverse life events if found to be positive, and a sense of futility if testing 
is not linked to HIV care. Accessibility and cost are also important. Making counselling and receipt of results 
available through home visits increased uptake of community-based VCT from 10%–12% to 37%–87% in 
four different African studies. Thus, the consistent finding is that relatively minor differences in accessibility 
translate into major differences in acceptability of [testing and counseling] in Africa. (Corbett et al., 2006, 
with many references) 
 
This appendix provides more information about some of the most relevant studies undertaken. 
 
African Countries 
 
Multi-country Studies 
 
Testing of Pregnant Women 
In the first such study, Cartoux et al. (1998) evaluated acceptability of VCT by pregnant women in the 
context of clinical trials assessing interventions to reduce mother-to-child transmission (MCT) of HIV in 
developing countries. 13 studies located in West, East and South Africa, and in Thailand were included in 
a cross-sectional mailing survey about the acceptability of VCT in antenatal clinics. Acceptance rate, 
return rate, overall acceptability of VCT (acceptance of both pre- and post-VCT sessions) were obtained 
using a standardized questionnaire. Seven of the 13 VCT study centers offered group counseling before 
testing. The mean duration of the individual pretest and post-test counseling sessions was 15 and 26 min, 
respectively. The acceptance rates of VCT at pretest session amongst the women who were offered VCT 
were high, with the exception of Malawi (median, 92 percent; range, 53 to 99.7 percent). Return rates 
varied widely between sites (median, 82 percent; range, 33 to 100 percent). A return rate of 100 percent 
was obtained in one site in Zambia where rapid test algorithms were used and HIV results were provided 
on the same day, before the women left the antenatal clinic. In 9 out of 13 sites, the return rates of women 
diagnosed as HIV-positive were below those of women found to be HIV negative. According to the 
authors, this suggests that HIV-positive women perceive themselves at risk of HIV infection and do not 
want to know their test result. The overall acceptability of VCT varied widely between sites. The median 
overall acceptability of VCT was 69 percent, ranging from 33 to 95 percent. Overall acceptability of VCT 
most frequently depended on return rates because acceptance rates of the test itself were generally high. 
Overall acceptability rates did not vary with HIV prevalence, basic training of counselors, specific 
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interventions and duration or techniques of pre-test counseling. The authors pointed out that their findings 
reflect the experience in research projects with optimal logistics and human resources, where VCT and 
intervention are offered free of charge. However, none of the interventions assessed in the trials was 
proven effective at the time of the study and in programs that included a placebo group, women could not 
be guaranteed to benefit from the intervention. Acceptability of VCT and interventions therefore are 
likely to differ when interventions are implemented in a public health program with a real cost and known 
benefits. In sites where a particular effort in implementing VCT programs had been made, overall 
acceptability of HIV testing of pregnant women was high. 
 
Botswana 
Testing of Pregnant Women 
Rakgoasi (2005) examined the extent to which women accessing antenatal-care services in Botswana 
were offered HIV-related information and counseling and an opportunity to take an HIV test as part of the 
PMTCT program, and how these women responded. Data were drawn from the Botswana AIDS Impact 
Survey 2001, a nationally-representative sample survey. The survey interviewed over 4,494 of 4,728 
eligible women on various issues relating to HIV/AIDS at both household and individual levels. Over half 
(57.9 percent) of the women were offered HIV/AIDS-related information, counseling, or testing. Age, 
education, and residence were important predictors of being offered HIV counseling or testing. Younger 
and more-educated women and those residing in towns were more likely to be offered both HIV 
counseling and testing than older, less-educated, and rural women. 79 percent of the women who were 
offered HIV testing agreed to undergo the test regardless of their background characteristics. However, 
the number of pregnant women who underwent HIV testing during antenatal care accounted for only a 
fifth (21 percent) of all antenatal-care attendees in 2001. Lack of capacity to deliver VCT services to all 
pregnant women attending antenatal care was seen as one of the biggest challenges to increased use of 
VCT services. 
 
A study of antenatal clinics in Francistown showed that in the first three months of routine opt-out testing, 
90.5 percent of women were tested for HIV, compared with 75.3 percent during the final four months of 
opt-in testing (Seipone et al., 2004). However, many of the women who were tested failed to return for 
their results – 29.4 percent during the opt-in period and 33 percent during the first three months of routine 
testing (a statistically insignificant difference: Seipone et al., 2004). 
 
Burkina Faso 
Testing of Pregnant Women 
Pignatelli  et al. (2006) identified factors predicting uptake of VCT in pregnant women. All pregnant 
women receiving ante-natal group health education at St Camille Medical Center in Ouagadougou from 1 
May 2002 to 30 April 2004 were offered VCT. If they consented, the women were pre-test counseled, 
tested by two rapid tests giving immediate results and post-test counseled. Less than one-fifth of pregnant 
women [1,216/6,639 (18.3%, CI 17.4-19.3%)] accepted VCT. The HIV prevalence rate was 10.6 percent. 
While the two-step approach of group education followed by VCT yielded a low uptake rate, the drop-out 
rate after enrolling in the program was nearly zero. The authors concluded that effective scaling-up of 
VCT requires a mass sensibilization campaign pointing out the program’s benefits and addressing the 
stigma of HIV. 
 
Cameroon 
Testing of Pregnant Women 
Welty et al. (2005) reported about a PMTCT program implemented as part of the routine antenatal care at 
the Cameroon Baptist Convention Health Board. Nurses, midwives, nurse aides, and trained birth 
attendants counseled pregnant women, obtained risk factor data, and offered free HIV testing with same-
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day results. From February 2000 through December 2004, this program rapidly expanded to 115 facilities 
in 6 of Cameroon’s 10 provinces, not only to large hospitals but to remote health centers staffed by 
trained birth attendants. 690 health workers were trained in PMTCT and counseled 68,635 women, 91.9 
percent of whom accepted HIV testing. Of 63,094 women tested, 8.7 percent were HIV-1-positive, and 
98.7 percent of positive and negative mothers received post-test counseling. Of 5550 HIV-positive 
mothers, 5433 (97.9 percent) were counseled on single-dose NVP prophylaxis. 
 
Ghana 
Testing of Pregnant Women 
Baiden et al. (2005) report the results of a cross-sectional questionnaire survey undertaken in the Kassena-
Nankana district of Ghana to assess the perception and attitude of 270 antenatal clinic attendants towards 
VCT. Although 92.6 percent of respondents indicated a willingness to get tested, only 51 percent 
considered HIV testing for pregnant women to be useful. Most (93.6 percent) indicated they would like 
their husbands (partners) to know the result of the test and 52.2 percent indicated that their husbands 
would be willing to accompany them to antenatal clinic (ANC) at least once during the pregnancy. The 
perception of the usefulness of HIV testing, the willingness to disclose test result to the husband and 
perceived willingness of husband to accompany wife to antenatal clinic were found to be independent 
predictors of a woman’s willingness to get tested. The willingness to disclose test result to husband and 
knowledge of at least one mode of MTCT transmission were found to be independent predictors of a 
woman’s perception that getting tested was useful. According to the authors, the results suggest that for 
pregnant women, the willingness to get tested for HIV does not equate with the perception of the test’s 
usefulness, and that spouses are likely to exert strong influence on the attitude of pregnant women 
towards VCT. The authors suggested that couple counseling facilitated through couple-friendly ANC 
services be explored as a strategy for the intended VCT program in this district. 
 
Ivory Coast 
Testing of Pregnant Women 
A PMTCT program in Ivory Coast included group counseling before HIV testing, conducted by trained 
social workers, followed by private sessions with social workers during which individual women accepted 
or refused HIV testing, and HIV testing; counseling two weeks after the test by trained social workers or 
program doctors; and, for women whose test results were positive, monthly follow up visits with a 
program midwife before starting free prophylaxis at 36 weeks’ gestation; and zidovudine before and 
during labor. During the program’s first 15 months of operations, from February 1998 to the end of May 
1999, HIV testing was offered to 9657 women, of which 6982 (72 percent) accepted the test. Of the 884 
women who tested positive, 395 (45 percent) received their test results. Only 118 women eventually 
started taking zidovudine. Of those who did not, 84 percent refused to return or discontinued follow up 
visits, and 16 percent were lost to follow up or removed from the program for a variety of reasons. At the 
request of the program, Painter et al. (2004) set out to find out so many women who receive HIV-positive 
test results and are offered short course antiretroviral prophylaxis to prevent MTCT do not participate in 
necessary follow up visits. They undertook a qualitative interview study with a purposive sample of 27 
women who had received HIV-positive test results and were invited to return for monthly follow up 
visits, but who had either refused or discontinued the visits. Most of the women explained their non-
participation in follow up visits by referring to negative experiences they had had while interacting with 
program staff or to their views about the program. Additional reasons concerned their disbelief of HIV 
positive test results and personal factors. The authors concluded that training and supervision of program 
staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating 
women’s participation in the PMTCT program; and that outreach and community mobilization should 
complement these measures and contribute to increased social support for women’s efforts to prevent 
MTCT. Painter et al. (2005) also examined the possible effects of women’s sociocultural and economic 
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circumstances at the MTCT prevention program. Participants (n = 30) completed follow-up visits and 
prophylaxis. Non-participants (n = 27) refused or discontinued follow-up visits and did not begin 
zidovudine. The authors found that fewer non-participants had been born in Cote d’Ivoire (67 percent vs. 
97 percent) or were Ivorian nationals (48 percent vs. 77 percent); they had lived in the country for less 
time (21 vs. 26 median years). They were less likely to be French-literate (37 percent vs. 77 percent), and 
more of them reported having had Koranic education only (18 percent vs. 0). They more often reported 
miscarriages, stillbirths, or infant deaths (69 percent vs. 33 percent), and had partners with low-ranked 
jobs (63 percent vs. 30 percent). This suggested that the non-participants were more marginal 
socioculturally and economically in Ivorian society than participants. According to the authors, greater 
attention to mitigating the effects of broader structural factors on women’s participation in interventions 
may increase the effectiveness of MTCT prevention in Africa. 
 
Brou et al. (2005) followed for 12 months 400 women who had tested HIV negative during pregnancy. 
They found that for about 60 percent of women, the HIV test allowed them to reinforce communication 
with their partner on issues related to STDs and AIDS. For about 20 percent, the HIV test was the 
occasion to start a dialogue on these issues. On the whole, communication between spouses on these 
questions became more frequent after the HIV test in all socio-demographic classes. Ninety percent of 
women asked their husband (or regular sexual partner) to use condoms in case they had sexual intercourse 
with other women. They used different strategies to tackle this difficult subject with their husband. Ninety 
seven percent of the women notified their partner they had been tested for HIV. This notification was easy 
because they were HIV negative. Then 94 percent of women asked their partner he should also be tested. 
However, only about 25 percent of the partners eventually took an HIV test. Many of them were afraid 
and did not want to know their HIV status. Others thought they did not need to be tested since their wife 
was tested and was HIV negative. One third of the couples used condoms at the resumption of sexual 
activity after childbirth. When the woman was instructed, condoms were more frequently used. Generally, 
women used the contraceptive role of the condom to convince their partner to use it. The ability of HIV 
negative women to adopt prevention practices in order to avoid a possible HIV infection from their 
husband (or regular partner) depended strongly on the quality of the conjugal relationship. Behavioral 
changes were easier when both partners were instructed or when the woman was financially independent.  
 
Kenya 
TB clinics 
For example, until recently, TB clinics did not routinely offer HIV testing or even refer TB patients to 
HIV services. Efforts to improve the HIV diagnosis rate in TB patients began in Nyanza province, the 
region with the highest HIV prevalence (around 15 percent). The programme began with a pilot at 
Nyanza General Hospital in 2004. Patients were offered an opt-out HIV test with a same day result, and 
pre-test counseling emphasised the importance of diagnosing HIV infection for the patient’s medical care 
at the TB clinic. Sixty-eight percent received counseling, of whom 83 percent chose to undergo HIV-
testing. Of those who tested, 81 percent were HIV-positive. Following the pilot at Nyanza General 
Hospital, province-wide scale-up began in 2005. From 935 TB patients tested in the first quarter of 2005, 
the province scaled up to test 2273 in the fourth quarter. All patients who test HIV-positive receive 
cotrimoxazole through the TB clinic and are referred for HIV care. The program also encourages TB 
patients to refer their partners for HIV testing, and includes HIV prevention counseling as well as condom 
provision. According to the researchers evaluating the program, the biggest difficulty facing it is the lack 
of access to ART for patients who test HIV-positive. Only 15 percent of those eligible for ART actually 
get it at present (Alcorn, 2006, with reference to Onyango et al., 2006).  
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Cost of VCT 
Forsythe et al. (2002) performed an economic evaluation of VCT services in two rural health centres and 
an urban health centre in Nairobi. A contingent valuation study was also performed among VCT clients. 
The study found that integrating services into existing health centres can significantly reduce the cost of 
VCT. Furthermore, it appears that some level of cost recovery from VCT clients is feasible and can 
contribute to sustainability, although it is very unlikely that the full cost of the service could be recovered 
from the clients. The national provision of VCT in all Kenyan health centres is likely to be an affordable 
option. 
 
Testing of Pregnant Women 
Kiarie et al. (2000) conducted an early study to evaluate HIV-1 testing acceptability and return for test 
results in two Nairobi city council antenatal clinics. Pregnant women attending the clinics received pre-
test counseling and were offered HIV-1 testing at the time of routine syphilis and haemoglobin level 
testing. Only two of 399 women offered HIV-1 testing declined testing (an acceptance rate of 99.8 
percent) and 379 said HIV testing should be offered to all antenatal mothers. Fifty (12.6 percent) of the 
397 women tested were HIV-positive. However, only 69 percent of the women returned to collect their 
results. Women who did not return to collect their results were more likely to be HIV-positive (44 percent 
did not collect their results) and to have had a previous pregnancy. The authors felt that not returning to 
collect their test results was perhaps a more culturally acceptable way for the women to decline the offer 
of testing, and suggested that “allowing women to choose to obtain results may be an important way to 
maintain their autonomy.” They pointed out that at the time of the study (1994) there were no effective 
options to prevent perinatal transmission of HIV, and that testing may be more acceptable today. 
 
A more recent study examined whether HIV testing using a rapid assay increases the proportion of 
pregnant women obtaining results and the uptake of perinatal HIV interventions (Malonza et al., 2003). 
Pregnant women attending public health clinics in Nairobi were offered VCT. Consenting women were 
randomly assigned to receive either rapid or conventional testing. Women randomly assigned to rapid 
testing were allowed to receive same-day results or to return later. The results for women randomly 
assigned to conventional testing were available after 7 days. HIV-positive women were referred for 
antiretroviral prophylaxis to prevent mother-to-child transmission of HIV. Of 1282 women offered VCT, 
1249 (97 percent) accepted testing, of whom 627 were randomly assigned to rapid testing and 622 to 
conventional testing. The percentage receiving results was significantly higher among women who 
received rapid testing (96 percent) compared with conventional testing (73 percent). However, of 161 
HIV-1-seropositive women, only 24 took up antiretroviral prophylaxis. Surprisingly, significantly fewer 
HIV-positive women who received rapid testing accepted referral for perinatal HIV interventions than 
women who received conventional testing. The authors suggested that women  
 
may have been unable to cope with the HIV/AIDS information on the same day as receiving their HIV-1 test 
results. With rapid HIV-1 testing, there may be limited time for women to comprehend the implications of a 
positive diagnosis and to decide on what action to take. In contrast, conventional testing provides ample time 
for women to decide on their readiness to receive HIV-1 results, and those who choose to get their results are 
prepared to accept the diagnosis, the implications of a positive test, and referral for perinatal HIV-1 
interventions. 
 
They concluded that “thorough post-test counselling for HIV-1-infected pregnant women who receive 
same-day results is important for such women to understand their role in the prevention of infant HIV-1” 
and that “the overall uptake of perinatal HIV-1 interventions may be improved if women of reproductive 
age are educated about the prevention of mother-to-child transmission of HIV-1 before they become 
pregnant.” 
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Another study also documented high uptake of testing, but low uptake of perinatal HIV interventions 
(Temmerman et al., 2003). At the antenatal clinic of the Coast Provincial General Hospital (CPGH) in 
Mombasa, health information is provided, followed by pre-test HIV voluntary counseling and testing. Out 
of 3564 first-visit pregnant women receiving health education, 2516 were counseled (71 percent) and 
2483 were tested (97 percent); 348 were HIV positive (14 percent), and 106 women took nevirapine in 
labor. 
 
Farquhar et al. (2004) set out to determine effect of partner involvement and couple counseling on uptake 
of interventions to prevent HIV transmission. Women attending a Nairobi antenatal clinic were 
encouraged to return with partners for VCT and offered individual or couple posttest counseling. 
Nevirapine was provided to HIV-positive women and condoms distributed to all participants. Among 
2104 women accepting testing, 308 (15%) had partners participate in VCT, of whom 116 (38%) were 
couple counseled. Thirty-two (10%) of 314 HIV-positive women came with partners for VCT; these 
women were 3-fold more likely to return for nevirapine (P = 0.02) and to report administering nevirapine 
at delivery (P = 0.009). Nevirapine use was reported by 88% of HIV-infected women who were couple 
counseled, 67 percent of those whose partners came but were not couple counseled, and 45 percent of 
those whose partners did not present for VCT. HIV-positive women receiving couple counseling were 5-
fold more likely to avoid breast-feeding (P = 0.03) compared with those counseled individually. Partner 
notification of positive results was reported by 138 women (64%) and was associated with 4-fold greater 
likelihood of condom use (P = 0.004). The authors concluded that antenatal couple counseling may be a 
useful strategy to promote HIV-1 prevention interventions. 
 
Van’t Hoog et al. (2005) implemented a pilot project to evaluate approaches to increase program uptake 
at health facility level at New Nyanza Provincial General Hospital, a public hospital in western Kenya, an 
area with high HIV prevalence. Counseling, HIV testing, and dispensing of single-dose nevirapine were 
integrated into routine antenatal services rather than being presented as an optional service to which 
pregnant women could “opt in”. The proportion of clients who learned their HIV status increased from 55 
percent to 68 percent. According to the authors, this improvement was “primarily the result of more 
comprehensive pretest counseling, from 77% when the pretest counseling was conducted in a separate 
part of the hospital to 92% when integrated into the examination”. There was also a small improvement in 
the acceptance rate of HIV testing among those who received pretest counseling, from 80 to 83 percent. 
‘‘Not ready’’ or ‘‘undecided’’ were the most common reasons for declining the test, given by 65 percent 
of the women who refused. The wish to consult the husband first or to return with the husband was 
expressed by 11 percent. Fear, either of the result or of the husband’s reaction, was also commonly 
mentioned (20 percent). Less than 1 percent of partners came for partner or couples counseling, in both 
periods. Nevirapine uptake increased from 57 to 70 percent. The authors concluded that integration of 
PMCT into routine antenatal services is possible and that the way PMCT is implemented in the antenatal 
clinics can make a difference in uptake of counseling and testing. To improve program impact, they 
recommended “better patient flow to minimize inconvenience; routine HIV testing in ANC using rapid 
tests; repeated education concerning nevirapine administration; routine testing for women of unknown 
status in labor, or of their infants postnatally; expansion of PMCT Plus to improve follow-up and involve 
partners and families; and expansion of treatment efforts to provide HAART as a more efficacious 
regimen for women with low immunity”. 
 
Fenelly & Charles (2006) reported that in Kijabe hospital, a 205-bed facility located in a rural area north 
of Nairobi, 1177 of 1395 (85 percent) women newly registered for antenatal care in 2003 accepted VCT.  
 
Finally, Delva et al. (2006) appraised the quality and quantity of antenatal HIV counseling by observing 
and assessing 14 group educational sessions, 66 pre-test counseling sessions and 50 post-test counseling 
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sessions. They concluded that, in general, “the frequency and duration of the counseling was low. Crucial 
topics such as window period and partner involvement and follow-up support were covered haphazardly”. 
They suggested that “ample pre- and post-test counselling including follow-up should be pursued for 
optimal effectiveness of PMTCT” and proposed a number of health system interventions preceded and 
guided by ongoing audit.  
 
Malawi 
Testing of TB Patients 
Zachariah et al. (2003) undertook a study in new patients registered with TB in a rural district of Malawi 
in order to verify the acceptability of VCT. Patients diagnosed with TB between January and December 
2000 were offered VCT and were subsequently interviewed. Of 1,049 new TB patients enrolled in the 
study, 1,007 (96 percent) were pre-test counseled, 955 (91 percent) underwent HIV testing and 912 (87 
percent) were post-test counseled; 43 (4 percent) patients refused HIV testing. The overall HIV infection 
rate was 77 percent. The authors concluded that offering VCT to TB patients has a high acceptance rate 
and provides an opportunity to strengthen and integrate TB and HIV programs. 
 
Testing of Pregnant Women 
In Malawi, in the 9 months between April and December 2005, 14,495 (98.3 percent) women at prenatal 
clinics were counseled and 14,491 (98.3 percent) were tested after the government adopted new 
guidelines which advocate for an opt-out strategy in antenatal clinics – compared to 15, 343 women who 
came to clinics in the 9 months between July 2004 and March 2005, of whom 11,689 (76.2 percent) were 
counseled and 11,674 (76.1 percent) were tested. Under the new guidelines, women receive group pre-test 
counseling and are then tested for HIV unless they specifically request to not be tested. Post-test 
counseling is provided on an individual and confidential basis (Zimba et al., 2006). According to 
newspaper reports, however, some women are shunning the hospital “fearing that they will be forced to 
undergo an HIV test” (Kumwenda, 2006). 
 
Manzi et al. (2005) documented the uptake of VCT and follow-up interventions in a prevention of 
mother-to-child HIV transmission program at a hospital in rural Malawi, to determine: the acceptability of 
offering “opt-out” VCT; the progressive loss to follow up of HIV-positive mothers during the antenatal 
period, at delivery and to the 6-month postnatal visit; and the proportion of missed deliveries in the 
district. Of 3136 antenatal mothers, 2996 (96 percent) were pre-test counseled, 2965 (95 percent) 
underwent HIV-testing, all of whom were post-test counseled. Only 31 (1 percent) refused HIV-testing. 
646 (22 percent) were HIV-positive, and were included in the PMTCT program. 288 (45 percent) mothers 
and 222 (34 percent) babies received nevirapine. The cumulative loss to follow up was 358 (55 percent) 
by the 36-week antenatal visit, 440 (68 percent) by delivery, 450 (70 percent) by the first postnatal visit 
and 524 (81 percent) by the 6-month postnatal visit. This left just 122 (19 percent) of the initial cohort 
still in the program. The authors concluded that the progressive loss to follow up of more than three-
quarters of this cohort by the 6-month postnatal visit demands a “different way of acting” if PMTCT is to 
be scaled up. 
 
Acceptance and Uptake of HIV Testing 
DeGraft-Johnson et al. (2005) examined variation in past and desired use of VCT services among 868 
women and 648 men in a rural Malawi district population. Only 11 percent of men and 7 percent of 
women had been tested, but of those untested, 76 percent of men and 61 percent of women said they 
desired testing. Ninety percent of respondents willing to know their results preferred to hear them from a 
test site counselor and on the same day of the test. Knowledge of the behaviors of HIV prevention, 
knowing someone with AIDS, knowing the locations of a test site, and perceived risk of HIV infection all 
had a consistently significant association with past and future VCT use for men and women. 
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Mozambique 
Testing of TB Patients 
A pilot TB/HIV integration program was set up in Beira, a city of 600,000 people in Mozambique. HIV 
testing and counseling was offered on an opt-out basis at six TB clinics. Over the first seven months 
(September 2005 to March 2006), of 1290 registered TB patients, 60 percent agreed to be tested, 20 
percent already knew their status, and 20 percent opted out. 71 percent of those who tested were HIV 
positive. This represented a dramatic increase in testing at the TB sites. Before the program, about 20 TB 
patients in Beira were tested each month, compared to an average of 184 per month since the opt-out 
program began (Alcorn, 2006, with reference to Montoya et al., 2006). 
 
Nigeria 
Testing of Pregnant Women 
Chama et al. (2004) reported that between July 2002 and June 2003, 262 pregnant women received VCT 
at the antenatal clinic of the University of Maiduguri Teaching Hospital, and 207 (79 percent) agreed to 
be tested. Thirty-one (11.8 percent) were HIV positive. The majority of the HIV-positive mothers 
received nevirapine in labor while 35 percent had combination ARV drugs in pregnancy. All the infants 
received nevirapine suspension within 72 hours of delivery. According to the authors, expensive and slow 
testing facilities, insufficient and inconsistent counselors, lack of ARV drugs for both mother and baby as 
well as unaffordable caesarean delivery were some of the constraints being faced at the clinic. 
 
A number of studies were carried out among pregnant women attending antenatal clinics in different parts 
of the country to determine their knowledge and acceptability of VCT in pregnancy as a strategy for the 
prevention of MTCT of HIV. The majority of the women had good knowledge of the modes of HIV 
transmission, however, knowledge of specific aspects of PMTCT was poor. In one of the studies (Ekanem 
& Gbadegesin, 2004), almost all the women (96.1 percent) said that they were willing to undergo HIV 
testing in pregnancy particularly if it would assist preventing transmission of HIV to their babies; but only 
few said they would undergo the test if the result would be shared with relatives. In another, 13 percent of 
the women “disapproved” of VCT because of fear of stigmatization, isolation, and marriage security 
(Iliyasu et al., 2005). All studies agreed that, as the country embarks on its PMTTCT program, there is a 
need to “scale up health education” (Igwegbe & Ilika, 2005) in order to increase the level of knowledge, 
acceptability and adoption of VCT and other PMTCT strategies among pregnant women. 
 
Rwanda 
Testing of TB Patients 
In Rwanda, in 2004, 45.5 percent of the registered TB patients were tested for HIV, and 46 percent were 
found to be positive. By the first quarter of 2006, 64 percent were tested, and 49 percent were HIV 
positive. Much of the increase in testing has been attributed to two sites, Gisenyi District Hospital and 
Health Center and Kicukiro Hospital, which served as models for the integration of HIV and TB services 
for the rest of the country. To coordinate the process at each site, they hired a TB/HIV focal point person 
and established multidisciplinary team meetings between the TB and HIV personnel. A simple TB 
screening questionnaire was piloted at the HIV clinic and the TB clinic began offering what they call 
“healthcare worker initiated HIV counselling and testing.” Between the 3rd and 4th quarter of 2005, and 
the 1st quarter of 2006, there were 206 newly registered TB patients at Gisenyi. Eighty-six (42 percent) 
were aware of their status at the start of TB treatment (76 percent were HIV positive). Of the 120 who did 
not know their status, 106 (88 percent) consented to HIV testing, and 34 (32 percent) were HIV positive. 
Overall, the percentage of registered TB patients with known TB status rose from 61 percent in 2004 to 
92 percent during the pilot study period. Rwanda plans to roll out this model to the rest of the country 
(Alcorn, 2006, with reference to Gasana et al., 2006). 
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South Africa 
Acceptance and Uptake of Testing 
In an early article, Pronyk et al. (2002) described the introduction of VCT among five primary health care 
facilities in a rural South African setting. A baseline review of services demonstrated low levels of VCT, 
which were predominantly hospital-based. Twenty health workers in five primary health care facilities 
were trained to provide VCT using rapid-testing assays. One year after its introduction, a major increase 
in the quantity of HIV testing, the proportion of clients who receive their results, and the proportion who 
present voluntarily was observed. The majority of those presenting were women. The quality of VCT was 
rated very good in mock client encounters.  
 
Van Dyk & van Dyk (2003) set out to determine the needs, attitudes and beliefs of a sample of South 
Africans towards VCT, and to investigate possible barriers affecting participation in VCT programs in 
South Africa. A semi-structured questionnaire was used to survey the views of 1422 people. Results 
indicate that while subjects were not opposed to VCT in principle, 33% would go to clinics where nobody 
would know them. The following problems with VCT services were mentioned: Logistical problems (not 
enough counselors, long lines, lack of privacy); no trust in the health care system or fearing a breach of 
confidentiality; fear of rejection; and a lack of follow-up support after diagnosis. The authors made 
suggestions on how to improve VCT services in South Africa. 
 
Kalichman & Simbayi (2003) examined the relation between HIV testing history, attitudes towards 
testing, and AIDS stigmas. 224 men and 276 women living in a black township in Cape Town completed 
surveys. 47 percent had been tested for HIV. Compared to people who had been tested, individuals who 
were not tested for HIV demonstrated significantly greater AIDS related stigmas; ascribing greater shame, 
guilt, and social disapproval to people living with HIV. The authors concluded that efforts to promote 
VCT in South Africa require education about the benefits of testing and, perhaps more important, 
reductions in stigmatizing attitudes towards people living with HIV/AIDS; and suggested that structural 
and social marketing interventions that aim to reduce AIDS stigmas will probably decrease resistance to 
seeking VCT. 
 
Hutchison & Mahlalela (2006) used data from a population-based household survey and a government 
clinic survey in the Eastern Cape Province of South Africa to examine attitudes towards VCT services, 
patterns of utilization of VCT services and the relationships between HIV/AIDS-related stigma, VCT 
service availability and quality and use of VCT. The household survey data were linked with clinic-level 
data to assess the impact of expanded VCT services and access to rapid testing on the likelihood of being 
tested in rural areas and on HIV/AIDS stigma. The analysis found that while overall use of VCT services 
is low, utilization of VCT services is positively associated with age, education, socioeconomic status, 
proximity to clinics, availability of rapid testing and outreach services and lower levels of HIV/AIDS 
stigma. Importantly, the effects of stigma appeared considerably stronger for females, while men were 
more heavily influenced by the characteristics of the VCT services themselves. 
 
In a small qualitative study in a rural South African village, Mabunda (2006) found that participants knew 
of the availability of VCT services in the area, but did not utilize the services unless they had signs and 
symptoms suggesting possible HIV infection. 
 
Finally, Swanepoel (no date) suggests that the implementation of effective VCT programs in South Africa 
has been impeded by a number of factors at the level of policies, infrastructure and provisions. He points 
out that very little research has been forthcoming on the efficacy of the communication programs that are 
needed to support VCT services and suggests the following questions for urgent action research: 
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• Why are these VCT communication interventions not effective? 
• What can be done to optimize their efficacy in persuading those at risk for HIV to present themselves 
for VCT? 
He continues by saying that VCT communication interventions can fail for a variety of reasons: 
 
The limited impact of these interventions can be ascribed to, amongst others, the fact that their design was 
not supported by adequate, theory-driven empirical formative research on the contextual and personal 
determinants of the VCT uptake behaviour of their target audiences. To be effective, any intervention or 
interventions to increase the uptake of VCT would have to redress the problematic determinants (barriers) of 
VCT uptake behavior and support those that facilitate it. Decisions as to what these barrier and facilitating 
determinants are, how they relate to each other, and precisely how they are to be addressed in different kinds 
of interventions cannot be left solely to the intuition of intervention designers, but must be based on theory 
and theory-driven empirical research. 
 
The article provides such a theoretically and empirically motivated analysis of the contextual and personal 
determinants of VCT uptake behavior. According to the author, the analysis provided could “be 
considered a starting point for the formative research required for the design of effective VCT 
communication interventions”. 
 
Cost of Testing 
McConnell et al. (2005) set out to determine the cost per client completing VCT in an urban, church-
based, non-profit organization that offers rapid-test VCT services in KwaZulu-Natal, South Africa. 662 
clients completed VCT, at a cost of 101.58 dollars per client. Cost per client decreased over the year by 
66 percent because expenses remained stable as more clients were served. The authors concluded that the 
cost of providing VCT services in this study was higher than previously reported, but declined with 
expanding scale. 
 
Testing of Pregnant Women 
Coetzee et al. (2005) aimed to estimate the field efficacy of the first program for PMTCT initiated in 
South Africa, in the subdistrict of Khayelitsha. The program was initiated as a pilot at two midwife 
obstetric units in January 1999. Lay counselors conducted pre- and post-test counseling and nurses took 
blood. After 17 months protocol changes aimed at eliminating weaknesses included rapid HIV testing for 
both mothers and infants. An initial evaluation of the program showed that VCT was highly acceptable, 
with individual counseling more effective than group counseling (Abdullah et al., 2001). In 2003, the rate 
of acceptance for VCT attained 97 percent of the 7,314 women presenting for first antenatal visits. 
Coetzee et al. identified a consecutive sample of 658 mother-infant pairs for enrolment in their study. Of 
the 535 mother-infant pairs (81 percent) eventually included in the study, 410 (77 percent) received an 
effective PMTCT intervention according to the policy at the time. The rate of transmission of HIV from 
mother to child was 8.8 percent. According to the authors, the results of this study demonstrate the 
feasibility and effectiveness of a large-scale PMTCT program in an urban public-sector setting. 
 
Etiebet et al. (2004) interviewed 264 women attending prenatal care in clinics in Khayelitsha. All had 
been offered HIV testing, and 95 percent had accepted. Women who had not been tested were four times 
more likely to believe that in the community families reject HIV-positive women. Of women who tested, 
19 percent were HIV positive and 83 percent had told their partner that they had taken the test. HIV-
positive women who had not disclosed testing to their partners were three times more likely to believe 
that, in the community, partners are violent towards HIV-positive women. The study concluded that 
routinely offering prenatal HIV testing and interventions to reduce perinatal HIV transmission is 
acceptable to the majority of women in Khayelitsha, despite an awareness of discrimination in the 
community towards HIV-positive women. 
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Testing of Adolescents 
MacPhail et al. (2006) undertook group discussions among adolescents aged 12 to 24 years and their 
parents in two townships in Gauteng. The research represents the first attempt to understand the 
perceptions and attitudes of young people and their parents to VCT. It found that few youth have accessed 
VCT and that there are many perceived barriers to accessing it. These barriers primarily concern how they 
will be treated at the testing facility and a fear of what will result from a positive diagnosis. The authors 
concluded that a youth-friendly and appropriate model of VCT is required to encourage young people to 
learn whether or not they are HIV-positive and suggest that such a model include four components, 
including a community mobilization component.  
 
Uptake of Workplace VCT 
Day et al. (2003) conducted a study to identify attitudes that influence uptake of VCT amongst gold mine 
workers in South Africa. 105 healthy men were interviewed. The level of basic knowledge of HIV was 
high, but reported awareness of the extent of HIV infection in the workforce and perceived personal risk 
of HIV infection was low. Health issues were considered the most important indication for HIV testing 
and one-third had been tested. Fear of testing positive for HIV and the potential consequences, 
particularly stigmatization, disease and death, were the major identified barriers to VCT. Half of the 
participants felt workplace education programs needed to be improved to promote VCT access. Twenty-
six per cent became more favorably inclined towards HIV testing in response to information on 
improvements that have been made to the confidentiality and convenience of the company’s VCT service. 
Only 14 percent then indicated that they would be more likely to access VCT if ART became available. 
The authors concluded that a vigorous community education program is essential if the introduction of 
ART is to be effective in promoting uptake of VCT. 
 
Tanzania 
Acceptance and Uptake of Testing 
In an early pilot study, Killewo et al. (1998) assessed the acceptability of VCT in a rural village in 
Kagera. Village residents were prepared by their leaders and subsequently invited to health education 
group meetings to volunteer for the test. Of the 245 adults responding to the invitation, 137 (55.9 percent) 
subsequently volunteered for the HIV test and to receive the results, indicating a moderate level of 
acceptability.  
 
A study by Kakoko et al. (2006) determined the prevalence and factors associated with testing for HIV 
among Tanzanian teachers. It collected data through a cross-section questionnaire survey among 918 
primary school teachers in Mwanza region. About 20 percent of the participants had voluntarily tested for 
HIV. Teachers who were younger, had easy access to HIV testing services, had a partner with tertiary 
education, and perceived their health status positively were significantly more likely to have tested for 
HIV. Teachers who had tested for HIV were significantly less likely: to perceive that it is not necessary to 
test for HIV in absence of vaccine or cure for HIV/AIDS; to support that only people who suspect that 
they are HIV infected should test for HIV; and to believe that HIV infected people are likely to die 
quicker if they are tested for HIV and be informed about their positive results. The authors concluded that 
there is a need to promote positive views of voluntary testing for HIV among Tanzanian teachers.  
 
Testing of Pregnant Women 
Westheimer et al. (2004) assessed correlates of acceptance of HIV testing in the antenatal setting in and 
around Dar-es-Salaam. From August 13, 2001 to November 27, 2002, 14,235 pregnant women attending 
antenatal clinics were offered testing for HIV infection. Pre-test counseling consisted of a one-on-one 
conversation with a trained nurse. It included brief discussion of the modes of transmission of HIV; 
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options for proceeding if the test were positive or negative; and discussions of whether and how to inform 
one’s partner of the result. Participants were asked if they would like to have their blood tested for HIV. If 
they agreed, they were then asked to sign a written consent form. At the post-test counseling session, 
HIV-positive women were given the option of enrolling in a study of antibiotic treatment to prevent 
chorioamnionitis-related perinatal transmission of HIV. No ART was available at that time in Tanzania. 
Of the women offered testing, 10,991 (77.2 percent) accepted, and 11.4 percent were found to be HIV 
positive. Approximately 80 percent of the women screened returned for their results. 
 
According to the authors, the study confirms that while demographic characteristics may play some role 
in determining acceptance of HIV screening, counseling is by far the more important factor. One of the 
strongest predictors of testing acceptance was site of recruitment. The authors concluded that the most 
effective methods of increasing testing acceptance need to focus on the sites and counselors themselves: 
 
Ensuring adequate and frequent training of counselors can increase both the acceptance of testing and the 
return for results. In addition, ensuring that the clinics are as comfortable and as inviting as possible, with 
limited waiting time, should encourage women not only to accept testing for HIV but also to seek medical 
care earlier. Finally, any discussion of HIV in developing countries would not be complete without 
mentioning the need to address the enormous stigma and threat to women’s well-being associated with HIV 
infection in these settings. 
 
Msuya et al. (2006) aimed to determine the predictors of failure to return for HIV posttest results among 
pregnant women (N = 2654) receiving antenatal care at primary health clinics in Moshi urban district. 
Consenting pregnant women, who were in the third trimester of pregnancy, received individual pre-test 
counseling, followed by interview and screening for HIV. Post-test counseling and results were given 
after 1 week. A total of 182 (7 percent) failed to return for their HIV test results. Women were less likely 
to return for test results if their partners did not come for testing (adjusted odds ratio [AOR], 12.6; 95% 
CI, 3.1-51.4), if their partners consumed alcohol (AOR, 1.8; 95% CI, 1.3-2.7), and if they had never 
discussed reproductive health matters with their partners (AOR, 1.7; 95% CI, 1.1-2.7). Additionally, the 
site of recruitment, age, alcohol consumption, and advanced gestation age predicted failure to return for 
HIV test results. The authors recommended promotion of antenatal couple counseling and strengthening 
of community awareness of the availability of perinatal interventions, with special efforts targeting men. 
In addition, they suggested that the predictors for failure to collect test-results be addressed during pre-test 
counseling. 
 
Cost-effectiveness of free VCT 
Thielman et al. (2006) evaluated the cost-effectiveness of fee-based and free testing strategies at a VCT 
program integrated into a community-based AIDS service organization in Moshi. The researchers waived 
the usual fee schedule during a 2-week free, advertised VCT campaign; analyzed the number of clients 
testing per day during pre-free, free, and post-free testing periods; and estimated the cost-effectiveness of 
limited and sustained free testing strategies. The number of clients testing per day increased from 4.1 
during the pre-free testing interval to 15 during the free testing campaign and remained significantly 
increased at 7.1 after resumption of the standard fees. HIV seroprevalence (16.7 percent) and risk 
behaviors were unchanged over these intervals. Modeled over 1 year, the costs per infection averted with 
the standard fee schedule, with a 2-week free VCT campaign, and with sustained free VCT year-round 
were $170, $105, and $92, respectively, and the costs per disability-adjusted life year gained were $8.72, 
$5.40, and $4.72, respectively. The study concluded that the provision of free VCT enhances both the 
number of clients testing per day and its cost-effectiveness in resource-limited settings. 
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Uganda 
Acceptance and Uptake of Testing 
The AIDS Information Center (AIC) was established in Kampala, Uganda in 1990 in response to 
increasing interest in VCT. By 1996, over 300,000 clients had been seen. Approximately 25 percent of 
clients failed to learn their HIV status as a result of failure to return or late arrival of results. To address 
these issues, AIC carried out a pilot project using rapid HIV assays over a period of 5 working days. 325 
clients were seen, all of whom left AIC knowing their HIV status and having spent less than two hours at 
the Center. According to the authors, the results demonstrate that “same-day” results can be provided in 
counseling and testing settings without compromising the quality of counseling or the accuracy of HIV 
testing (Downing et al., 1998). 
 
Nuwaha et al. (2002) examined the factors influencing uptake of VCT in Bushenyi district with a view of 
suggesting measures for increased uptake. Focus group discussions were used to elicit reasons for 
carrying out VCT and a cross sectional survey to estimate the proportion of people who undertake VCT. 
17 percent of 219 people interviewed had ever undergone HIV. The factors influencing VCT for HIV 
were consequences of a test result, influences from a sexual partner, cost of VCT, physical accessibility of 
VCT, awareness, risk of HIV infection, need for linking VCT with care (especially availability of 
antiretrovirals) and perceived quality of care of VCT services. The authors concluded that increased 
mobilisation and access for VCT, reducing costs of VCT, linking of VCT with care, and emphasising the 
positive consequences of VCT as well as providing high quality VCT services may increase the number 
of people seeking VCT. 
 
A number of studies analyzed the experience of the Community HIV Epidemiological Research study in 
the rural Rakai district. Study participants were visited once every 10 months. VCT was one of the service 
components of the Project, and was offered free of charge to all those who provided blood and requested 
their HIV test results. The Project also offered condom promotion and supplies, community HIV /AIDS 
education, and treatment for opportunistic infections. Project counselors visited those who requested their 
HIV results in their homes. Motovu et al. (2002) showed that in 1999/2000, 90 percent of those who 
participated in the ongoing epidemiological research study requested their HIV results, and 64.6 percent 
of those who requested them ultimately received them. The proportion of people receiving HIV results 
almost doubled between 1994 and 2000 from about 35% in 1994 /1995 to 65% in 1999 /2000. These data 
indicate high proportions of acceptance and receipt of VCT in this rural population-based cohort, 
suggesting that home delivery of VCT could offer a unique opportunity for people in the rural areas to 
access counseling and testing services, given adequate resources. Nyblade et al. (2003) found that during 
the initial phase of the population-based free VTC program, certain high-risk groups were 
underrepresented among VTC recipients and concluded that there is a need to target VTC to ensure 
participation by high-risk individuals most in need of services. In a more recent study, Matovu et al. 
(2005) found no effect of VCT acceptance on subsequent risk behaviors or on HIV incidence in HIV-
negative persons. The authors concluded that their findings in this community-based VCT program in 
rural Uganda “suggest selective uptake of services by persons who are less likely to be HIV infected, high 
rates of retesting among HIV-negative persons which may be associated with a false sense of security, 
and a lack of impact of VCT on risk reduction and HIV incidence among initially HIV-uninfected 
individuals”. 
 
Another intervention offering counseling and HIV results at home, followed by a qualitative evaluation 
exploring nature of demand and barriers to knowing HIV status, found that offering HIV results at home 
significantly increased uptake of results. Previous male advantage in uptake of test results was effectively 
eliminated. Focus group discussions and in-depth interviews highlighted substantial non-monetary costs of 
getting HIV results from high-visibility public facilities. Inconvenience, fear of stigmatization, and 
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emotional vulnerability of receiving results from public facilities were the most common explanations for 
the relative popularity of home-based VCT. It was however seen as less appropriate for youth and couples 
with conflicting attitudes toward testing. The authors suggested that integrating VCT into other services, 
locating testing centres in less visible surroundings, or directly confronting stigma surrounding testing 
may be less expensive ways to reproduce increased uptake with home VCT (Wolff et al., 2005).  
 
Testing of Pregnant Women 
Giuliano et al. (2006) evaluated the five-year performance of a program at St Francis Hospital Nsambya 
in Kampala. The program included VCT for pregnant women and administration of antiretroviral 
prophylaxis in the peripartum period for HIV positive women.  Overall 24 133 women received 
counseling, 76 percent (18 384) agreed to be tested, and 2011 (10.9 percent) were HIV positive; 1341 
(66.7 percent of the HIV positive women) were enrolled in the program and received antiretroviral drugs. 
Acceptance of the test increased from 72.7 percent in 2000-2 to 79.9 percent in 2003-4, when a drug 
access program became available in the hospital. 
 
Homsy et al. (2006) evaluated the uptake of routine intrapartum testing and counseling in the maternity 
ward of a 200-bed hospital in rural Uganda and compared it with the uptake of “opt-out” testing and 
counseling in the antenatal clinic. They found that routine counseling and testing using an opt-out strategy 
was well received and achieved high coverage: 97 percent of 3,696 women and 97 percent of 107 male 
partners counseled in the antenatal clinic accepted testing. 20 percent of the men tested HIV positive, 16 
of whom shared their result with their wife. Fourteen couples (13.5 percent) had discordant HIV test 
results. In the maternity ward, 86 percent of women and 98 percent of men counseled accepted testing. 88 
percent of all women presenting with undocumented HIV status were discharged knowing their HIV 
status after implementing the opt-out routine intrapartum rapid HIV counseling and testing strategy, as 
compared with 39 percent during the 7-month period preceding the introduction of intrapartum 
counseling and testing. The authors concluded that PMTCT programs should promote routine opt-out 
counseling and testing for HIV in both antenatal clinics and maternity wards. 
 
Finally, Andia et al. (2006) looked at the effects of introducing routine testing at their clinic on the 
clinical profile of HIV-positive patients in their care. They found that over the course of a year, routine 
testing shifted the profile strongly towards asymptomatic patients who needed less intensive clinical 
management when they started treatment. Although the clinic had more patients under care as a result of 
routine testing, these patients were likely to have a better chance of success when they began treatment. 
One of the advantages for patients noted was the fact that routine testing was free; previously patients had 
had to pay for a test, which was a significant disincentive to testing (Alcorn, 2006, with reference to 
Andia et al., 2006). 
 
Zambia 
Acceptance and Uptake of Testing 
Fylkesnes & Siziya (2004) examined factors affecting readiness for and acceptability of VCT. 
Participants in a population-based HIV survey conducted in an urban population in Zambia in 1996 were 
offered VCT. Although 29% of them expressed interest in being tested (readiness), only 4% of this group 
used the services (i.e. acceptability). When the survey was repeated 3 years later, VCT was designed 
differently to assess acceptability. The participants were randomly allocated to VCT either at the local 
clinic (similar to 1996, n = 1102) or at an optional location (n = 1343). The acceptability was 11.8% 
among the group allocated to VCT at the local clinic compared with 55.8% for the group allocated to an 
optional location. The authors concluded that “a strong effect of placement on acceptability of VCT was 
demonstrated, indicating this barrier to be important in explaining low demands for VCT in the past. 
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Differences in perceptions of how confidentiality is handled at the two locations might be an important 
underlying factor.” 
 
Testing of Pregnant Women 
Stringer et al. (2003) undertook a first study to evaluate a NVP-based perinatal HIV prevention program 
initiated in Lusaka in November 2001. The first 12 months cost US$221 000 and enabled 178 district 
health employees to be trained in VCT. 17 263 pregnant women were counseled for HIV, 12 438 (72%) 
were tested, and 2924 (24%) were found to be infected with HIV. NVP has been taken by 1654 (57%) 
mothers and 1157 (40%) babies. It is estimated that at least 190 infants have been spared HIV infection 
(11 per 1000 counseled women or 65 per 1000 identified HIV-infected women). The authors concluded 
that “prevention of mother-to-child HIV transmission is feasible and cost effective in resource-limited 
settings”, but noted that “patient attrition and non-adherence represented a major source of program 
inefficiency, which requires to be systematically addressed”. 
 
A more recent study by Stringer et al. (2005) determined the population effectiveness of the city-wide 
perinatal HIV prevention program in Lusaka. Of 8787 women in the surveillance population, 7204 (82%) 
had been offered antenatal HIV testing, of which 5149 (71%) had accepted, and of which 5129 (99%) had 
received a result. Using anonymous surveillance of newborn cord blood for HIV serology and nevirapine 
(NVP), the study found that only 675 of 2257 (30%) seropositive mother-infant pairs in the surveillance 
population received both a maternal and infant dose of NVP. It concluded that “successful perinatal HIV 
prevention requires each mother-infant pair to negotiate a cascade of events that begins with offering HIV 
testing and continues through adherence to the prescribed regimen. This novel surveillance demonstrates 
that failures occur at each step, resulting in reduced coverage and diminished program effectiveness.” 
 
Semrau et al. (2005) examined whether whether women counseled antenatally as part of a couple were 
more likely to accept HIV testing and nevirapine in a pMTCT program, and whether they would be less 
likely to experience later adverse social events than women counseled alone. A pMTCT program that 
included active community education and outreach to encourage couple counseling and testing was 
implemented in two antenatal clinics in Lusaka, Zambia. A subset of HIV-positive women was asked to 
report their experience of adverse social events six months after delivery. Couple-counseled women were 
compared with individual-counseled women stratified by whether or not they had disclosed their HIV 
status to their partners. Nine percent (868) of 9409 women counseled antenatally were counseled with 
their husband. Couple-counseled women were more likely to accept HIV testing (96%) than women 
counseled alone (79%); however uptake of nevirapine was not improved. Six months after delivery, 28% 
of 324 HIV-positive women reported at least one adverse social event (including physical violence, verbal 
abuse, divorce or separation). There were no significant differences in reported adverse social events 
between couple- and individual-counseled women. 
 
Zimbabwe 
Acceptance and Uptake of Testing 
Laver (2001) undertook a study among 204 adults, including 102 females, to describe rural adult 
preparedness to test for HIV. None of the participants had knowingly been tested for HIV prior to the 
study; 55.8 percent had heard about VCT and 21 percent had thought about testing. Of these, 34.8 percent 
(n=15) had already talked to somebody about testing. When compared with married respondents, 
significantly more singles expressed preparedness to test for HIV in the next six months. Only 14.2 
percent of respondents expressed willingness to pay for a test. Strongly articulated fears about testing 
included being seen by friends at a VCT centre, stigmatization, violence and stress. Women were more 
fearful than men about taking an HIV test. The author concluded that the study showed “some 
preparedness” among adults from rural communities to test for HIV. “While current strategies to promote 
 17
VCT in urban areas reflect sensitivity to many of the fears of adults expressed in this study, the initiative 
must be expanded to embrace rural communities. There is a need to build on positive perceptions about 
testing and embrace a strategy that disables fear, particularly among women. The initiative must go 
beyond the individual as the primary target and be promoted within the broader context of the community 
with the assistance of credible opinion leaders. It should also link closely with other services that offer 
primary prevention, pilot treatment and support activities.” 
 
Morin et al. (2006) provided free anonymous mobile VCT using 2 rapid HIV tests in 12 marketplaces in 
Epworth and Seke. Qualitative interviews were conducted to assess motivations for and barriers to testing. 
A subsample of HIV testers and individuals near testing vans who declined testing (nontesters) completed 
a questionnaire. A total of 1099 individuals participated in mobile VCT between March 2002 and August 
2003, and 29.2 percent tested HIV-positive. Overall, 98.8 percent of participants elected to receive HIV 
test results the same day. Reasons for not testing previously were often logistic (eg, inconvenience of 
hours [25.6%] and location [20.7%] or cost [8%]). Those who used the same-day mobile testing services 
(testers vs. nontesters) perceived themselves at higher risk for HIV infection but were less likely to have 
known people with HIV or where to get tested. The authors concluded that “same-day HIV testing in 
community settings seems to be acceptable in sub-Saharan Africa. Barriers to HIV testing are often 
logistic and can be overcome with community-based strategies. These strategies need to be refined to 
address the needs of those not using mobile testing services”. 
 
Uptake of Workplace VCT  
Corbett et al. (2006) identified businesses with occupational health clinics in Zimbabwe and divided them 
into two “intervention” groups. Employees at half the businesses were offered “on-site VCT”—pre-test 
counseling followed by same-day on-site rapid testing, results, and post-test counseling. Employees at the 
other businesses had the same pre-test counseling but were offered a voucher for an HIV test at an off-site 
testing center and a later appointment to discuss the results—so-called off-site VCT. Everyone had the 
same access to limited HIV care should they need it. Previous studies on VCT had indicated that the 
convenience of getting the test, whether the test is directly offered, and the attitude of staff supplying it 
are all very important. In this study, the researchers asked whether providing VCT in the workplace could 
improve the “uptake” of HIV testing in Africa. Half of the employees at the on-site VCT businesses took 
up the option of HIV testing, but only a fifth of employees at the off-site VCT businesses accepted 
vouchers for testing, and only one in five of these people actually used their voucher. On-site VCT 
resulted in about 12 times as many HIV tests as off-site VCT. The authors concluded that on-site VCT in 
the workplace might be one way to improve uptake of HIV testing in Africa from its current low level. 
Importantly, a relatively minor change in accessibility to testing can translate into a major difference in 
test uptake. This may hold true in non-occupational settings.  
 
Testing of Pregnant Women 
Perez et al. (2004) piloted the first program for prevention of mother to child transmission of HIV in rural 
Zimbabwe. VCT services were provided in the antenatal clinic of a 120-bed district hospital in Buhera 
district, and community mobilization was conducted. No services for prevention of mother to child 
transmission of HIV were available at baseline. Within 18 months, 2298 pregnant women had received 
pretest counseling, and the acceptance of HIV testing reached 93 percent. Of all 2137 women who had an 
HIV test, 1588 (74.3 percent) returned to collect their result; 326 of the 437 HIV positive women 
diagnosed had post-test counseling, and 104 (24 percent) mother-child pairs received nevirapine 
prophylaxis. 
 
Shetty et al. (2005) assessed the feasibility and acceptability of VCT by pregnant women using 
community volunteers. From July 1999 to June 2001, a perinatal HIV prevention program was 
undertaken in two antenatal clinics. Community volunteers, recruited from local community 
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organizations, underwent a two-week training course in VCT. Rapid HIV testing was performed after 
informed consent. Lay counselors conducted individual pre- and post-test counseling for HIV. A total of 
35 women community volunteers were trained in VCT; 34 graduated and committed to work four hours 
per week in the clinic. Of the 6051 pregnant women presenting for antenatal clinics (ANC), 1824 (30 
percent) underwent pre-test counseling, 1547 (26 percent) were tested, and 429 (28 percent) were HIV-
positive. Overall, 1283 (83 percent) returned for their test results including 406 (95 percent) of HIV-
positive women. Only 203 (50 percent) opted for ZDV prophylaxis to prevent MTCT of HIV. Over the 
two-year study period, two counselors died and three sought employment at other organizations. 
Adherence to duty roster was 97 percent and no breach of confidentiality was reported. The authors 
concluded that, despite many challenges, VCT delivered by community volunteers is feasible and 
acceptable for pregnant women aiming to reduce their risk of transmitting HIV to their infants. 
 
In another study, Perez et al. (2006) conducted an exploratory cross-sectional survey conducted in 6 
PMTCT sites in rural Zimbabwe. This was among the first attempts to evaluate the acceptability of a 
routine opt-out strategy for HIV testing during pregnancy among women using maternal and child health 
services in a developing country with high HIV prevalence. Women who had attended ANC in health 
centers where PMTCT was provided were surveyed in postnatal services. Of 520 women sampled, 285 
(55 percent) had been HIV tested during their last pregnancy. Women who had been tested were more 
likely to report having received group education and individual pretest counseling (81.4 percent) than 
untested women (22.1 percent). When untested women were asked why they did not receive group 
education, the main reasons were not having booked in time or not having group counseling available the 
same day as the day of booking. The three most important reasons quoted for not accepting to be tested 
were, in order of decreasing frequency: it was never mentioned to them; they needed to talk to their 
partner; and they were not prepared to go through pretest counseling. Among the 235 women not HIV 
tested in ANC, 79 percent said they would accept HIV testing if opt-out testing was introduced; 16 
percent said they would decline routine HIV testing, mainly because of their fear of knowing their HIV 
status and the need to have their partner’s consent. Among the women already tested in ANC (n = 285), 
97% would accept the opt-out approach. The authors concluded that the findings from their study “favor 
very much the adoption of the opt-out testing strategy”. However, they emphasized the importance of the 
quality of group pretest counseling and individual post-test counseling for HIV-negative and HIV-
positive women, and warned that “possible negative impacts in the implementation of this strategy should 
not be neglected”. They suggested that there will be a need to include “interventions to raise community 
awareness and to develop critical attitudes concerning domestic violence when introducing the opt-out 
strategy”; and to monitor the implementation of routine testing to assess “how it will influence the use of 
prenatal care. Will it deter women from seeking prenatal care? Will it result in fewer women returning for 
their test results?” 
 
 
Other Low- or Middle-Income Countries 
 
China 
Testing of Pregnant Women 
Hesketh et al. (2005) assessed knowledge and attitudes towards HIV and HIV testing among pregnant 
women and health professionals in Yunnan Province, to inform the introduction of VCT programs. The 
study design was a cross sectional survey using self completion questionnaires. It was carried out in 12 
hospitals in four high prevalence areas of Yunnan Province. Questionnaires were completed under 
examination conditions by health professionals, and at the routine antenatal examination by pregnant 
women. Completed questionnaires were obtained from 840 pregnant women and 780 health professionals. 
Knowledge of HIV and its modes of transmission were good in health professionals but patchy in 
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pregnant women. The weakest area in both groups was knowledge of maternal to child transmission. 
There was strong support for compulsory testing in pregnancy and at the premarital examination. But 
attitudes towards HIV/AIDS were negative: 23 percent of health professionals and 45 percent of pregnant 
women thought HIV was a disease of “low class and illegal” people, 48 percent of health professionals 
and 59 percent of pregnant women thought that HIV positive individuals should not be allowed to get 
married, and 30 percent of the health professionals were not willing to treat an HIV positive individual. 
Levels of knowledge were higher and attitudes more positive in younger health professionals and better 
educated pregnant women. The authors concluded that community education programs and intensive 
training of health workers must precede or accompany VCT programs and address negative attitudes 
towards people with HIV. 
 
India 
Cost of Testing 
Dandona et al. (2005) obtained detailed cost and output data for the 2002-03 fiscal year from written 
records and interviews in 17 VCT centers in the public health system in Andhra Pradesh. They found that 
32 413 clients received the complete sequence of services at the 17 VCT centers, including post-HIV test 
counseling. The number of clients served by each VCT center ranged from 334 to 7802 (median 979). 
The overall HIV-positive rate in post-test counseled clients was 20.5 percent (range 5.4 to 52.6 percent). 
The cost per client for the complete VCT sequence varied 6-fold between VCT centers (range US 2.92-
17.14 dollars, median US 7.51 dollars). The cost per client was significantly lower at VCT centers with 
more clients, due to substantial fixed costs. Personnel made up the largest component of cost (53.7 
percent). Fourteen VCT centers reported that they could serve more clients with the available personnel 
and infrastructure, and that inadequate demand for their services was the main hurdle towards achieving 
this. 
 
Testing of Pregnant Women 
Shankar et al. (2003) examined acceptability among pregnant women and their husbands of HIV testing 
within the antenatal clinic and delivery room of a government hospital in Pune from September 2000 to 
November 2001. Acceptance of HIV counseling and testing was high with 83 percent of eligible women 
in the antenatal clinic and 68 percent of eligible women in the delivery room getting tested on the same 
day. Structured interviews were conducted on 94 pregnant women in the antenatal clinic and 50 women in 
the delivery room, and 100 husbands who accompanied their wives in the antenatal clinic. The majority of 
women agreed to be tested independently, without the need for further consultation with family members, 
a view that was strongly supported by accompanying husbands. For delivering women who were not 
progressing in their labor, counseling in the delivery room allowed for individual attention to questions 
and concerns thereby making counseling in the delivery room feasible. 
 
Bharucha et al. (2005) found that 61 percent of the women admitted for normal delivery in a government 
hospital in Pune between April 2001 and March 2002 had been previously tested for HIV during their 
pregnancy. If previously seen in the hospital’s affiliated antenatal clinic, the likelihood of being 
previously tested was 89 percent, in contrast to 27 percent of women having prenatal care elsewhere. 
 
Nieburg, Cannell & Morrison (2005, at 13) reported that at one prenatal testing site it was found that at 
one site virtually all women agreed to be tested, but few stayed to receive their results – illustrating “how 
girls and women may feel intimidated or obliged to comply with the health care providers’ request to be 
tested, but at the same time perceive too many risks in actually learning their status and in acting upon 
that knowledge”. 
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Jamaica 
Testing of Pregnant Women 
Johnson et al., 2004 evaluated a PMTCT program in Kingston, Jamaica. Pregnant women presenting had 
HIV serology performed by ELISA or a rapid test after receiving group counseling. HIV-positive women 
were referred to high risk antenatal clinics and antiretroviral prophylaxis was given. In year one, 5,558 
(40 percent) of 14,054 women who started antenatal care received group counseling and 7,383 (53 
percent) received HIV testing. HIV prevalence was 2.1 percent (152/7 383). The authors reported “sub-
optimal identification of the HIV+ pregnant woman and administration of AZT chemoprophylaxis, along 
with issues of patient confidentiality and stigma” on the labor ward. They concluded that the program 
needed strengthening. 
 
Thailand 
Testing of Pregnant Women 
Kanshana & Simonds (2002) described the development, components, and initial uptake of Thailand’s 
national program for PMTCT. They reported that research, monitoring and evaluation of pilot projects, 
training, and policy-making provided the information, experience, infrastructure, and guidance to develop 
a PMTCT program that was implemented in all Ministry of Public Health hospitals in Thailand in 2000. 
A national system was established to monitor program implementation. Monitoring reports were received 
from 669 hospitals in 65 provinces for the period October 2000 through July 2001. During this period, 93 
percent of 318 721 women who gave birth were tested for HIV; 69 percent of 3958 HIV-positive women 
giving birth received zidovudine; and 86 percent and 80 percent of the 3865 children born to HIV-positive 
women received zidovudine and infant formula, respectively. The authors concluded that a national 
PMTCT program was successfully implemented in Thailand; that early monitoring indicates good 
program uptake; and that lessons learned from implementing this program include the importance of 
paying attention to counseling, communication, and training in the program, and using pilot projects and 
focused monitoring and evaluation data to guide the program development, expansion, and improvement. 
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